Annual Report 2011-12 Cover images Top- The OPAL research reactor building (p.29). © ANSTO Bottom row left- Elvis Shoko standing in front of ANSTO’s Linux cluster server essential for detailed computational research into the storage of hydrogen (p.25). © ANSTO Bottom row middle- ANSTO’s environmental studies look at many aspects of our planet’s environmental systems from the impact of humans on the environment to how we can mitigate and adapt to climate change (p.21-24). © iStockphoto Bottom row right- Karina Meredith working in ANSTO’s Isotope Ratio Mass Spectrometry Laboratory (p.21). © ANSTO ChAiRmAn’s leTTeR 17 September 2012 senator the hon Chris evans minister for Tertiary education, skills, science and Research Parliament house CAnBeRRA ACT 2601 Dear Minister In accordance with Section 9 of the Commonwealth Authorities and Companies Act 1997 (CAC Act), I am pleased to present the Annual Report of the Australian Nuclear Science and Technology Organisation (ANSTO) for the period 1 July 2011 to 30 June 2012. This report has been prepared in accordance with the requirements of the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and in accordance with section 9 of the Commonwealth Authorities and Companies Act 1997 (CAC Act). Under section 9 of the CAC Act, ANSTO Board members must prepare an annual report in accordance with schedule 1 of the CAC Act, and are responsible for the preparation and contents of the Annual Report and its Operations prepared in accordance with the Finance Ministers Orders. The report has been approved for presentation to you by a resolution of the ANSTO Board members on Friday 14 September 2012. Yours sincerely Dr Paul Greenfield AO Chairperson AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION New Illawarra Road, Lucas Heights (Locked Bag 2001, Kirrawee DC 2232) T +61 2 9717 3111 F +61 2 9717 9210 www.ansto.gov.au ANSTO ANNUAL REPORT 2011-12 PAGE i COntents Chairman’s letter i Contents ii About ANSTO 1 Members of the board 3 ANSTO executive team 5 Organisational chart 7 Chairman’s report 9 Chief executive officer’s report 11 2011-12 highlights 13 2011-12 report of activities (Report of research operations) 17 Financial statements 43 Governance and performance 85 Appendices 94 Appendix 1 Equality of employment opportunity 94 PAGE ii CONTENTS Appendix 2 Functions and powers of the organisation under the ANSTO Act 95 Appendix 3 Environmental Protection and Biodiversity Conservation Act 1999, (EPBC Act) section 516A 99 Appendix 4 Occupational Health and Safety (Commonwealth Employment) Act 1991, section 74 104 Appendix 5 Freedom of Information Act 1982, subsection 8(1) 108 Appendix 6 Index of compliance with reporting guidelines 110 Acronyms 111 Index 114 Contact details 121 Pictured: ANSTO’s OPAL reactor pool ANSTO ANNUAL REPORT 2011-12 PAGE iii AbOut AnstO For over 50 years, the Australian Nuclear Science and Technology Organisation (ANSTO) has proudly been the home to Australia’s nuclear expertise. Nuclear science and technology is a dynamic and exciting area of endeavour that focuses on the basic building blocks of matter at the atomic level. Many of the most important questions facing society today are within the domain of ANSTO’s expertise; whether in the area of health, climate change or driving innovation for industry. ANSTO’s state-of-the-art research facilities and our connection with other local and international research centres, means our scientists have the resources and networks to make a significant contribution today and in the future. Central to realising the capabilities of some of Australia’s significant science infrastructure are our people – ANSTO has over 1,100 dedicated scientists, engineers and support staff who strive daily to exploit the opportunities nuclear science and technology offers, for the benefit of all Australians. As a Federal Government agency, ANSTO provides advice to the Federal Government on all matters relating to nuclear science, technology and engineering. ANSTO supports Australia’s international roles and obligations, contributing to nuclear non-proliferation and participating in international decision making, keeping Australia at the forefront of nuclear science and technology. At the heart of ANSTO’s research capabilities is the OPAL reactor which is one of the world’s best multi-purpose research reactors. OPAL is used for scientific research, the production of medical radioisotopes, and the irradiation of silicon used in microelectronics in superfast trains and hybrid cars. OPAL facilitates specialised research using a growing suite of neutron beam instruments at ANSTO’s Bragg Institute where scientists apply neutron scattering and X-ray techniques to solve complex research and industrial problems such as developing renewable, clean energy technologies. ANSTO also operates two particle accelerators, STAR and ANTARES, which are used to analyse materials to determine their elemental composition and age, and are fundamental to advancing knowledge in areas as important as climate change. Development of the Federal Government funded Centre for Accelerator Science at ANSTO, is now well underway. The new Centre will attract local and international scientists from a wide range of scientific disciplines working in areas such as radiocarbon dating and environmental studies, which are key in understanding past human activity (eg. rock art) and climate variability. PAGE 1 ABOUT ANSTO ANSTO is central to Australia’s nuclear medicine manufacturing capabilities. Each week ANSTO delivers 10,000 patient doses of potentially lifesaving nuclear medicines to over 250 partner hospitals and medical practices across Australia. It’s estimated one in two Australians will benefit from the nuclear medicines that originate from ANSTO at some point in their lifetime. The minerals industry relies on ANSTO to provide advice and technology to handle naturally occurring radioactive materials in mineral processing. ANSTO also provides expert advice on the safe treatment and disposition of nuclear waste and specialised irradiation services. ANSTO is connected with all Australian and New Zealand universities through the Australian Institute of Nuclear Science and Engineering (AINSE), providing researchers access to Australia’s nuclear science, technology and engineering expertise and landmark infrastructure which, in turn, facilitates greater national science collaboration. ANSTO’s strategic international collaborations ensure Australian scientists are connected with important global research projects. ANSTO’s partnerships include agreements with Japan’s High Energy Accelerator Research Organization; the French Commissariat à l’énergie atomique et aux énergies alternatives (CEA); and the European Organization for Nuclear Research (CERN). Our corporate plan Statement of compliance In 2010, the ANSTO Corporate Plan for This report is written with reference to 2010-2015 was developed and approved the Commonwealth Authorities (Annual by the ANSTO Board and accepted by Reporting) Orders 2011. the responsible minister. Our 2010-2015 Corporate Plan is a public document, available via the ANSTO website, and Responsible minister sets out the organisation’s key goals and Minister for Tertiary Education, Skills, strategic direction for this period. Science and Research, Senator the Hon Chris Evans. Our vision To deliver excellence in innovation, insight and discovery through our people, partnerships, nuclear expertise and landmark infrastructure. Our strategic directions for 2010-2015 • Deliver world-class research and innovation in nuclear science and technology • Expand ANSTO’s reach and contribution, exploiting landmark technologies • Serve the nuclear needs of government, industry, community and the people of Australia • Drive organisational renewal. Senator the Hon Chris Evans ANSTO ANNUAL REPORT 2011-12 PAGE 2 MeMbeRs OF tHe bOARD Professor Paul Professor David Professor John ms Christine Dr susan Pond Greenfield AO Copolov OAM hearn mcloughlin Am (Chair) MBBS, PhD, FRACP, BSc, MSc, PhD BA, LLB(Hons), FAICD BMBBS (Hons), MD, BE (Hons), B.Econ, FRANZCP, MPM, DPM DSc, FTSE, FRACP PhD, FTSE, FIEAust, Deputy Vice- Chair of ANSTO’s Risk FIChE, FAICD, CPEng, Pro Vice-Chancellor, Chancellor and Audit Committee Adjunct Professor, CEng, CSci Office of the (International) to 30 June 2012; University of Sydney Vice-Chancellor and Professor of Lawyer and Medicine; Vice-Chancellor and Professor of Physiology University businesswoman. Scientist and University of Psychiatry, Monash of Sydney; businesswoman. Queensland; University; Biomedical Appointed Academic and Academic and researcher and 13 March 2009 Appointed engineer. psychiatrist. biotechnologist. 1 July 2010Term concludes Chairman since Appointed Appointed 12 March 2013 Term concludes 24 February 2011 1 May 2008 1 May 2008 30 June 2014 Appointed Reappointed Term concluded 25 July 2007 28 June 2012 30 April 2012 Reappointed Term concludes 25 July 2010 27 June 2016 Term concludes 24 July 2014 PAGE 3 MEMBERS OF THE BOARD Professor Judy A mr John Ryan Professor ms erica smyth Dr Adrian (Adi) Raper Psm Andrew scott MSc, FAICD Paterson PhD, BE (Hons) BEc, MEc MBBS (Hons), MD, BSc, PhD FRACP, DDU, FAICD Scientist and Deputy Vice- Chair of ANSTO’s Risk businesswoman. Chief Executive Chancellor (Research) and Audit Committee Director Ludwig University of from 1 July 2012; Institute for Cancer Appointed Officer; Chemical engineer. Wollongong; Executive Director, Research; 12 December 2008 Academic and Cloon Economics and Nuclear medicine Appointed engineer. economist. physician, scientist Term concludes 1 March 2009 and academic. 11 December 2012 Appointed Appointed Term concludes 28 June 2012 24 February 2011 Appointed 28 February 2014 26 September 2007 Term concludes Term concludes 27 June 2016 23 February 2016 Reappointed 29 September 2011 Term concludes 28 September 2016 ANSTO ANNUAL REPORT 2011-12 PAGE 4 AnstO exeCutive teAM Dr Adrian (Adi) mr Peter Arambatzis mr michael Beckett mr Robert (Rob) Paterson Chief Financial Officer General Manager, Blissett Chief Executive Officer Support Services and Chief General Manager, Human Information Officer Resources Mr Hefin Griffiths mr shaun Jenkinson mr Paul Jones ms nadia levin General Manager, Safety, General Manager, General Manager, Security General Manager, Environmental and Commercial Operations and Safeguards Government, International Radiological Assurance and External Relations By invitation: Professor Richard ms stephanie Cole mr Kobus naude Banati Legal Counsel Senior Manager, Strategy Distinguished Research and Planning Fellow and ANSTO LifeSciences PAGE 5 ANSTO EXECUTIVE TEAM mr Douglas (Doug) Professor John Professor lyndon Dr marie-Claude Cubbin Dodson edwards Gregoire General Manager, Business Head, Institute for Head, Institute of Materials Head, ANSTO LifeSciences Development and Environmental Research Engineering Commercialisation mr Con lyras Dr Greg storr Dr Robert (Rob) General Manager, Head, Nuclear Operations Robinson Engineering and Capital Head, Bragg Institute Programs ANSTO ANNUAL REPORT 2011-12 PAGE 6 ORGAnisAtiOnAl CHARt minister Senator the Hon Chris Evans AnstO Board Chief executive Officer Adi Paterson Office of nuclear support Government, safety, Finance the CeO Operations services international and environment Procurement and external Relations and Radiological Quality Adi Paterson Greg Storr Michael Beckett Assurance Nadia Levin Peter Arambatzis Hefin Griffiths AnstO legal Council Stephanie Cole strategic Planning Kobus Naude Governance, Audit and Risk Riaan Bredell PAGE 7 ORGANISATIONAL CHART Commercial human Business security and engineering and Research and Operations Resources Development and safeguards Capital Programs innovation Commercialisation Shaun Jenkinson Rob Blissett Paul Jones Con Lyras Rob Robinson Doug Cubbin AnstO life sciences Marie-Claude Gregoire institute of materials engineering Lyndon Edwards institute for environmental Research John Dodson The Bragg institute Rob Robinson ANSTO ANNUAL REPORT 2011-12 PAGE 8 CHAiRPeRsOn’s RePORt I look back proudly on 2011-12 as a year do here today. Work undertaken in the past where ANSTO has contributed to incredible year includes implementation of zoning discovery, where we have met considerable to guide development of like business challenges, and where we have built our units in the same broad areas on site, and capacity to enhance the lives of Australians enactment of improved building codes that through adding to our suite of infrastructure will guide sustainable future development and delivering on our strategies. around the campus. This year ANSTO has made significant In line with our plans, a focus for 2011 progress on rolling out our medium and – 2012 has been working across the long term visions for our organisation. government to magnify our influence We are now in our second year of and spread the benefit of our expertise. implementing the ANSTO 2010 - 2015 Notably, we continue to collaborate closely Corporate Plan, which sets out ANSTO’s with Department of Foreign Affairs and strategic priorities in terms of delivering Trade (DFAT) and relevant state and federal world class infrastructure; expanding security agencies to contribute to Australia’s ANSTO’s reach and contribution; serving the ongoing national security, including counter- needs of the public and our stakeholders; terrorism preparedness. ANSTO’s nuclear and driving organisational renewal. This is expertise continues to ensure Australia has a plan which is being lived, and its continued a seat at the table when it comes to ongoing successful roll out is evidenced in everything regional nuclear non-proliferation talks. from construction of new accelerators and environmental facilities at Lucas Heights, It is always pleasing when good work is to our continued strengthening of recognised, and this year Australia was partnerships with domestic and acknowledged as having the best nuclear international science organisations. materials security practices in the world, according to the Nuclear Threat Initiative Focussing on the longer term, ANSTO – an international organisation that works has also made significant initial steps to improve global security and fulfilment this year towards delivering on the vision of the goals of non-proliferation treaties. outlined in the ANSTO 2055 Infrastructure As home of Australia’s only nuclear Plan. This is the long term plan that will reactor and a significant proportion of see transformation of our Lucas Heights our nuclear materials, and forensics and campus into a site that is welcoming, science expertise, the report was a strong interactive and more accessible to the public endorsement of the security and safety – with state-of-the-art facilities that equal measures that ANSTO has in place. the world-leading science that we already PAGE 9 CHAIRPERSON’S REPORT Particularly against the backdrop of a tight federal budget, it is pleasing that ANSTO’s financial performance this year was strong, and continues to track well. Earnings by ANSTO’s commercial groups were up $12.9 million to $63.9 million this year – an increase of more than 25%. This growth has been driven across several of ANSTO’s business units, including those in the health, minerals and silicon irradiation areas. I am pleased to present my second ANSTO annual report. I take this opportunity to thank the Board, Executive Team and staff for all your hard work, and congratulate you on your achievements throughout the year. I know you share my excitement about ANSTO’s strong and continuing role in improving Australia’s health and environment, in partnering with key industries to make them more profitable, and in pushing the frontiers of Australian science. Dr Paul Greenfield AO Chairperson ANSTO ANNUAL REPORT 2011-12 PAGE 10 CHieF exeCutive OFFiCeR’s RePORt I have great pleasure in presenting ANSTO’s year we have had a notable increase Annual Report for 2011-12. We are on in the performance of our commercial track to deliver against the objectives of groups. This considerable achievement was our Corporate Plan. The ANSTO Board is underpinned by an operational excellence playing a critical role in ensuring that we program and other organisational changes stay focussed and continue to reflect on our that had been put in place to support strategy on a regular basis. I would like to sustainable results. I would like to give record my appreciation to our Chairman, great credit to the people who have Professor Paul Greenfield, and the Board embraced the training and have converted members for the governance role they play that training into practical actions that have and the great value they contribute to the delivered this very visible result. For ANSTO development of ANSTO as a strategically this is not so much about the growth of managed and accountable organisation. revenue but a focus on the needs of our customers, and their customers, so that Each year we convert our strategic plan we can create benefits in Australia and the into a one year ‘strategy on a page’ that region through the specialised services and guides us in a more detailed way to achieve products we supply. clear goals and objectives. In the current In the domain of innovation and business development, ANSTO has undergone a significant transformation in the last few years. We have new capabilities to convert research and development outcomes into practical and accessible products and services and introduce innovation into Australia from other parts of the world. This is one of the most exciting areas of our work. For example, during the course of this year a unique membrane technology that cleans waste water went through its final stage of transfer into the market where it is being successfully operated by BioGill Environmental Pty Ltd. We are very proud of their success which is built on inventions initially developed at ANSTO. PAGE 11 CHIEF EXECUTIVE OFFICER’S REPORT ANSTO mobilises landmark infrastructure ANSTO has developed strong relationships to serve users. During the year we brought with a range of stakeholders in a number of facilities into service. These government. We have sought to engage included a solid targetry laboratory local stakeholders so that there is a keen developed in partnership with the Ludwig understanding of the importance of careful Institute at the Austin Hospital in Melbourne stewardship in relation to the benefit we and a national imaging facility developed receive from nuclear medicine. In May in collaboration with the University of we launched a communication initiative Sydney in Camperdown. These two in relation to the return of waste from partnerships were complemented by the our spent fuel. We have been greatly opening of a facility for the measurement of encouraged with the positive feedback and environmental radioactivity by our minister, the helpful engagement that has resulted Senator the Hon Chris Evans in April. from this. It is clear that the vast majority of people interested in this topic are seeking Neutron scattering, accelerator techniques, to deepen their understanding using an radioisotope labelling and working with evidence based approach. active materials does not immediately lead to headline grabbing outcomes. Our The Annual Report contains significantly research platforms create the potential for more detail on what has proved to be a our users, researchers and collaborators safe and successful year for ANSTO. The to do science and engineering that will period ahead will be challenging in a more change the way we live and how healthy uncertain global context but I am sure we will be in the future, as well as creating that the organisation is well prepared to opportunities to save resources, sustain continue to seek positive outcomes and our fragile environment and ensure effective progress in meeting our corporate safety and security for all Australians. objectives. I would like to express a final The infrastructure is important but our thank you to the Executive and senior people are more important. Our scientific leadership at ANSTO for their critical productivity and impact has improved even contribution both now and into the future. as we have expanded the number of users, partners and collaborators. Dr Adrian (Adi) Paterson Chief Executive Officer ANSTO ANNUAL REPORT 2011-12 PAGE 12 2011-12 hiGhliGhTs New centre for environmental measurement Built from materials with ultra-low background radiation levels, ANSTO’s state-of-the-art centre for environmental measurement allows scientists to detect tiny amounts of radioactive material that would normally be lost amongst background radiation in a regular laboratory. Isotopic and nuclear techniques to trace the impacts of humans on the environment, including monitoring radiation levels at ANSTO’s Lucas Heights campus, will be undertaken at the centre. Designed to the highest OHS standards following input from ANSTO’s Safety, Environmental and Radiological Assurance Minister for Tertiary Education, (SERA) team, and with a range of ‘green’ environmentally Skills, Science and Research, friendly features, the Centre will be used as a benchmark for Senator the Hon Chris Evans design and development of new buildings at ANSTO. at the opening of the new centre for environmental The innovative building design accommodates the ITRAX measurement. Corescanner, the only scanner of its type in Australia that can reconstruct the environmental and climate history of an area by analysing sediment cores and tree ring samples. It is anticipated that the new equipment will attract scientists from universities and research organisations from across Australia. The Centre was officially opened on 24 April by the Minister for Tertiary Education, Skills, Science and Research, Senator the Hon Chris Evans. ANSTO’s new centre for environmental measurement. PAGE 13 2011-12 HIGHLIGHTS National Imaging Facility Research Cyclotron A new $25 million National Imaging Facility (NIF) Research Cyclotron for biomedical imaging was opened at Camperdown in Sydney. The result of collaboration between ANSTO and the University of Sydney, the facility also comprises Australia’s most advanced radiolabelling equipment and access to nearby biomedical imaging laboratories located at the University of Sydney’s Brain and Mind Research Institute (BMRI). As the most advanced facility of its type in Australia, the laboratories are equipped with preclinical and clinical scanners that probe soft tissue at the molecular level to measure specific biological functions related to disease. A high performance computing platform then provides advanced imaging analysis and modelling. More than 30 scientists are working under the partnership, developing new research techniques and studying diseases involving the brain. The facility also allows access by external scientists through the NIF network. Officially opened on 6 December by Her Excellency Professor Marie Bashir AC CVO, Governor of New South Wales, the facility received investment from the Australian Government, ANSTO, the University of Sydney and the NSW Government. Her Excellency Professor Marie Bashir AC CVO (centre) at the opening of the new facility. t nde l S Aru University of Sydney St atta R d rick Brod e Parram en Std Mars gs StBrig St unbl ane D ucas St L Royal Prince National Imaging Facility Alfred Hospital er LnowlF Salisbury Ln bury Rd Carillon Ave Salis ANSTO ANNUAL REPORT 2011-12 PAGE 14 Cardiga Nn e S lst on St Cardigan Ln Susan St City Rd e S t osR Rd de n sse n Mi ch St Chur St Mall ett St Austr alia son St Deni 2011-12 hiGhliGhTs Membrane bioreactor and sewage treatment technology In March a ground-breaking water cleansing technology developed at ANSTO was successfully commercialised and the intellectual property sold to Australian clean- tech company, BioGill Environmental Pty Ltd, a manufacturing company based in Sydney. The system has numerous industrial and environmental applications, including the treatment of grey water, sewage and wastewater from aquaculture, and food and beverage processing. The technology is also considered to have great potential for cleaning water on ships, offshore platforms and remote islands where protecting sensitive environments is essential. (L-R) Founder and CEO of BioGill, John West; BioGill Director of Finance and Administration, Louise West: ANSTO Business Development Manager, Rosanne Robinson; and ANSTO General Manager, Business Development and Commercialisation, Doug Cubbin. 2011 Eureka Prizes ANSTO’s Vanessa Peterson was a nominee for the Australian Museum’s 2011 Eureka Prize People’s Choice Award for her work on one of the world’s biggest challenges - developing renewable, clean energy technologies. Using OPAL, Vanessa’s research is helping to better understand materials that store and deliver charge, particularly those for the transportation sector. These materials include batteries for use in electric vehicles, and alternative energy-systems based on hydrogen. The results of this research could ultimately help us to make petrol engines redundant, with power produced from hydrogen resulting in clean water as the only by-product. Although Vanessa did not win the award, her nomination was a fantastic opportunity to raise the profile of ANSTO’s research addressing Australia’s sustainable energy future. (L-R) ANSTO’s Dr Geraldine Jacobson, ANSTO also sponsored the inaugural Innovative Use of Dr Michael Law and Dr Vanessa Peterson. Technology prize at the Australian Museum’s 2011 Eureka Prizes. This prize is awarded to individuals or groups who have used new or existing technology in an innovative way to improve the outcome of their research. PAGE 15 2011-12 HIGHLIGHTS External revenue External earnings by ANSTO business ANSTO Minerals’ revenue earnings for and commercial groups amounted to 2011-12 were $14.1 million. This was up $63.9 million in 2011-12. This was up $1.9 million from the previous year, largely $12.9 million, a 25.3 per cent increase on due to continual commercial activities in the the previous year. minerals industry including uranium and rare earths. The ANSTO Health business continues to grow and now exports Molybdenum-99 ANSTO silicon irradiation revenue earnings (Mo-99) to the United States of America for 2011-12 were $4.8 million. This was also (USA). ANSTO Health’s revenue earnings up on the previous year’s results with an were $28.2 million in 2011-12, up $0.95 increase of $0.8 million. million from the previous year. AnstO Minerals $14.1 million AnstO silicon irradiation $4.8 million AnstO Health $28.2 million Other $16.8 million ANSTO ANNUAL REPORT 2011-12 PAGE 16 2011-12 RePORt OF ACtivities Australia’s nuclear experts Australian nuclear security ranked Fukushima marine best in the world environment study In January a global report on nuclear Australia is leading a study within the materials security around the world Asia-Pacific region to assess the extent of ranked Australia number one out of 32 contamination and its impact on the marine countries including the United Kingdom, environment from the Japanese Fukushima United States of America (USA) and Japan. Daiichi nuclear plant incident in March 2011. According to the Nuclear Materials Security The project was launched at a meeting in Index Report released by the Nuclear Threat Sydney in late 2011, attended by nuclear Initiative — a non-profit, non-partisan specialists from over 20 Asia-Pacific nations. organisation that works to improve global security and fulfilment of the goals of The meeting set out the activities that will non-proliferation treaties — Australia has be implemented over the life of the project. the best nuclear materials security practices These include sampling of seawater, in the world. sediment, plant and animal life; analysis of sampling results to determine current As custodian of Australia’s only nuclear radiation levels; modelling of radionuclide reactor, this report is an independent fate and transfer from seawater to living endorsement of the security and safeguards organisms; and training programs for ANSTO, working closely with the Australian countries lacking the skills to undertake Safeguards and Non-Proliferation Office, these activities. has in place. The overall aim of the project is to provide a comprehensive overview of the total extent of the subsequent radioactivity and its impact and provide reassurance as to the safety of our region’s people, animals and environment. The International Atomic Energy Agency (IAEA) initiated four year project is being jointly funded by the Australian, Japanese, New Zealand and USA governments. The Australian National Project Team includes ANSTO, Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Institute of Marine Science (AIMS) and the Australian National University (ANU). Fukushima Aerial view of ANSTO’s Lucas Heights campus located 30 km south-west of the Sydney CBD, and situated on a 70 hectare site surrounded by large areas of natural bushland. PAGE 17 REPORT OF ACTIVITIES leading the way in decommissioning Plan in place to safely manage medical With ANSTO’s former reactor Moata now and research waste fully decommissioned and dismantled, In April, ANSTO announced it would apply and preparations under way for the for a licence to construct an interim storage future dismantling of ANSTO’s other facility for Australian intermediate level former reactor HIFAR, ANSTO has a radioactive waste generated by several level of decommissioning expertise that decades of nuclear medicine production is being harnessed to provide training and scientific research. and demonstration to other countries considering reactor decommissioning. In the absence of a national radioactive waste management facility, the proposed This expertise was demonstrated at a new interim storage facility at Lucas Heights workshop in May on Research Reactor would enable Australia to meet obligations Decommissioning, hosted by ANSTO’s to repatriate Australian waste currently decommissioning team, as part of the being reprocessed in France and due to IAEA’s Research Reactor Decommissioning return to Australia by the end of 2015 under Demonstration Project (R2D2). The R2D2 arrangements established by governments Project provides a platform that can be in the 1990s. used for ‘hands-on’ and practical training in activities related to safe decommissioning. Subject to regulatory approval, the proposed interim facility would operate from late 2015 while planning is underway AnstO hosts successful for the siting, design and construction of iron Koala exercise a permanent national radioactive waste management facility. As a leader in global nuclear security, ANSTO hosted a Global Initiative to Combat The proposed facility will be assessed Nuclear Terrorism (GICNT) activity in Sydney by the independent regulator ARPANSA in May. Known as Iron Koala, the exercise and the assessment will include a public was organised by the GICNT Nuclear consultation process. Forensic Working Group of which Australia is the chair. The purpose of the event was to increase awareness of the need for legislated, regulated and routine information sharing between countries and professions, in order to prevent the trafficking of nuclear and radioactive material. Artist’s impression of the proposed intermediate level waste storage building. ANSTO ANNUAL REPORT 2011-12 PAGE 18 2011-12 RePORt OF ACtivities Health and life sciences Cell membrane studies helping to understanding inflammation in tackle antibiotic resistance the brain Due to the increase in antibiotic-resistant The translocator protein is a marker bacteria, there is a large international of inflammation in the brain, research effort underway to develop neuroinflammation, which is implicated antibiotics that attack bacterial membranes in diseases such as multiple sclerosis and to help combat the threat posed by Alzheimer’s disease. antibiotic resistance. An understanding of the structure and As around 40 per cent of all new medical function of this protein is vital in developing drugs target cell membranes, more drugs to treat neuroinflammation. ANSTO advanced cell membrane models are needed research, headed up by Claire Hatty and to assist with this important area of research. scientists from the University of Sydney, used the Platypus neutron reflectometer ANSTO’s Anton Le Brun has developed to study the structure of the translocator simple models of the bacterial outer protein at the molecular level, to gain a membrane and investigated the molecular deeper understanding of the protein and its structure of the model membrane using interactions with potential drugs. neutron reflectometry on ANSTO’s reflectometer, known as Platypus. This fundamental information could help in understanding how the translator protein As membranes are highly complex relates to inflammatory disease. structures, models, or man-made copies of a bacterial membrane, are needed to better understand the effectiveness of a potential new drug. Initial results indicate that Anton’s models reflect the properties of membranes in nature and the models will be an important tool for studying how membranes function and how antibacterial agents and other drugs interact with membranes. An artist’s impression (David S. Goodsell 1999) of A better understanding of the translocator protein molecules in a slice of an E. coli cell. The green areas will assist with the development of drugs to treat show the membrane under study. inflammatory disease in the brain. PAGE 19 REPORT OF ACTIVITIES Assessment of gamma irradiation on internal mango quality The Australian mango fruit grower’s market Australian mango fruit hybrids to varying is a substantial industry sector that is doses of gamma irradiation following anticipated to grow by 20 per cent in 2014. harvest. Of particular interest was the The ripening, transportation, and saleable question of whether irradiation may degrade life-span of mangoes depends on keeping the fruit, such as cause damage to lenticels the fruit free from pests and disease. (small pores on the fruit’s outer skin). Worldwide, the use of irradiation is The study illustrates how ANSTO’s emerging as a viable, chemical-free expertise makes a crucial contribution to alternative to traditional pesticides. the development of Australia’s national food security by providing new insight into Research by ANSTO’s Radiation Technologist the viability of irradiation to achieve safe Connie Banos, working with the University phytosanitary (pest and disease) protocols of Sydney and the Queensland Department for the agriculture industry. of Employment, Economic Development and Innovation, builds upon our knowledge of the physiological responses of three new ANSTO ANNUAL REPORT 2011-12 PAGE 20 2011-12 RePORt OF ACtivities Environment and climate change miniature Antarctic forests give us a Groundwater ‘age’ assessment in the glimpse into future climate change Gnangara mound, Western Australia ANSTO research could provide valuable Accelerator mass spectrometry research insights into the future effects of climate using ANSTO’s tandem particle accelerator, change including the potential for STAR, is helping to understand the age of significant disruptions in growth patterns groundwater aquifers of the Perth Basin for the world’s vegetation, based on water and how frequently the water is being availability, and the subsequent flow-on replenished, in order to determine how effects that could be expected further up much of the resource is available for use. the food chain. Led by Karina Meredith, a team of ANSTO The studies by ANSTO’s Senior Research scientists worked with the Government of Scientist Quan Hua and scientists from Western Australia’s Department of Water, the University of Wollongong on Antarctic determined the age of groundwater to be moss shoots, one of the smallest and last 23,000 to 35,000 years old. Although this untouched species on the planet, suggest result was expected, what was surprising the plant species is showing symptoms of was the identification of an area of younger climate change. groundwater at depths of 300 metres below the ground surface. This area is of Through carbon dating and measuring prime interest for water resource managers the depth of moss colonies, considered because it shows fresh water is replenishing to be the ‘old growth forests’ of Antarctica the otherwise isolated underground system. in miniature, scientists observed up to a seven-fold slowdown in the growth of some The Gnangara groundwater system supplies species from changes in temperature and up to 70 per cent of Perth’s potable water wind speeds. during periods of drought. The sustainable use of this important resource is of major importance for future development in and around Perth. Radiocarbon in the shoots of moss are revealing the Karina Meredith in the Institute for Environmental effects of Antarctic climate change. Research working in the Isotope Ratio Mass Spectrometry Laboratory. PAGE 21 REPORT OF ACTIVITIES some corals like it hot When water temperatures get too hot, reefs for sustenance and their livelihoods, tiny algae that provide coral its colour and particularly those in the fishing and tourism major source of food are expelled. This industries. phenomenon, called coral bleaching, can lead to the death of corals. Planning is now underway for potential future studies of corals in areas of the While working in the central Pacific region, world that have not experienced a team of international scientists including significant historical changes in ANSTO’s Post-Doctoral Fellow Jessica Carilli, water temperatures. discovered that coral which has survived heat stress in the past is more likely to survive it in the future. The findings will help scientists identify habitats and areas where reefs may persist in the face of climate change. A finding that will be welcomed by some of the millions of people worldwide who rely on coral ANSTO ANNUAL REPORT 2011-12 PAGE 22 2011-12 RePORt OF ACtivities Forest soil erosion in the wake of Prehistoric cold case links humans to major bushfires Tasmanian megafauna extinctions The results from ANSTO research into A team of Australian and New Zealand the effects of severe bushfires, such as researchers including ANSTO’s Vladimir Australia’s 2009 Victorian ‘Black Saturday’ Levchenko have discovered fresh evidence bushfires, is helping bushland and forest that could unravel the mystery of what killed conservation efforts. Tasmania’s giant marsupials over 40,000 years ago. Severe bushfires expose the soil in bushland. Subsequent high intensity storms — possibly Analysis carried out at ANSTO on the once-in-a-hundred year events — can then skeletal remains of extinct mega fauna generate significant erosion with massive provided substantial proof that for about debris flows even in small creek systems. 2000 years they in fact shared the island with early humans before suddenly A study by ANSTO’s Michael Hotchkis disappearing before the last ice age. together with researchers from the University of Plymouth in the United The findings challenge current historical Kingdom and the University of Melbourne, views, now placing our ancestors in Tasmania was undertaken to better understand at the same time as large prehistoric animals, processes that influence the evolution of like the Protemnodon anak (a giant wallaby) landscapes subject to such events. and raising the real possibility we were involved in their extinction. The fate of the forest soil is of particular interest as it can tell us whether the existing Geological work on sea level change conditions are sustainable or not. For suggests humans could not have crossed example, if severe bushfires are followed by Bass Strait until around 43,000 years ago severe storms resulting in a net depletion of when the island was temporarily connected soil, then we know that there is going to be by a land bridge to mainland Australia. damage to the soil and subsequently, the forest, rather than a sustainable equilibrium. The next steps in the research are to find evidence of interactions between humans Fallout plutonium isotopes, measured at and megafauna to make the findings trace levels using the ANTARES accelerator, conclusive. were used for the first time in this kind of study. Melbourne Bass Strait Launceston Hobart Photo of Myrtle Creek showing significant debris deposits left behind after sudden intense storm events in 2009. Approximate contour for the Bass Strait land bridge. PAGE 23 REPORT OF ACTIVITIES Climatic instabilities’ effect on Australia’s monsoon tropics Recent climate predictions suggest Australia Corresponding with these ice ages, will experience more high-intensity tropical global temperatures rapidly increased cyclones and flooding leading to extensive in association with polar-ice melting and economic and social disruption. sea-level rise. Therefore climatic instability, potentially induced by current global These predictions are based on modelling warming, may increase the magnitude global warming scenarios using short- of tropical cyclones and storms and thus duration historical cyclonic records. In order associated floods. These results indicate to improve future modelling of cyclone that rapid increase of global temperature frequency, we need to find evidence of and future increases in global sea-level, may extreme events occurring over the past few increase the magnitude of tropical cyclones tens of thousands of years. and extreme flood events. Research results using ANSTO’s ANTARES These results are consistent with the accelerator and headed up by ANSTO’s findings of the Intergovernmental Panel Toshiyuki Fujioka together with the on Climate Change Report ‘Climate Change University of Wollongong, have indicated 2007: Synthesis Report’. mega floods in the Kimberley region occurred during the end of the last three major episodes of global ice ages, occurring Below: about 10,000-18,000, 125,000-135,000, and Members of Cosmogenic-Exposure Dating Group 240,000-250,000 years ago. at ANTARES. (L-R) Charles Mifsud, Steven Kotevski, Toshi Fujioka, David Fink and Krista Simon. ANSTO ANNUAL REPORT 2011-12 PAGE 24 2011-12 RePORt OF ACtivities Materials engineering Cheaper, more-efficient electric hydrogen storage for clean energy equipment screens Environmental sustainability is driving Organic light-emitting diodes (OLEDs) energy production and use towards are extensively used in devices such as cleaner and greener technologies such as television and mobile phone screens, but using hydrogen as a fuel. However, this their life-time depends significantly on the raises the problem of how best to safely stability of the chemical layers that form store hydrogen. these devices. Structural changes at the An ANSTO study, led by Elvis Shoko and interfaces between these layers, which can using ANSTO’s Linux cluster computer occur during production or when the device server, investigated trapping hydrogen heats up, dramatically affect how electrical molecules (H2) in ice. This forms a clathrate charge travels through the device leading to hydrogen hydrate, which is essentially an changes in its performance. ice cage which can hold hydrogen. Together with the University of Queensland, Although this research focuses on ice, there ANSTO’s Tamim Darwish and his team are other options for cage materials and used neutron reflectometry and specifically we need to understand how the hydrogen synthesised deuterated molecules that interacts with the container carrying it. are typically used in OLEDs, to study the This is best done by analysing how the combining of layers and the structural hydrogen molecules move around in the changes that take place on the nanoscale, cage. The research also tackled the question or sub-microscopic level. of whether the cage’s own thermal motion is important. The results will improve the functioning and efficiency of the next generation of Although complex, these questions must be these devices. understood because they relate directly to the performance and safety of the hydrogen storage material. This research used a more rigorous approach than has been commonly used previously, taking into account the cage’s flexibility rather than assuming that the cage is rigid. This has highlighted the shortcomings of previous experiments. It is crucial to correctly calculate the interaction between the hydrogen and the cage so that we can work towards ice composite materials that can safely store more hydrogen. Tamim Darwish is setting up a hydrothermal deuteration reaction in a Parr high pressure reactor. PAGE 25 REPORT OF ACTIVITIES understanding radiation damage at extending the service life of welded the atomic scale components Materials for future nuclear applications The study of welds — and most importantly, all share one important property: the the residual stresses induced during ability to maintain functionality during welding — is receiving greater attention exposure to extreme levels of irradiation. within a wide range of engineering Developing such materials requires an fields due to safety issues that may be in-depth understanding of the atomic experienced if the weld fails. processes that attribute to the build-up of radiation damage. Weld-induced residual stresses are a particular concern in safety critical ANSTO’s Greg Lumpkin and Karl Whittle, components and assemblies, since these together with researchers from Curtin stresses may lead to the premature failure University, used atomistic scale simulations of a given system. One of the most common to discover the mechanisms of initial defect causes of failure are cracks that develop in formation. Allowing a first-hand look at or near welds; the problem of premature which factors contribute to a material’s cracking is exacerbated in a severely hot or radiation tolerance or susceptibility will corrosive environment. help us understand and design prospective nuclear materials and bring us one step For this reason, the effects of welds are closer to developing more radiation considered when performing remaining- tolerant materials. life assessments and safety inspection schedules for the power generation industry, where a complex system of welded components and piping are used to produce and deliver steam to turbines. As the cost associated with extensive experimental analyses can be prohibitive, simulations via numerical analyses are employed to predict the weld-induced residual stress field in a component. These predicted stresses may then be used to study the in-service structural integrity of an object. ANSTO’s research led by Cory Hamelin developed a model to predict this intricate phenomenon. Ultimately, this weld model may be used to optimise the welding process used for ferritic (iron) steels, in an attempt to extend the service life of welded components. ANSTO’s Greg Lumpkin is part of a team using atomic scale simulations to better understand what factors contribute to a material’s radiation tolerance. ANSTO ANNUAL REPORT 2011-12 PAGE 26 2011-12 RePORt OF ACtivities An investigation of residual stresses in insulated rail joints Insulated rail joints (IRJs) are an integral from track ballast work. Neutron diffraction part of any rail track system, as they split a can tell us what happens to material and continuous rail track into electrically residual stresses within used rails and trace isolated sections for signalling and easy down accumulation of damage caused by detection of rail track damage. Bonded stresses throughout rail service history. IRJs are safety-critical components that must satisfy requirements for structural ANSTO’s study led by Vladimir Luzin integrity as well as the isolation function for and working with The University of both railway signalling and track condition Wollongong and the Queensland University monitoring systems. of Technology, Cooperative Research Centre (CRC) for Rail Innovation is helping In heavy haul corridors in Australia and railway engineers better understand how around the world, IRJs are periodically residual stress fields evolve in service replaced due to accumulated damage in and enable them to develop IRJs with their railhead, often within 10-20% of the longer service lives, as well as determine useful life of other rail components. the most appropriate rail maintenance and replacement schedules for safe and Their replacement is the single largest track economic operation. maintenance cost in New South Wales, apart Understanding residual stress in insulated rail points is vital for rail maintenance and extending service lives. not damaged Partly damaged Badly damaged Neutron diffraction can show the evolution of the residual stress in rails of different service history. PAGE 27 REPORT OF ACTIVITIES New technologies for national security investigating the impact of radiation improving the identification of and radioactive contamination on radiological and nuclear materials forensic trace evidence The illicit trafficking of radiological and The collection, handling and analysis of nuclear material is a major concern for forensic evidence from a radiological crime the international community. In the near scene presents significant challenges. The future the United States will require all potential for the use of radioactive materials trade partners to perform passive radiation in a malevolent act has been heightened in screening on 100 per cent of the cargo at recent years, and it is highly likely that some the country of origin. or all of the physical evidence recovered However, the current limited performance after such an event may have been exposed of radiation detection systems in border to ionising radiation or contaminated with security applications can impact the flow of radioactive material. commerce (through high false alarm rates at Authorities need a way to safely collect, ports of entry) and potentially fail to detect handle and examine potential evidence the presence of illicit radioactive material. contaminated with radioactive material. Research by ANSTO’s David Boardman has ANSTO’s research being led by Nuclear led to the development and evaluation of a Forensics Research Facility team member, new technology in the form of identification Tegan Evans and working with the University algorithms that address these issues and of Canberra, the University of Technology, maintain a high true positive alarm rate Sydney and the Australian Federal Police whilst minimising the false positive alarm Forensic and Data Centres, explored the rate. This research will contribute directly to impact that high-energy alpha particles our national and international security. have on traditional evidence types including fingermarks, DNA, hairs and fibres. The study also developed new methods for handling and processing traditional evidence contaminated with radioactive material, in particular the examination of the evidence in modified glove boxes (sealed enclosures that are designed to allow hazardous materials to be safely handled in a separate atmosphere). These boxes featured fingerprint development equipment, a variable wavelength light source for enhancing and viewing fingerprints, and a camera for imaging of enhanced fingerprints. David Boardman, Alison Flynn and Mark Reinhard are helping Australia meet its international requirements for radiation screening. ANSTO ANNUAL REPORT 2011-12 PAGE 28 2011-12 RePORt OF ACtivities Operation of OPAL and other facilities OPAl In the 2011-12 financial year, the OPAL operational excellence initiative that is research reactor operated for 294 days improving operation efficiencies across the at high power, which translates to a total organisation. availability of 80 per cent and a planned availability against the schedule of 96 per The Cold Neutron Source supplies cent. There has been a steady improvement important low energy neutrons for scientific in reactor availability over the early years research, which allows researchers to study of operation, with the latest result being the structure and properties of a wide range amongst the highest in the world for of biological materials, plastics and ceramics research reactors. at the nano-scale. The Cold Neutron Source System was unavailable for about OPAL staff produced a major safety report, 33 per cent of the year due to work being called the OPAL Periodic Safety Review undertaken on the helium gas compressors. 2011, which was submitted to ARPANSA to Further major rectification work is planned fulfil a condition of the operating licence. for this system in 2012-13 to improve The report was subjected to an international availability above 90 per cent. peer review, and the initial response from ARPANSA noted that the report had The commissioning of the Heavy Water ‘international significance’. Upgrade System was completed, and the heavy water purity was increased to near Successful production of reactor based optimum levels, which will assist with radiopharmaceuticals, neutron activation improved production efficiency. analysis for scientific research, and irradiation of neutron transmutation ANSTO plans to operate the reactor for doped silicon was achieved during the about 270 days in 2012-13. A six-week major year using OPAL. The efficiency of the shutdown is scheduled to commence in delivery of these products and services November 2012 to install Bilby, a second was enhanced through the ANSTO wide small angle neutron scattering instrument. ANSTO staff viewing the OPAL reactor pool. PAGE 29 REPORT OF ACTIVITIES neutron-beam instruments Radiopharmaceutical OPAL’s neutron research facilities contain production facilities neutron-beam instruments which use Each week ANSTO Health delivers 10,000 OPAL’s neutrons for solving complex patient doses of potentially lifesaving nuclear research and industrial problems in many medicines to over 250 partner hospitals and important fields. medical practices across Australia. These Neutron scattering allows scientists to nuclear medicines are used to diagnose see what X-rays cannot. Neutrons are and treat a wide range of illnesses such as used to see the internal structure of many cardiac conditions and cancer. classes of materials, thus helping scientists ANSTO’s Mo-99 processing facility recovers, understand why materials have the separates and purifies the Mo-99 to properties that they do, and helping tailor meet the demand for this important new materials that suit specific technological radiopharmaceutical. This product is needs in computing, refrigeration, mobile exported to Southeast Asia, the USA and batteries, solar cells, renewable plastic South Africa. packaging and medicine. The other radiopharmaceuticals distributed Six additional neutron-scattering to over 220 nuclear medicine centres across instruments were under procurement or Australia and New Zealand are iodine-131 construction during 2011-12, four of which (I-131) for the diagnosis and treatment were funded under a national Education of thyroid cancer and hyperthyroidism; Investment Fund (EIF) project. gallium-67 (Ga-67) to determine the extent Following the Japanese Fukushima Daiichi of Hodgkin’s disease, lymphomas and nuclear plant incident that affected Japan’s bronchogenic carcinoma; and iodine-123 JRR-3M research reactor and the J-PARC mIBG (I-123) for detection, staging and spallation neutron source, ANSTO provided follow-up to therapy for neuroblastomas. neutron instrument beam time for several The OPAL reactor provides a constant supply Japanese universities and hosted the 2011 of radiopharmaceuticals for Australians. Asia-Oceania Neutron Scattering Association (AONSA) Neutron Scattering School which was previously scheduled to be held jointly at JRR-3M and J-PARC. Molybdenum-99 decays to form technetium-99m the most commonly Pelican’s massive seven tonne vessel being positioned. used radioisotope. ANSTO ANNUAL REPORT 2011-12 PAGE 30 2011-12 RePORt OF ACtivities national Deuteration Facility irradiation facility ANSTO’s National Deuteration Facility ANSTO’s irradiation facility, known as GATRI enables scientists to more effectively (Gamma Technology Research Irradiator), is investigate the relationship between the used to irradiate items for medical health, structure and function of proteins, DNA, industry, agriculture and research. synthetic polymers and other materials known as ‘soft matter’. GATRI is the only Australian provider of high precision irradiation services including: The facility offers the capability to produce molecules where all or part of the • Underpinning the sterility of donated molecular hydrogen is in the form of the human bone and tendons for stable non-radioactive isotope of hydrogen transplants and grafting in surgery, called deuterium. leading to improved outcomes for patients Deuteration of parts of a molecule creates visible contrast between those • Irradiation of the Queensland fruit fly to parts containing deuterium and those help control infestations with normal hydrogen, thus providing • Irradiation of quarantined goods more information about the molecular structure, when a neutron scattering • Plant mutation studies experiment is done at OPAL. Deuteration • Sterilisation of medical products allows particular parts of molecules to be highlighted (or painted) so that they show • Accelerating long term storage effects up markedly against the background of on products such as plastics and the other parts (which would otherwise be electronics. indistinguishable). Molecular deuteration assists in making it possible to observe the arrangement of sub-units of an enzyme, or changes in shape when molecules interact or become active or inactive. This can be done with molecules in solution under relevant real life conditions. The technique is used for research into areas such as Alzheimer’s and Parkinson’s disease, the behaviour of environmentally friendly plastics and the development of new nano and biotech materials. The GATRI pool. GATRI is a wet storage cobolt-60 batch irradiator. PAGE 31 REPORT OF ACTIVITIES Accelerators Accelerators are used to analyse materials, The Centre will act as a strong drawcard often using extremely small samples, to for Australian and overseas scientists determine their elemental composition and from nearly every scientific field, working age to help understand human history and in areas such as radiocarbon dating and the environment. ANSTO currently has two environmental studies. accelerators, ANTARES and STAR, both of which are used in ion beam analysis and ANSTO has a formal agreement with accelerator mass spectrometry. the European Organization for Nuclear Research (CERN) home to the world’s largest ANSTO is well underway with the accelerator, the Large Hadron Collider (LHC) construction of the Centre for Accelerator which is a 27 kilometre circular accelerator, Science (CAS) at Lucas Heights, with a located 100 metres underground at CERN, $62 million grant funded by the national near Geneva. Education Investment Fund (EIF) project. By engaging with CERN, ANSTO and The Centre, which is expected to be Australia are benefiting from cutting-edge completed in early 2013, will house research and gaining the opportunity ANTARES and STAR, as well as two new to develop expertise through CERN’s accelerators - a low-energy multi-isotope particle-therapy platforms and large-scale accelerator mass spectrometer and a new accelerator facilities. medium-energy tandem accelerator. Artist’s impression of the new CAS building being constructed at ANSTO’s Lucas Heights site. ANSTO ANNUAL REPORT 2011-12 PAGE 32 2011-12 RePORt OF ACtivities Community and education ANSTO has provided free guided tours of Significant education initiatives developed in its facilities to the public for over 20 years. 2011-12 included: The tours are a powerful tool for educating the community on the facts and benefits • A popular range of Science Workshops of nuclear science while helping dispel for Kids, where children aged 8 to 14 commonly held misconceptions. years conduct science experiments with ANSTO scientists including the Cosmetic A total of 10,916 people participated in a Chemistry, Water Rocket, Easter Egg and record 563 tours in the 2011-12 financial Water Science Workshops year, this is compared to 535 tours in the previous year. • Fact or Fiction, a highly interactive and entertaining event for National ANSTO offers a range of tours which Science Week are tailored for primary, high school and university students, community • Historical tours of the HIFAR reactor organisations, business and scientific • Sponsorship of the 2011-2012 Ultimate associations and VIPs. Science Guide, a magazine supplement designed to encourage year 10, 11 and 12 students to consider a career in science • Customised education tours in line with national curriculum. ANSTO’s Discovery Centre Team Leader, Rod Dowler, helping a young workshop participant launch her hand made water rocket. Over 700 people attended four Fact or Fiction sessions held during National Science Week. A series of extremely popular historical tours were run of ANSTO’s HIFAR reactor. PAGE 33 REPORT OF ACTIVITIES Sponsorship and events In 2011-12 ANSTO sponsored and awarded ANSTO also supported key Australian and the inaugural Eureka Prize for Innovative international conferences and workshops Use of Technology to Dr Philip Dinning from to increase the profile and awareness of the Flinders University, and Dr John Arkwright organisation’s user access programs. of the CSIRO. ANSTO also continued its support for the Fulbright Scholarship in ANSTO’s Distinguished Lecture Series Nuclear Science and Technology. ran for a second year. ANSTO hosted nine lectures aimed at providing a forum ANSTO also supported community and for esteemed scientists from across the industry events such as the Sutherland world to address the general public and Shire Australia Day celebration, the scientific community in Sydney. Visiting Innovation Series events, the Four Societies scientists included one of Australia’s most Lecture, and the Australian Academy of distinguished molecular biologists and Technological Sciences and Engineering resident of the Australian Academy of (ATSE) Clunies Ross Awards. Science, Professor Suzanne Cory, and global polymer science expert, Emeritus Professor ANSTO has continued to focus on Dame Julia Higgins. education, supporting the National Youth Science Forum (NYSF), participating in the Australian Museum’s Science Unleashed program, and sponsoring two high school students attending the International Science Olympiads. Dr Adi Paterson (centre) with the winners of the inaugural ANSTO sponsored Innovative Use of Technology Eureka Award, CSIRO’s (L-R) Dr John Arkwright and Flinders University’s Dr Philip Dinning. National Science Week in Perth on 8 August 2011 at John Dodson presenting at the Innovation Series in Scitech, Western Australia. Sydney on 19 June 2012. ANSTO ANNUAL REPORT 2011-12 PAGE 34 2011-12 RePORt OF ACtivities Businesses External earnings by ANSTO business and commercial groups amounted to $63.9 million in 2011-12. This was up $12.9 million, being a 25.3 per cent increase on the previous year. AnstO Health export low enriched uranium Mo-99 ANSTO Health is the commercial division of The Mo-99 produced by ANSTO is Low ANSTO that produces radiopharmaceuticals Enriched Uranium (LEU) + LEU (target plates in Australia and operates a production + fuel), consistent with ANSTO’s support of facility from ANSTO’s southern Sydney non-proliferation. In 2011-12, after meeting campus. ANSTO Health plays an important Australia’s Mo-99 requirements, ANSTO role in the nuclear medicine and health Health exported the product to the USA, industries in Australia, supplying 10,000 Japan, China and Korea. patient doses of potentially life saving nuclear medicines each week. The ANSTO Health business continues to grow and as mentioned previously, now exports Mo-99 to the USA. ANSTO Health’s revenue earning was $28.2 million in PeTneT 2011-12. This was up $0.95 million from the PETNET Australia Pty Ltd (trading as previous year. PETNET Solutions), is a wholly owned subsidiary of ANSTO, which operates two medical cyclotrons for radiopharmaceutical production at the southern Sydney campus through an agreement with Siemens Medical Solutions. PETNET has routinely supplied NSW hospitals as part of the state tender and continues to gain market share based on its value proposition of reliable supply of quality product. PETNET’s revenue earnings for 2011-12 were $2.5 million. This was up $1.2 million from the previous year. ANSTO Health delivers a constantly reliable supply PETNET’s twin mini-cyclotrons produce of the ANSTO Gentech® Generators to the Australian radiopharmaceuticals used in positron emission nuclear medicine community. tomography (PET). PAGE 35 REPORT OF ACTIVITIES AnstO Minerals external radiation services ANSTO Minerals is a commercial ANSTO is the leading provider of radiation consultancy group focussed on the uranium protection services and advice in Australia. and rare earths sector. ANSTO has over ANSTO has practical expertise in almost 30 years’ experience and expertise that all facets of radiation safety and dealing includes chemical engineering, metallurgy, with radioactive materials. Services are mineralogy, chemistry, geology and tailored to client requirements. They radiation safety. include radiation safety training, radiation protection advice, measurement and ANSTO Minerals, a business unit of ANSTO, management plan development and offers solutions and innovative technology reviews, radiation instrument calibration, including flow sheet design, bench testing systems safety and reliability consultancy. and scale up pilot plant. These services delivered by ANSTO Minerals generate ANSTO also provides services and advice substantial financial and environmental in high-dose irradiation and high-dose benefits to mineral processing customers. dosimetry for scientific research and the provision of irradiation services to health ANSTO Minerals revenue earnings for care, agriculture and industry clients. 2011-12 were $14.1 million. This was up $1.9 million from the previous year, due to continual commercial activities in uranium and rare earths by mining companies. membrane bioreactor and sewage treatment technology Ground-breaking water cleansing technology developed at ANSTO was successfully commercialised and the intellectual property sold to Australian clean-tech company, BioGill Environmental Pty Ltd, a manufacturing company based in Sydney, in March. The system has numerous industrial and environmental applications, including the treatment of grey water, sewage and wastewater from aquaculture, and food and beverage processing. ANSTO Minerals provides commercial services and The technology is also considered to have consulting advice to the minerals industry. great potential for cleaning water on ships, offshore platforms and remote islands neutron transmutation doping silicon where protecting sensitive environments is essential. ANSTO silicon revenue earnings for 2011-12 were $4.8 million. This was up $0.8 million from the previous year. ANSTO silicon irradiation service has continued to grow sales by delivering high quality consistent irradiation of silicon ingots that are used in high end electronic devices such as a hybrid cars and high- speed trains. ANSTO ANNUAL REPORT 2011-12 PAGE 36 2011-12 RePORt OF ACtivities Partnerships and associations CeRn (the european Organization for nuclear Research) ANSTO has a formal agreement with the European Organization for Nuclear Research (CERN) which allows scientists affiliated with each organisation to collaborate and receive reciprocal use of equipment. This means scientists from CERN benefit from access to ANSTO’s facilities, including the OPAL reactor. The agreement is laying a pathway for collaborative research by Australia’s best and brightest scientists in areas such as accelerator science, health and life sciences, information technology and radiation detection. By engaging with CERN, ANSTO and Australia are benefiting from cutting-edge research and develop expertise in areas such as particle-therapy platforms and large-scale accelerator facilities. The collaboration also involves the joint supervision of research students, staff exchanges and negotiated arrangements for the exploitation of intellectual property. Inside the tunnel of CERN’s Large Hadron Collider. Image courtesy of CERN. PAGE 37 REPORT OF ACTIVITIES Australian synchrotron Synchrotron radiation-based techniques are vital to a wide range of research fields including physics, chemistry, materials science, structural biology, polymer research, environmental science and geophysics. Synchrotron radiation techniques are similar to neutron scattering techniques that require a reactor such as OPAL, and the results from each are often complementary. While each has its particular area of strength and uniqueness, there is significant overlap in the user communities in some scientific disciplines. ANSTO is one of ten foundation investors in the Australian Synchrotron and has special access to it, averaging six days per year on each beam line. Proposals for this special access are internally reviewed by ANSTO. ANSTO has used this beam time to perform strategic experiments; to initiate new projects; to conduct preliminary and pilot studies; for training and familiarisation of staff on new techniques; for a small molecule crystallography service; and to give increased time allocations to ANSTO proposals which have been submitted via the regular scientific merit system. ANSTO researchers were awarded 53 days of beam time at the Australian Synchrotron, which is a substantial increase over the previous year (30 days awarded). ANSTO researchers made use of all nine Australian Synchrotron beam lines in this period. The trend of increasing demand for the small angle X-ray scattering (SAXS) beam line, which has emerged in recent years, continued in 2011-12. This reflects the close complementarity of synchrotron SAXS with small angle X-ray scattering (SANS) at the Quokka instrument at OPAL, particularly in the field of structural biology where small angle scattering provides a unique capability of elucidating the structure of proteins in solution. ANSTO has entered a collaboration with the Australian Synchrotron and Monash University to augment the SAXS beam line by jointly funding the purchase of automated protein solution handling and analysis equipment. This will further enhance Australian capability, which is already world- class with the combination of the SAXS and SANS beam lines/instruments and the National Deuteration Facility. The Australian Synchrotron’s online proposal and user administration system was developed and continues to be maintained under contract by the Bragg Institute. This is a significant benefit to users of the synchrotron and the neutron scattering instruments at OPAL as both facilities run the same online user system. ANSTO, the Australian Synchrotron, Monash University and other partners organise the annual ‘Synchrotron and Neutron New Users Symposium’ to educate potential new users about the landmark infrastructure available and the user-access programs at ANSTO’s Bragg Institute and the Australian Synchrotron. The symposium is held in July each year, and alternates between Sydney and Melbourne, with the 2011 event having been held at the University of New South Wales. ANSTO ANNUAL REPORT 2011-12 PAGE 38 2011-12 RePORt OF ACtivities Australian institute of nuclear science and engineering The Australian Institute of Nuclear Science and Engineering (AINSE) provides a platform for training and cooperation in the nuclear science and engineering fields. Its membership comprises 46 Australian and New Zealand universities and science organisations, including ANSTO, making it one of few scientific institutions with such a wide membership. AINSE facilitates access to ANSTO and other associated nuclear capabilities through research grants, fellowships and support for conferences and workshops. Japanese sPring-8 Centre In late 2011, ANSTO signed a Memorandum of Understanding (MoU) with the Japanese SPring-8 Centre that will give Australian scientists access to a world leading fundamental physics facility – ‘a free-electron laser’. The MoU was signed on behalf of the Australian Collaboration for Accelerator Science (ACAS), meaning the benefits will extend to ANSTO’s ACAS partners which are Melbourne University, Australian National University and the Australian Synchrotron. The MoU demonstrates the value of pooling Australia’s top experts in accelerator science into one body known as ACAS. The agreement opens up opportunities for collaboration amongst Australian and overseas scientists to undertake reciprocal visits and facilitate greater co-operation. university of sydney In September 2011, a re-signing of an MoU between ANSTO and the University of Sydney reinforced a productive scientific partnership. The renewed MoU enables scientists from the University of Sydney to continue research using OPAL and, in return, ANSTO will have access to experts and scientific facilities at the University, which ranks among the best research institutions in the world. The MoU also ensures that representatives of both organisations meet regularly to consider opportunities for joint research and the sharing of facilities. Monash university Although ANSTO and Monash University have undertaken many individual research collaborations over the years, a new formal agreement was signed in late 2011 that is helping facilitate knowledge sharing and creating new training and development opportunities for researchers from both organisations. In particular, the common research areas of biomedical imaging, cancer therapy, accelerator science and neutron science are benefiting from the agreement. Macquarie university An agreement was signed this year between ANSTO and Macquarie University that will help geologists and scientists better understand everything from where earthquakes might PAGE 39 REPORT OF ACTIVITIES occur to where gold is deposited. The partnership provides joint funding for a senior-level research appointment in the University’s Department of Earth and Planetary Sciences. This arrangement is the first of its kind between the University and ANSTO. The successful appointee will help lead work to replicate environments located 400 kilometres beneath earth’s surface: specifically a layer called the upper mantle, which is the source of most magma or molten rock beneath the surface. The study of the physical and chemical processes at these depths will provide a better understanding of the earth, including how mineral deposits are formed. Furthermore, by providing a fuller working model of the processes that occur in the earth’s interior, scientists hope to better understand how to predict and anticipate geologic events such as earthquakes and volcanic eruptions. ludwig institute for Cancer Research and Austin health In April, a partnership between ANSTO, the Ludwig Institute for Cancer Research and Austin Health saw a new, state-of-the-art Positron Emission Tomography (PET) Solid Targetry Laboratory opened. The lab will enable researchers from the three organisations to pursue vital research into new nuclear imaging techniques to benefit patients affected by different types of cancers. The partnership will provide a reliable and cost effective system for the production of relevant long-lived PET radionuclides suitable for radiolabelling of biomolecules for research and clinical imaging applications. In addition, the partnership will encourage knowledge transfer between ANSTO, Ludwig Institute for Cancer Research, Austin Hospital staff, and the Australian scientific community. This improved training will mean more patients can benefit from this innovative and highly effective technique to detect cancer. us Radiopharmaceuticals Under a new agreement reached in June, Australian patients will benefit from a new collaboration announced between ANSTO and US Radiopharmaceuticals (USR). The agreement will see USR supply ANSTO with vital diagnostic imaging isotopes for SPECT (single photon emission computed tomography) imaging as well as disease specific biomarkers. This will provide a diversified supply of accelerator-based radioisotopes for Australian hospitals. SPECT isotopes are not currently manufactured in Australia and under this collaboration they will be produced at USR’s high-energy accelerator facility in Texas, USA. The isotopes offer improved 3D imaging of internal organs, as well as cardiac and brain function. SPECT, and hybrid SPECT/CT (computed tomography), procedures are growing in prevalence globally because of their effectiveness in detecting endocrine and neuroendocrine tumours, as well as lung cancer, brain tumours, lymphoma, breast and prostate cancer. ANSTO ANNUAL REPORT 2011-12 PAGE 40 2011-12 RePORt OF ACtivities Capital investment Numerous major construction projects were completed or underway at ANSTO in 2011-12. The new works will deliver highly improved scientific facilities and infrastructure. Some of the key constructions include: • Environmental Radioactivity • Centre for Accelerator Science (CAS) Measurement Centre – officially - which will reinforce ANSTO’s place opened in April. This Centre is enabling at the forefront of accelerator mass our scientists to detect the tiniest spectrometry and ion beam analysis amounts of radioactive material, research, and provide our researchers, amounts that would previously have collaborators and users with two new been undetectable due to background accelerators in addition to ANTARES and radiation, and to monitor ANSTO’s STAR. The Centre, which is expected to local environment. The Centre features be completed in early 2013, will also new laboratories and office space ensure Australia is able to support key and was built from materials with low research areas of national importance background radiation levels to ensure and act as a strong drawcard for interference does not occur during tests Australian and international scientists. of low levels of radioactivity • ANSTO Minerals Precinct Facilities - will • OPAL building extension – will better allow the amount and scope of work by cater for needs of the reactor and ANSTO Minerals, a successful ANSTO enable increased radiopharmaceutical research and engineering business, to production to assist in alleviating the expand. Australia is in a minerals boom, world shortage of molybdenum. The and ANSTO Minerals plays a key role in extension will include a two storey keeping our minerals industry profitable office, laboratories and workshops through innovative technology solutions. to accommodate 100 nuclear Construction is expected to be complete operations staff currently located in by August 2012. other areas across the Lucas Heights site. Construction is expected to be • Integrated Waste Management Facility completed December 2012. – will improve operational efficiency through the consolidation of a number of operations into one location. In addition, a super compactor will be added that can further compress nuclear waste, reducing the volume of waste on site. Construction of the building was completed in March 2012 and complete fit out will be completed in the first quarter of 2012-13. Construction of the OPAL building extension is well underway and expected to be completed by the end of 2012. PAGE 41 REPORT OF ACTIVITIES Performance against strategic objectives Key Performance indicators 2010-11 2011-12 Facility availability • Neutron Beam instruments - % days operated per days beamline availability 83% 88% • Total availability of OPAL: % of days at power 76% 80% • Planned availability of OPAL: % of actual operating to scheduled operating time 90% 96% • Accelerators: average % of days operated per planned operation 78% 80% nuclear science Facilities project • Percentage of capital funding completed 48.4% 58.1%1 Radiopharmaceutical doses • Potential Doses 2,276,764 2,324,663 1 Actual expenditure was less than originally estimated for 2011-12 but in line with the Deed of Variation signed with DIISRTE during the financial year. ANSTO ANNUAL REPORT 2011-12 PAGE 42 2011-12 FinAnCiAl stAteMents PAGE 43 FINANCIAL STATEMENTS ANSTO ANNUAL REPORT 2011-12 PAGE 44 2011-12 FinAnCiAl stAteMents statement by Directors and Chief Financial Officer Australian Nuclear Science and Technology Organisation PAGE 45 FINANCIAL STATEMENTS CAoUSnTsRoAlLidIAaNt NeUdC sLtEaAtRe SmCIeEnNCt Eo AfN cDo TECHNOLOGY ORGANISATIONCONSOLIDATED STATEMENT OF COMPmREpHrEeNhSIeVnE sINivCeO MinEcome ffoorr th teh yeea yr eenadred e 3n0 dJuende 230012 June 2012 Consolidated Notes 2012 2011 $'000 $'000 EXPENSES Employee benefits 6A 1 14,702 1 03,062 Suppliers expenses 6B 5 5,670 6 1,255 Depreciation and amortisation 6C 8 4,073 8 0,174 Write down and impairment of assets 6D 1 08 5 ,241 Grants 6E 5 ,021 6 ,225 Finance costs 6F 1 2,490 1 5,192 Foreign exchange losses 6G 8 54 6 96 Losses from asset sales 6H 91 3 ,151 TOTAL EXPENSES 2 73,009 274,996 LESS: OWN-SOURCE INCOME Own-source revenue Sale of goods and rendering of services 5B 6 9,988 56,582 Interest 5D 5 ,040 7,357 Grants 5C 1 ,674 2,084 Total own-source revenue 7 6,702 66,023 Gains Gains from sale of assets 5E 1 72 270 Foreign exchange gains - non speculative 5F 1 ,831 832 Other revenue 5G 7 9 2,550 Total gains 2 ,082 3,652 Total Own-source income 7 8,784 69,675 Net cost of services 1 94,225 205,321 Revenue from Government 5A 1 57,676 165,592 (Deficit) before income tax on continuing operations (36,549) (39,729) Income tax (expense) benefit 23 1,200 ( 345) (Deficit) after income tax on continuing operations (35,349) (40,074) (Deficit) after income tax (35,349) (40,074) (Deficit) attributable to the Australian Government (35,349) (40,074) OTHER COMPREHENSIVE INCOME Changes in asset revaluation reserves 10 129,148 10,652 Total other comprehensive income (deficit) after income tax 93,799 (29,422) Total comprehensive income (deficit) attributable to the Australian Government 93,799 (29,422) The above statement should be read in conjunction with the accompanying notes 2 ANSTO ANNUAL REPORT 2011-12 PAGE 46 2011-12 FinAnCiAl stAteMents AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION CCoOnNSsOoLliIdDAaTtEeDd B bAaLAlaNnCcEe S HsEhEeTet aass aat t3 03 J0u nJeu 2n0e12 2012 Consolidated 2 012 2011 Notes $'000 $'000 ASSETS Financial assets Cash and cash equivalents 7A, 21 3,411 3,278 Trade and other receivables 7B, 21 15,968 11,727 Investments 7C, 21 67,389 115,268 Total financial assets 86,768 130,273 Non-financial assets Land and buildings 8A 281,404 209,164 Infrastructure, plant and equipment and major facilities 8B 740,445 696,513 Inventories 8C 22,247 15,629 Intangibles 8D 20,800 18,948 Tax assets 8E 1,200 - Other non-financial assets 8E 2,643 7,255 Total non-financial assets 1,068,739 947,509 Total assets 1,155,507 1 ,077,782 LIABILITIES Payables Suppliers 9E, 21 1 4,786 1 1,383 Employees 9F, 21 5 ,544 3 ,836 Grants 9G, 21 4 81 6 87 Other 9H, 21 1,480 1,433 Total payables 2 2,291 1 7,339 Interest bearing liabilities Other 9A, 21 5 2 2,484 Total interest bearing liabilities 52 2 ,484 Provisions Employee provisions 9B 31,373 28,528 Decommissioning provision 9C 263,011 291,465 Other 9D 45 286 Total provisions 294,429 320,279 Total liabilities 3 16,772 3 40,102 Net assets 8 38,735 737,680 EQUITY Contributed equity 10 489,356 481,956 Reserves 10 480,341 350,809 Retained (deficit) 10 (130,962) (95,085) Total equity 838,735 737,680 The above statement should be read in conjunction with the accompanying notes 3 PAGE 47 FINANCIAL STATEMENTS CAoUSnTsRoAlLidIAaNt NeUdC sLtEaAtRe SmCIeEnNCt Eo Af NcDa TsEhC flHNoOwLsOGY ORGANISATION fCoOrN tShOeLI DyAeTaErD e SnTdATeEdM 3EN0T J uOFn CeA 2S0H1 F2LOWS for the year ended 30 June 2012 Consolidated 2 012 2 011 $'000 $'000 Inflows Inflows Note (Outflows) (Outflows) OPERATING ACTIVITIES Cash received Sales of goods and rendering of services 7 0,162 56,640 Interest 5 ,376 8 ,377 Receipts from Government 1 57,676 165,592 Total cash received 2 33,214 230,609 Cash used Employees (110,149) ( 99,000) Suppliers (71,038) ( 81,201) Total cash used (181,187) ( 180,201) NET CASH FLOWS FROM OPERATING ACTIVITIES 11 5 2,027 50,408 INVESTING ACTIVITIES Cash received Proceeds from sale of property, plant and equipment 1,483 1 ,526 Proceeds from investment sales 2 36,933 1 73,525 Total cash received 2 38,416 1 75,051 Cash used Purchase of property, plant and equipment and intangibles (108,656) ( 81,511) Loans to related parties - - Purchase of investments (189,054) ( 159,793) Total cash used (297,710) (241,304) NET CASH USED BY INVESTING ACTIVITIES ( 59,294) ( 66,253) FINANCING ACTIVITIES Cash received Appropriation - contributed equity 7,400 1 4,100 NET CASH FLOWS FROM FINANCING ACTIVITIES 7,400 14,100 NET INCREASE/(DECREASE) IN CASH HELD 1 33 ( 1,745) Cash and cash equivalents at the beginning of the reporting period 3 ,278 5 ,023 Cash and cash equivalents at the end of the reporting period 3,411 3 ,278 The above statement should be read in conjunction with the accompanying notes 4 ANSTO ANNUAL REPORT 2011-12 PAGE 48 2011-12 FinAnCiAl stAteMents AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION CCoOnNSsOoLlIiDdAaTEtDe SdT AsTtEaMtEeNTm ofe CnHtA NoGfE Sc hin aEQnUgITeYs in equity foforr ttheh yee ayr eeandre de 3n0d Jeunde 32001 2June 2012 Consolidated Asset Retained Deficit Revaluation Reserve Other Reserves 2012 2 011 2012 2 011 2012 2 011 $'000 $'000 $'000 $'000 $'000 $'000 Opening Balance (95,085) (58,404) 339,108 328,456 11,701 14,902 Foreign currency translation - - - - ( 144) 2 01 Revaluation increment - - 129,148 10,652 - - Other - - - - - ( 139) Deficit for the period (35,349) (40,074) - - - - Total comprehensive income (35,349) (40,074) 129,148 10,652 ( 144) 6 2 Contributions by Owners Appropriation (equity injection) - - - - - - Sub-total Transactions with Owners - - - - - - Transfers between equity components (528) 3,393 - - 5 28 (3,263) Closing balance as at 30 June (130,962) (95,085) 468,256 339,108 12,085 11,701 Closing balance attributable to (130,962) (95,085) 468,256 339,108 12,085 11,701 Australian Government The above statement should be read in conjunction with the accompanying notes AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION CONSOLIDATED STATEMENT of CHANGES in EQUITY for the year ended 30 June 2012 Consolidated Contributed Equity/Capital Total Equity 2012 2 011 2 012 2 011 $'000 $'000 $'000 $'000 Opening Balance 481,956 467,856 737,680 752,810 Foreign currency translation - - ( 144) 201 Revaluation increment - - 129,148 10,652 Other - - - ( 139) Deficit for the period - - (35,349) (40,074) Total comprehensive income - - 9 3,655 (29,360) Contributions by Owners Appropriation (equity injection) 7 ,400 14,100 7 ,400 14,100 Sub-total Transactions with O w n e r s 7 ,400 14,100 7 ,400 14,100 Transfers between equity components - - - 1 30 Closing balance as at 30 June 489,356 481,956 838,735 737,680 Closing balance attributable to 489,356 481,956 838,735 737,680 Australian Government The above statement should be read in conjunction with the accompanying notes PAGE 49 FINANCIAL STATEMENTS 5 AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION CCoOnNSsOoLlIiDdAaTtEeDd S CsHcEhDeUdLEu OleF CoOfM cMoITmMmENiTtSm NOeTn RtEsC nOoGNt ISreEDc oASg nLIiAsBeILdIT IES aas alti a30b Jiulnite i2e0s12 as at 30 June 2012 Consolidated Notes 2 012 2011 BY TYPE $'000 $'000 Commitments receivable Other commitments receivable GST recoverable from Australian Taxation Office on Commitments 7,972 6,290 Total other commitments receivable 7,972 6,290 Commitments payables CAPITAL COMMITMENTS Infrastructure, plant and equipment 71,972 67,944 Total capital commitments 71,972 67,944 OTHER COMMITMENTS Replacement Research Reactor Project (OPAL) (a) 3,093 6,786 Operating lease (b) 1,725 1,862 Fuel elements purchase 9,693 1,242 Mo-99 plates purchase 6,024 901 Total other commitments 20,535 10,791 Net commitments by type 84,535 72,445 BY MATURITY Capital commitments payable One year or less 8,581 22,693 From one to five years 63,391 45,251 71,972 67,944 OTHER COMMITMENTS One year or less 12,022 9,066 From one to five years 7,610 685 Over five years 903 1,040 Total other commitments 20,535 10,791 Other commitments receivable One year or less 2,209 2,176 From one to five years 5,763 4,114 7,972 6,290 Net commitments by maturity 84,535 72,445 (a) A contract was executed on 13 July 2000 between ANSTO and INVAP SE for the design, construction and commissioning of a replacement research reactor at Lucas Heights. The remaining amount of $3.093 million (2011: $6.786 million) is included in commitments. (b) ANSTO has a twenty five year lease contract with Central Sydney Area Health Services that will expire on 29 Jan 2025 with an annual rental payable of $137,000 (2011: $137,000).The annual rental is subject to review every three years. The amounts reported as commitments payable includes GST where relevant. Recoveries due from the Australian Taxation Office in relation to commitments payable are disclosed as commitments receivable. The above schedule should be read in conjunction with the accompanying notes. ANSTO ANNUAL REPORT 2011-12 PAGE 50 6 2011-12 FinAnCiAl stAteMents AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION sSCHEDULE OF CONTINGENCIESasc aht e30d Juunlee 2 o01f2 contingencies as at 30 June 2012 Unquantifiable Contingencies At 30 June 2012, ANSTO still has the likelihood of claims in relation to asbestos related diseases. It is not possible to estimate the amounts of any eventual payments that may be required in relation to these claims. Such claims are however covered by the Department of Finance and Deregulation provision dealing with asbestos related claims against any Commonwealth Authorities including ANSTO in the event of any litigation or claim for compensation. Contingent Liabilities On 25 June 2012, Cyclopharm Limited's wholly owned subsidiary, CycloPet Pty Ltd., commenced proceedings against ANSTO and PETNET Australia Pty Ltd, the wholly owned subsidiary of ANSTO in the Federal Court of Australia alleging anticompetitive conduct. ANSTO and PETNET Australia Pty Ltd will strongly defend the case and will manage any litigation claim exposure under the Professional Indemnity section of the 2011/2012 Comcover policy. The above schedule should be read in conjunction with the accompanying notes. PAGE 51 FINANCIAL STATEMENTS 7 AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION NOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTS for the yearn eondteeds 3 0t oJu anen 2d0 1f2orming part of the Financial statements for the year ended 30 June 2012 Note Description 1 Objectives of the entity 2 Summary of significant accounting policies 3 Events subsequent to reporting date 4 Reporting of outcomes 5 Own source revenue 6 Expenses 7 Financial assets 8 Non-financial assets 9 Liabilities 10 Equity 11 Cash flow reconciliation 12 Government funding 13 Board membership 14 Remuneration of members of the Board 15 Remuneration of senior executives 16 OPAL Nuclear Research Reactor 17 Insurances 18 Remuneration of auditors 19 Related party disclosures 20 Trust money 21 Financial instruments 22 Operating lease arrangements 23 Income tax expense (benefit) 24 Other comprehensive income 25 Information relating to ANSTO ('the parent entity") ANSTO ANNUAL REPORT 2011-12 PAGE 52 8 2011-12 FinAnCiAl stAteMents AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION NnOToESt eTOs AtNoD aFOnRdMING PART OF THE FINANCIAL STATEMENTS for the year ended 30 Ju nfeo 2r0m12 ing part of the Financial statements for the year ended 30 June 2012 1 Objectives of Australian Nuclear Science and Technology Organisation Australian Nuclear Science and Technology Organisation (ANSTO) is an Australian Government controlled entity. The objectives of ANSTO are detailed in the body of this Annual Report. ANSTO has only one outcome as reflected in the 2011-12 Portfolio Budget Statement as indicated below: Outcome 1: Improved knowledge, innovative capacity and healthcare through nuclear -based facilities, research, training, products, services and advice to Government, industry, the education sector and the Australian population. ANSTO's activities contributing towards the outcome are classified as departmental. Departmental activities involve the use of assets, liabilities, revenues and expenses controlled or incurred by ANSTO in its own right. Administered activities involve the management or oversight by ANSTO, on behalf of the Government, of items controlled by the Government. ANSTO does not have any administered activities. The continued existence and operations of the Australian Nuclear Science and Technology Organisation (ANSTO) and its present programs is dependent on Government policy and on continuing funding by the Commonwealth Government for ANSTO's administration and programs. Reference to ANSTO, means ANSTO Consolidated except for under taxation note 2(s). 2 Summary of significant accounting policies (a) Basis of preparation of the Financial Statements The financial statements and notes are required by clause 1(b) of Schedule 1 to the Commonwealth Authorities and Companies Act 1997 (CAC Act) and are general purpose financial statements. They have been prepared: i. having regard to the provisions of the Australian Nuclear Science and Technology Organisation (ANSTO) Act 1987 (as amended) ii. in accordance with: . Finance Minister's Orders (FMOs) for reporting periods ending on or after 1 July 2011; and . Australian Accounting Standards and Interpretations issued by the Australian Accounting Standards Board (AASB) that apply for the reporting period. The financial statements have been prepared on an accruals basis and in accordance with the historical cost convention, except for certain assets which are stated at fair value. Except where stated, no allowance is made for the effect of changing prices on the results or the financial position. The financial report is presented in Australian dollars and values are rounded to the nearest thousand dollars unless otherwise specified. Unless an alternative treatment is specifically required by an Accounting Standard or the FMOs, assets and liabilities are recognised in the Balance Sheet when and only when it is probable that future economic benefits will flow to ANSTO or a future sacrifice of economic benefits will be required and the amounts of the assets or liabilities can be reliably measured. However, assets and liabilities arising under executor contracts are not recognised unless required by an Accounting Standard. Liabilities and assets that are unrecognised are reported in the Schedule of Commitments or the Schedule of Contingencies. Unless alternative treatment is specifically required by an Accounting Standard, income and expenses are recognised in the Statement of Comprehensive Income when and only when the flow, consumption or loss of economic benefits has occurred and can be reliably measured. (b) Significant Accounting Judgements and Estimates In the process of applying the accounting policies listed in this note, ANSTO has made the following judgements that have the most significant impact on the amounts recorded in the financial statements. • The fair value of land and buildings. • The fair value of OPAL and other plant and equipment and their useful life. • Decommissioning costs provision. Apart from these assumptions and estimates no other accounting assumptions or estimates have been identified that have a signif icant risk of causing a material adjustment to carrying amounts of assets and liabilities within the next accounting period. (c) Statement of Compliance Australian Accounting Standards require a statement of compliance with International Financial Reporting Standards (IFRSs) to be made where the financial report complies with these standards. Some Australian equivalents to IFRSs and other Australian Accounting Standards contain requirements specific to not-for-profit entities that are inconsistent with IFRS requirements. ANSTO is a not-for-profit entity and has applied these requirements, so while this financial report complies with Australian Accounting Standards including Australian Equivalents to International Financial Reporting Standards (AEIFRSs) it does not comply with IFRS in all respects. PAGE 53 FINANCIAL STATEMENTS 9 AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION NOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTS fonr thoet yeasr etnode ad n30d Ju fnoe 2r0m12ing part of the Financial statements for the year ended 30 June 2012 (d) Adoption of new Australian Accounting Standard requirements No accounting standard has been adopted earlier than the application date as stated in the standard. No new standards/revised standards/Interpretations or amending standards were issued prior to the signing of the statement by the chief executive and chief financial officer, which were applicable to the current reporting period and had a financial impact on ANSTO. Other new standards/revised standards/Interpretations or amending standards that were issued prior to the signing of the statement by the chief executive and chief financial officer and are applicable to the current reporting period did not have a financial impact, and are not expected to have a future financial impact on ANSTO. Future Australian Accounting Standard Requirements No new standards/revised standards/Interpretations or amending standards were issued by the Australian Accounting Standards Board prior to the signing of the statement by the chief executive and chief financial officer, which are expected to have a financial impact on ANSTO for future reporting periods. Other new standards/revised standards/Interpretations or amending standards that were issued prior to the signing of the statement by the chief executive and chief financial officer and are applicable to the future reporting period are not expected to have a future financial impact on ANSTO. (e) Reporting by outcomes A comparison of current and prior years' figures by outcome as specified in the Portfolio Budget Statements relevant to ANSTO, is presented in Note 4. (f) Revenue recognition Revenue from Government Funding received or receivable from Department of Innovation, Industry, Science and Research (DIISR) (appropriated to ANSTO as a CAC Act body) is recognised as Revenue from Government unless it is in the nature of an equity injection. Equity injections Amounts that are designated as equity injections for a year are recognised directly in contributed equity in that year. Operating revenue from goods and services Revenue from the sale of goods is recognised when: • The risks and rewards of ownership have been transferred to the buyer; • ANSTO retains no managerial involvement nor effective control over the goods; • The revenue and transaction costs incurred can be reliably measured; and • It is probable that the economic benefits associated with the transaction will flow to ANSTO. Receivables for goods and services are recognised at the nominal amounts due less any impairment allowance. Collectability of debts is reviewed at balance date. Allowance is made when collectability of the debt is no longer probable. Revenue received in advance Revenue received in advance is initially brought to account as "unearned revenue" and subsequently recognised as revenue when earned. Contract revenue Revenue from the rendering of a service is recognised by reference to the stage of completion of each contract. The stage of completion is determined by reference to the proportion that the completed physical contract work bears to the estimated total physical contract work. Interest revenue Interest revenue is recognised using the effective interest method as set out in AASB 139 Financial Instruments: Recognition and Measurement. Gains from sale of assets Revenue is recognised when control of the asset has passed to the buyer. ANSTO ANNUAL REPORT 2011-12 PAGE 54 10 2011-12 FinAnCiAl stAteMents AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION NnOToESt TOs AtNoD aFOnRMING PART OF THE FINANCIAL STATEMENTS for the year ended 30 dJu nfeo 2r0m12 ing part of the Financial statements for the year ended 30 June 2012 Core operations All material revenues described in this note are revenues relating to the core operating activities of ANSTO. Details of revenue amounts are given in Note 5. Resources Received Free of Charge Resources received free of charge are recognised as revenue when and only when a fair value can be reliably determined and the services would have been purchased if they had not been donated. Use of those resources is recognised as an expense. Resources received free of charge are recorded as either revenue or gains depending on their nature i.e. whether they have been generated in the course of the ordinary activities of ANSTO. Parental Leave Payments Scheme Amounts received under the Parental Leave Payments Scheme not yet paid to employees are presented gross as cash and a liability (payable). Amounts received and not paid at 30 June 2012 amounted to $10,759 (2011: nil). (g) Employee benefits Benefits Liabilities for services rendered by employees are recognised at the reporting date to the extent that they have not been settled. Liabilities for wages and salaries and annual leave are measured at their nominal amounts. Other employees benefits expected to be settled within 12 months of their reporting date are also measured at their nominal amounts. The provision for employee entitlements encompasses annual leave and long service leave that ANSTO has a present obligation to pay resulting from employee services provided up to balance date. The leave liabilities are calculated on the basis of employees' remuneration, including employer superannuation contribution rates to the extent that the leave is likely to be taken during service rather than paid out on termination. ANSTO has used the Department of Finance and Deregulation shorthand method in valuation of the liability for long service leave. The estimate of the present value of the liability takes into account attrition rates and pay increases through promotion and inflation. The nominal amount is calculated with regard to the rates expected to be paid on settlement of the liability. General leave The Enterprise Agreement provides under the heading General Leave for an employee entitlement which combines sick leave, carer's leave and leave for other prescribed purposes. No provision has been made for general leave as all such leave is non-vesting and the average general leave taken by employees is less than the annual entitlement. Separation and redundancy Provision is made for separation and redundancy benefits payments. ANSTO recognises a provision for termination when it has developed a detailed formal plan for the termination and has informed those employees affected that it will carry out the termination. The total provision in the financial statements for 1 staff (2011: 5) amounted to $25,000 (2011: $436,000). (h) Superannuation ANSTO contributes to the Commonwealth Superannuation (CSS) and the Public Sector (PSS) superannuation schemes or PSS accumulation plan (PSSap) which provide retirement, death and disability benefits to employees. The CSS and PSS are defined benefit schemes for the Commonwealth while the PSSap is a defined contribution scheme. Contributions to the schemes are at rates calculated to cover existing and emerging obligations. Applicable contribution rates in 2012 were 17.8% (2011 14.4%) of salary (PSS), 16.9% (2011 17.0%) of salary (CSS), and 15.4% (2011 15.4%) of salary (PSSap). An additional 3% is contributed to PSS and CSS for employer productivity benefits. The Enterprise Agreement signed in March 2012 provided that all ANSTO employees under the agreement who contributed to non Commonwealth superannuation schemes, are to receive a contribution equivalent to 15.4% of salary. For those staff who do not contribute to any of these schemes and are not covered by Enterprise Agreement, ANSTO contributes an amount equivalent to 9% of salary to the Australian Government Employees Superannuation Trust fund or to the complying fund nominated by the employee. ANSTO makes employer contributions to the employees' superannuation scheme at rates determined by actuary to be sufficient to meet the current cost to the Government. ANSTO accounts for contributions as if they are contributions to defined contribution plans. The liability for superannuation recognised as at 30 June represents outstanding contributions for the final fortnight of the year. Contributions during the year are detailed in Note 6A. (i) Leases Operating leases payments are expensed on a straight-line basis which is representative of the pattern of benefits derived from the leased assets. PAGE 55 FINANCIAL STATEMENTS 11 AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION NnOToEtSe TsO AtNoD a FOnRdM IfNoGr PmARiTn OgF pTHaEr FtIN oANf CtIAhLe S TFAiTnEaMEnNcTiSa l statements for the year ended 30 June 2012 for the year ended 30 June 2012 (j) Cash Cash is recognised at its nominal amount. Cash and cash equivalents includes: • cash on hand; • demand deposits in bank accounts with an original maturity of 3 months or less that are readily convertible to known amounts of cash and subject to insignificant risk of changes in value. (k) Financial instruments ANSTO classifies its financial assets in the following categories: • 'financial assets as at fair value through profit or loss' • 'held-to-maturity investments', • 'loans and receivables'. The classification depends on the nature and purpose of the financial assets and is determined at the time of initial recogniti on. Financial assets are recognised and derecognised upon ‘trade date’. Effective interest method The effective interest method is a method of calculating the amortised cost of a financial asset and of allocating interest income over the relevant period. The effective interest rate is the rate that discounts estimated future cash receipts through the expected life of the financial asset, or, where appropriate, a shorter period. Income is recognised on an effective interest rate basis except for financial assets ‘at fair value through profit or loss’. Financial assets at fair value through profit or loss Financial assets are classified as financial assets at fair value through profit or loss where the financial assets have been acquired principally for the purpose of selling in the near future. Assets in this category are classified as current assets. Financial assets at fair value through profit or loss are stated at fair value, with any resultant gain or loss recognised in the profit orloss. The net gain or loss recognised in the profit or loss incorporates any interest earned on the financial assets. Where a reliable fair value cannot be established for unlisted investments in equity instruments, cost is used less impairment if applicable. Held-to-maturity investments Non-derivative financial assets with fixed or determinable payments and fixed maturity dates that the group has the positive intent and ability to hold to maturity are classified as held-to-maturity investments. Held-to-maturity investments are recorded at amortised cost using the effective interest method less impairment, with revenue recognised on an effective yield basis. Loans and receivables Trade receivables, loans and other receivables that have fixed or determinable payments that are not quoted in an active market are classified as ‘loans and receivables’. Loans and receivables are measured at amortised cost using the effective interest method less impairment. Interest is recognised by applying the effective interest rate. Impairment of financial assets Financial assets are assessed for impairment at each balance date. • Financial assets held at amortised cost - If there is objective evidence that an impairment loss has been incurred for loans and receivables or held to maturity investments held at amortised cost, the amount of the loss is measured as the difference between the asset’s carrying amount and the present value of estimated future cash flows discounted at the asset’s original effective interest rate. The carrying amount is reduced by way of an allowance account. The loss is recognised in the statement of comprehensive income. • Available for sale financial assets (held at cost) - If there is objective evidence that an impairment loss has been incurred the amount of the impairment loss is the difference between the carrying amount of the asset and the present value of the estimated future cash flows discounted at the current market rate for similar assets. Financial Liabilities Financial liabilities are classified as either financial liabilities ‘at fair value through profit or loss’ or other financial liabilities. Financial liabilities are recognised and derecognised upon ‘trade date’. Other financial liabilities Other financial liabilities, including borrowings, are initially measured at fair value, net of transaction costs. These liabilities are subsequently measured at amortised cost using the effective interest method, with interest expense recognised on an effective yield basis. ANSTO ANNUAL REPORT 2011-12 PAGE 56 12 2011-12 FinAnCiAl stAteMents AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION NOnToESt eTOs AtNoD aFOnRdM INfGo rPmARTin OgF TpHaE rFItN AoNfC tIAhL eST FATinEMaEnNTcSi al statements for the year ended 30 June 2012 for the year ended 30 June 2012 The effective interest method is a method of calculating the amortised cost of a financial liability and of allocating interest expense over the relevant period. The effective interest rate is the rate that exactly discounts estimated future cash payments through the expected life of the financial liability, or, where appropriate, a shorter period. Supplier and other payables Supplier and other payables are recognised at amortised cost. Liabilities are recognised to the extent that the goods or services have been received (and irrespective of having been invoiced). (l) Contingent Liabilities and Contingent Assets Contingent liabilities and contingent assets are not recognised in the balance sheet but are reported in the relevant schedules and notes. They may arise from uncertainty as to the existence of a liability or asset or represent an asset or liability in respect of which the amount cannot be reliably measured. Contingent assets are disclosed when settlement is probable but not virtually certain and contingent liabilities are disclosed when settlement is greater than remote. (m) Acquisition of Assets Assets are recorded at cost on acquisition except as stated below. The cost of acquisition includes the fair value of assets transferred in exchange and liabilities undertaken. Financial assets are initially measured at their fair value plus transaction costs where appropriate. Assets acquired at no cost, or for nominal consideration, are initially recognised as assets and revenues at their fair value at the date of acquisition, unless acquired as a consequence of restructuring of administrative arrangements. In the latter case, assets are initially recognised as contributions by owners at the amounts at which they were recognised in the transferor's accounts immediately prior to the restructuring. (n) Buildings, infrastructure, plant and equipment and major facilities Asset recognition threshold Items of buildings, infrastructure, plant and equipment and major facilities are recorded at cost of acquisition and depreciated asoutlined below. Items of plant and equipment with a cost of less than $3,000 are expensed in the year of acquisition. The initial cost of an asset includes an estimate of the cost of dismantling and removing the item and restoring the site on which it is located at the end of its useful life. This is particularly relevant to ‘make good’ or decommissioning provisions on buildings, infrastructure, plant and equipment and major facilities, taken up by ANSTO where there exists an obligation to restore the property to its original condition. These costs are included in the value of the asset it relates to with a corresponding provision for the ‘make good’ or decommissioning taken up. Any changes to the initial decommissioning cost attributable to adjustments to the consumer price index (cpi) and discount rate at 30 June each year will be reflected as an adjustment to the Provision for Decommissioning cost and Asset Revaluation Reserve in accordance with the Department of Finance and Deregulation Accounting Guidance Note. The cost of assets constructed by the entity includes the cost of materials, direct labour and an appropriate proportion of fixed and variable overheads. Revaluations Fair values for each class of asset are determined as shown below: Asset Class Fair value measured at Land Market Value Buildings Market Value Site infrastructure Market Value Electrical infrastructure Market Value Plant and equipment Market Value National and major facilities Market Value Following initial recognition at cost, buildings, infrastructure, plant and equipment and major facilities are carried at fair value less accumulated depreciation and accumulated impairment losses. Valuations are conducted with sufficient frequency to ensure that the carrying amounts of assets do not differ materially from the assets’ fair values as at the reporting date. The regularity of independent valuations depends upon the volatility of movements in market values for the relevant assets. Revaluation adjustments are made on a class basis. Any revaluation increment is credited to equity under the heading of asset revaluation reserve except to the extent that it reverses a previous revaluation decrement of the same asset class that was previously recognised through profit and loss. Revaluation decrements for a class of assets are recognised directly through profit and loss except to the extent that they reverse a previous revaluation increment for that class. Any accumulated depreciation as at the revaluation date is eliminated against the gross carrying amount of the asset and the asset restated to the revalued amount except for assets relating to decommissioning that are not subjected to revaluation. All valuation are carried out by qualified parties, independent of ANSTO. The valuations were performed by independent valuers of the Australian Valuation Officers (AVO), Mr. Simon O'Leary (registered Valuer No. 1128), Mr. Christofer Fratzia (registered Valuer No. 3794) and Mr. Kashyap Budhbhatti at 30 June 2012, based on the asset list at 31 October 2011. PAGE 57 FINANCIAL STATEMENTS 13 AnUSoTtReALsIA tNo N UaCnLdEA fRo SrCmIENiCnEg A NpDa TrEtC oHNfO tLhOGeY F OiRnGaAnNIcSATIONNOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTiaS l statements fofro thre ytehare e nydeda 3r0 Jeuned 2e01d2 30 June 2012 Depreciation and amortisation Items of buildings, infrastructure, plant and equipment and major facilities, but excluding freehold land, are depreciated over their estimated useful lives to ANSTO using the straight line method. Depreciation and amortisation rates applying to each class of depreciable asset are based on the following useful lives: 2012 2011 Buildings on freehold land 5 to 50 years 5 to 50 years Plant and equipment 2 to 30 years 2 to 30 years Infrastructure 20 years 20 years National and major facilities 5 to 40 years 5 to 40 years The depreciation rates (useful lives) of ANSTO's buildings, infrastructure, plant and equipment and major facilities have been reviewed during the year and found to be appropriate. The aggregate amount of depreciation allocated for each class of asset during the reporting period is disclosed in Note 6C. Impairment All assets were assessed for impairment at 30 June 2012. Where indications of impairment exist, the asset’s recoverable amount is estimated and an impairment adjustment made if the asset’s recoverable amount is less than its carrying amount. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use. Value in use is the present value of the future cashflows expected to be derived from the asset. Where the future economic benefit of an asset is not primarily dependenton the asset's ability to generate future cash flows, and the asset would be replaced if the entity were deprived of the asset, its value in use is taken to be its depreciated replacement cost. (o) Inventories Stores are valued at purchase cost on a first-in-first-out basis. Provision is made for obsolete inventory and diminution in value. Inventories of Cobalt-60 and enriched uranium are valued on the basis of lower of cost and net realisable value. Stocks of reactor fuel are valued at average purchase price. Heavy water is valued at lower of cost and net realisable value. Finished goods and work in progress are valued at cost of direct materials and labour plus attributable costs that are capable of being allocated on a reasonable basis. (p) Intangibles Software Items of software are recorded at cost and amortised as outlined below. Items with a cost of less than $3,000 are expensed in the year of acquisition. There is no material internal software development. Software and licences are reported at cost. Intellectual property Intellectual property treated as intangible assets and acquired separately is measured on initial recognition at cost. The useful lives of intangible assets are assessed as either finite or indefinite. Intangible assets with finite lives are amortised over the useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired. Intangible assets with indefinite useful lives are not amortised, but are tested for impairment annually, either individually or at the cash-generating unit level. ANSTO ANNUAL REPORT 2011-12 PAGE 58 14 2011-12 FinAnCiAl stAteMents AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION NOnTEoS tTeOs A NtDo F aOnRMdIN fGo PrAmRTi nOFg TpHaE rFItN AoNfC tIAhLe S TFAiTnEaMEnNTS for the year ended 30 June 2012 cial statements for the year ended 30 June 2012 Amortisation Intangibles are amortised over their estimated useful lives to ANSTO using the straight line method. Amortisation rates applying to intangibles are as follows: 2012 2011 Purchased software 2 - 7 years 2 - 7 years Licences 3 years 3 years The amortisation rates (useful lives) of ANSTO's software and licences have been reviewed during the year and found to be appropriate. The aggregate amount of amortisation allocated for each class of asset during the reporting period is disclosed in Note 6C. Impairment All assets were assessed for impairment at 30 June 2012. Where indications of impairment exist, the asset’s recoverable amount is estimated and an impairment adjustment made if the asset’s recoverable amount is less than its carrying amount (q) Patents Due to the uncertain commercial value of patents, trademarks, designs and applications, and because benefits extending beyond one accounting period cannot be assured, the costs associated with the development and registration of patents are expensed in the year in which they are incurred, unless recoverability is assured beyond any reasonable doubt. At 30 June 2012 there were 208 patents, trademarks, design and applications (212 at 30 June 2011) registered to ANSTO and no associated costs are recognised as an asset (nil at 30 June 2011). (r) Foreign currency Transactions denominated in a foreign currency are converted to Australian currency at the rate of exchange prevailing at the date of the transaction. At balance date, amounts receivable and payable in foreign currency are translated to Australian currency at the exchange rate prevailing at that date and any exchange differences are brought to account in the Statement of Comprehensive Income. ANSTO did not enter into speculative forward exchange contracts during the reporting period. (s) Taxation ANSTO is exempt from all forms of taxation in Australia except fringe benefits tax (FBT) and the goods and services tax (GST). ANSTO is not subject to exemption from any foreign taxation laws relative to its overseas operations. ANSTO's subsidiaries are subject to normal taxation. ANSTO Inc, a USA company, is subject to US tax laws. No Deferred Tax Asset has been recognised at 30 June 2012 in relation to ANSTO Inc as the directors do not believe it is probable that sufficient profits will be generated to utilise the tax losses. Revenues, expenses and assets are recognised net of GST except: • where the amount of GST incurred is not recoverable from the Australian Taxation Office; and • for receivable and payables. Subsidiaries Unbooked deferred tax assets in relation to unrecouped tax losses including timing difference in the subsidiaries is $52 thousand (2011: $1,047 thousand) The total deferred tax assets recognised in relation to PETNET Australia Pty Ltd for 30 June 2012 is $1,200 thousand. In respect of the subsidiaries, current tax assets and liabilities for the current and prior periods are measured at the amount expected to be recovered from or paid to the taxation authorities based on the current period's taxable income. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted by the balance sheet date. Deferred income tax is provided on all temporary differences at the balance sheet date between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes. Deferred income tax liabilities are recognised for all taxable temporary differences except: • when the deferred income tax liability arises from the initial recognition of goodwill or of an asset or liability in a transaction that is not a business combination and that, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss; or • when the taxable temporary difference is associated with investments in subsidiaries, associates or interests in joint ventures, and the timing of the reversal of the temporary difference can be controlled and it is probable that the temporary difference will not reverse in the foreseeable future. PAGE 59 FINANCIAL STATEMENTS 15 AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION NOnToESt eTOs AtNoD a FnORdM fINoGr mPAiRnTg O Fp TaHrEt F oINfA tNhCIeAL F SiTATEMENTS for the year ended 30 June 2012 nancial statements for the year ended 30 June 2012 Deferred income tax assets are recognised for all deductible temporary differences, carry forward of unused tax credits and unused tax losses, to the extent that it is probable that taxable profit will be available against which the deductible temporary differences and the carry forward of unused tax credits and unused tax losses can be utilised, except: • when the deferred income tax asset relating to the deductible temporary difference arises from the initial recognition of an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss; or • when the deductible temporary difference is associated with investments in subsidiaries, associates or interests in joint ventures, in which case a deferred tax asset is only recognised to the extent that it is probable that the temporary difference will reverse in the foreseeable future and taxable profit will be available against which the temporary difference can be utilised. Unrecognised deferred income tax assets are reassessed at each balance sheet date and are recognised to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realised or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the balance sheet date. Deferred tax assets and deferred tax liabilities are offset only if a legally enforceable right exists to set off current tax assets against current tax liabilities and the deferred tax assets and liabilities relate to the same taxable entity and the same taxation authority. (t) Principles of consolidation ANSTO has investments in a number of companies (refer Note 7D) over which it has control. These companies have been established for the purpose of (i) commercialisation of ANSTO's intellectual property or (ii) a requirement for ANSTO to operate in the industry as in the case of ANSTO Inc., an operation in the U.S.A.. (u) Interest in joint venture A joint venture is a contractual arrangement whereby ANSTO and the other parties undertake an economic activity that is subject to joint control ( i.e when the strategic financial and operating policy decisions relating to the activities of the joint venture require the unanimous consent of the parties sharing control). ANSTO has an investment in Element 42 LLC (refer Note 7E) over which it has shared control. (v) Comparatives Where necessary, comparative information for the preceding financial year has been reclassified to achieve consistency in disclosure with current financial year amounts and other disclosures. (w) Rounding Amounts are rounded to the nearest one thousand dollars except in relation to: - remuneration of members of the Board - remuneration of executives - audit fees 3 Events subsequent to reporting date No events have arisen since the end of the financial year which require disclosure or the financial statements to be adjusted. ANSTO ANNUAL REPORT 2011-12 PAGE 60 16 2011-12 FinAnCiAl stAteMents AUnSToRtAeLIsA Nt oNU aCnLEdA Rfo SrCmIENiCnEg A pNDa rTEt CoHfN OthLOeG FY iOnRaGnANcIiSaAlT sIONNOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTS tatements for fthoer y etahr en dyeed a30r J eunne d20e1d2 30 June 2012 4 Reporting of Outcomes ANSTO operates mainly within Australia, and mainly in the nuclear scientific research industry. Reporting by outcomes: ANSTO has only one outcome. Major Classes of Departmental Revenues and Expenses by Outcome - Consolidated Consolidated 2012 2011 $'000 $'000 Operating revenues Revenue from Government 157,676 165,592 Sale of goods and services 69,988 56,582 Interest 5,040 7,357 Net gain from sale of assets 172 270 Other 3,584 5,466 Income tax benefits 1,200 - Total operating revenues 237,660 235,267 Operating expenses Employees 114,702 103,062 Suppliers 55,670 61,255 Depreciation and amortisation 84,073 80,174 Finance costs 12,490 15,192 Write-down and impairment of assets 108 5,241 Other 5,966 10,417 Total operating expenses 273,009 275,341 Major Classes of Departmental Assets and Liabilities by Outcome - Consolidated Consolidated 2012 2011 $'000 $'000 Assets Cash and cash equivalents 3,411 3,278 Trade and other receivables 15,968 11,727 Investments 67,389 115,268 Land and buildings 281,404 209,164 Infrastructure, plant and equipment 740,445 696,513 Inventories 22,247 15,629 Intangibles 20,800 18,948 Tax assets 1,200 - Other 2,643 7,255 Total assets 1,155,507 1,077,782 Suppliers 14,786 11,383 Employees payables 5,544 3,836 Grants 481 687 Other payables 1,480 1,433 Interest bearing liabilities 52 2,484 Employee provisions 31,373 28,528 Decommissioning provision 263,011 291,465 Other provisions 45 286 Total liabilities 316,772 340,102 Notes: The net costs include intra - government costs that would be eliminated in calculating the actual Budget outcome. 17 PAGE 61 FINANCIAL STATEMENTS noAtUeSsT tRoA LaIAnNd N fUoCrLmEAiRn SgC pIEaNrCtE oAfN Dt hTEeC FHiNnOaLnOGciYa Ol RsGtAaNtIeSAmTIeOnNts forN tOhTeES y TeOa ArN eDn FdOReMdI N3G0 P JAuRnTe O F2 0TH1E2 FINANCIAL STATEMENTS for the year ended 30 June 2012 Consolidated 2012 2 011 Notes $'000 $'000 5 Own-source revenue 5A. Revenue from Government CAC Act payments from DIISRTE 157,676 165,592 5B. Sale of goods and rendering of services Radioisotope sales 27,876 27,176 Services and contract research 30,668 18,699 Silicon irradiation 5,193 4,310 CSIRO site support 1,210 1,218 Training courses 260 303 Land management 3,422 3,420 Australian Synchrotron Research Project - 15 AINSE interactions 1,359 1,441 Total sales of goods and rendering of services 69,988 56,582 5C. Grants 1,674 2 ,084 5D. Interest - Bank 5,040 7,357 5E. Gains from sale of assets Proceeds from sale of assets 687 8 13 Carrying value of assets sold (515) ( 543) Gain from disposal of infrastructure, plant and equipment 1 72 2 70 5F. Foreign exchange gains - non speculative 1,831 8 32 5G. Other revenue: Other 79 2,550 Total other revenue 79 2,550 Total own-source revenue 78,784 69,675 Total revenues from ordinary activities 236,460 235,267 5H. Sales of goods and rendering of services Goods 27,876 27,176 Services 42,112 29,406 Total sales of goods and rendering of services 5B 69,988 56,582 Provision of goods to: External entities 27,876 27,176 Total sales of goods 27,876 27,176 Rendering of services to: Related entities 1,822 1,324 External entities 40,290 28,082 Total rendering of services 42,112 29,406 ANSTO ANNUAL REPORT 2011-12 PAGE 62 18 2011-12 FinAnCiAl stAteMents AnUoSTtReAsL ItAoN NaUnCLdE AfoR rSmCIEiNnCgE ApNaDr TtE CoHfN tOhLOeG FY iOnRaGnANcISiaATl IOsNtatements NfoOTrE tSh TOe AyNeDa FrO ReMnINdGe PdAR 3T0 O FJ uTHnEe F I2NA0N1C2IAL STATEMENTS for the year ended 30 June 2012 Consolidated 2 012 2 011 6 Expenses Notes $'000 $'000 The breakdown of operating expenses is: 6A. Employee benefits: Wages and salaries 8 6,628 76,671 Superannuation 1 6,111 14,776 Leave and other entitlements 1 1,947 10,578 Separation and redundancy 16 1,037 Total employee benefits 114,702 103,062 Workers compensation premiums - - Total employee benefits 114,702 103,062 6B. Supplier expenses: Goods from related entities - - Goods from external entities 33,501 28,491 Services from related entities 2 5,895 22,332 Workers compensation premiums - related 806 1,042 Services from external entities - 4,532 9,187 Operating lease rentals - external - 203 Total supplier expenses 55,670 61,255 6C. Depreciation and amortisation Depreciation of property, plant and equipment (a) 8B 77,327 70,736 Impairment of property, plant and equipment (a) 8B - 3,711 Amortisation of intangible assets - licence 8D 72 3 0 Amortisation of intangible assets - software 8D 6,674 5 ,697 Total depreciation and amortisation 84,073 80,174 6D. Write-down and impairment of assets Financial assets: Receivables for goods and services 108 3 Write-down of investment - 5,000 Non financial assets: Materials - write off obsolete stock - 238 Total write-down of assets 108 5,241 6E. Grants 5,021 6 ,225 6F. Finance costs Unwinding of discount on decommissioning costs 12,298 15,087 Interest 192 105 12,490 15,192 6G. Foreign exchange losses Foreign exchange loss - non speculative -realised 765 347 -unrealised 89 349 854 696 6H. Losses from asset sales Proceeds from sale of assets 796 1,095 Carrying values of assets sold (887) (4,246) Total losses from asset sales 91 3,151 (a) Depreciation and impairment of property, plant and equipment: The aggregate amounts of depreciation expensed and impairment during the reporting period for each depreciable class of property, plant and equipment are as follows: Buildings on freehold land 1,428 4 ,565 Plant and equipment 47,811 38,622 Infrastructure 2,645 2,815 National and major facilities 25,443 28,445 77,327 74,447 Less: Impairment - (3,711) Total depreciation and amortisation 77,327 70,736 PAGE 63 FINANCIAL STATEMENTS 19 notes to and forming part of the Financial statements AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION NfOoTrE St hTOe A NyDe FaORrM eINnG dPAeRdT O3F 0TH JEu FnINAeN C2IA0L1 S2TATEMENTS for the year ended 30 June 2012 Consolidated 2012 2011 $'000 $'000 7 Financial assets 7A. Cash and cash equivalents Cash on hand or on deposit 3,411 3,278 Total cash and cash equivalents 3,411 3,278 7B. Trade and other receivables Goods and services (a) Goods and services - related entities 258 297 Goods and services - external parties 14,101 9,250 Total receivables for goods and services 14,359 9,547 Other receivables Interest accrued 292 628 Reimbursable foreign exchange loss - - Other 848 768 Loans to related parties - - GST receivable from the Australian Taxation Office 577 787 Total other receivables (a) 1,717 2,183 Less impairment allowance account: Goods and services 108 3 Total impairment allowance (b) 108 3 Total trade and other receivables (net) 15,968 11,727 Receivable are expected to be recovered in: No more than 12 months 14,336 11,727 More than 12 months 1,632 - Total trade and other receivable (net) 15,968 11,727 (a) Total receivables are aged as follows: Age analysis of trade and other receivables (net) Current 7,881 7,182 Overdue: Less than 30 days 2,739 1,991 30 to 60 days; and 196 721 60 to 90 days - 763 More than 90 days 5,152 1,070 Total receivables (gross) 15,968 11,727 (b) The provision for doubtful debts represents certain debts aged more than 90 days (2011: aged more than 90 days). The Impairment allowance is aged as follows: Age analysis of trade debtors More than 90 days 108 3 Total impairment allowance account 108 3 Reconciliation of the Impairment Allowance Account: Opening Balance 3 15 Amount provided 108 3 Amount recovered and reversed (3) (15) Closing Balance 108 3 20 ANSTO ANNUAL REPORT 2011-12 PAGE 64 2011-12 FinAnCiAl stAteMents nAUoSTtReAsL ItAoN NaUnCLdE AfRo rSmCIEiNnCgE ApNaDr TtE CoHfN tOhLOeG FY iOnRaGnANcISiaATl IOsNtatements NfoOTrE tSh TeO AyNeDa FrO ReMnINdGe PdA R3T0 O FJu THnEe F I2NA0N1C2IAL STATEMENTS for the year ended 30 June 2012 Consolidated 2012 2011 $'000 $'000 7C. Investments Bank bills 58,500 108,000 Treasury Bonds - - Term deposit 8,889 7,268 Investment in Australian Synchrotron (a) - - Investment in PETNET Australia Pty Limited - - Total investments 67,389 115,268 (a) The investment in Australian Synchrotron Holding Company (ASHCo) of $5 million was assessed as requiring impairment testing. Due to significant uncertainty regarding future funding, the decision was taken in 2011 that the investment be impaired. 7D. Investment in subsidiaries The details of the subsidiaries of ANSTO are: Name Place of % Owned Investment Loan/Convertible Notes Incorporation 2012 2011 2012 2011 $ $ $ $ ACN 120 875 498 Pty Limited (formerly Australian Membrane Technologies Pty Limited) Australia 100% 1 1 - - PETNET Australia Pty Ltd Australia 100% 14,457,588 13,627,588 - - ANSTO Inc. Delaware U.S.A. 100% - - - - 14,457,589 13,627,589 - - ANSTO Inc. was incorporated in Delaware, USA on 27 October 1999. At 30 June 2012: US$100 (2011: US$100). of capital has been invested in this wholly owned subsidiary. This investment has been written off in prior periods. In November 2004, the Board decided to utilise ANSTO Inc to promote the commercialisation of ANSTO Technology in the USA. The loan to ANSTO Inc., $US1,870,118 (2011: $US1,470,118) was considered impaired and hence fully provided as at 30 June 2012 in the parent entity due. to ANSTO Inc.'s net assets deficiency and unlikely ability to repay the loan. ANSTO assessed the carrying value of the ANSTO investment in PETNET, including a review of the cash flow projections. The resulting PETNET valuation based on a discount rate of 14.16% (2011, 13.81%) and 14 years (2011,15 years) cash flow plus the value of cash on hand (surplus asset) was $14,458 thousand (2011, $13,628 thousand) compared to a carrying value of the investment of $13,628 thousand (2011, $17,228), giving a write up of $830 thousand (2011, impairment of $3,600 thousand). For the financial year ended 30 June 2012, the financial statements of ANSTO Inc. were audited by Galusha, Higgings & Galusha, P.C. and there were no requirements for financial statements to be prepared or audited for ACN 120 875 498 Pty Limited ( previously Australian Membrane Technologies Pty Limited) as it is a dormant company. 7E. Investment in joint venture Name Place of Incorporation % Owned Element 42 LLC Delaware U.S.A 50% Element 42 LLC. was incorporated in Delaware, USA on 1 June 2010. At 30 June 2012 ANSTO's investment was carrying value of investment: US$400 (2011: US$200). Element 42 LLC has not traded. 7F. Investment - other Name Place of Incorporation % Owned Investment 2012 2011 $ $ Clarity Pharmaceuticals Pty Ltd Australia 5% - - Advance Polymetrik Australia 4% - - - - Clarity Pharmaceuticals Pty Ltd. was incorporated in New South Wales, Australia on 17 Sept 2010. Advance Polymetrik Pty Ltd. was incorporated in Victoria, Australia on 20 Dec 2001. PAGE 65 FINANCIAL STATEMENTS 21 nAUoSTtReAsL IAtNo N aUnCLdEA fRo SrCmIENiCnEg A NpDa TrEtC HoNfO tLOhGeY FORinGAaNnIScAiTaIOlN statements fNoOTrE tS hTOe A yNeD aFOrR eMnINGd ePAdR T3 O0F JTuHEn FeIN A2N0C1IA2L STATEMENTS for the year ended 30 June 2012 Consolidated 2012 2011 $'000 $'000 8 Non-financial assets 8A. Land and buildings Land - 30 June fair value 97,200 78,700 97,200 7 8,700 Buildings - 30 June fair value 148,858 1 42,039 Less accumulated depreciation 9,144 37,395 139,714 1 04,644 Building under construction 44,490 25,820 Total buildings 184,204 1 30,464 Total land and buildings 281,404 2 09,164 8B. Infrastructure, plant and equipment and major facilities 8B(i). Plant and equipment Plant and equipment - 30 June fair value 294,808 336,232 Less accumulated depreciation 107,820 130,480 186,988 2 05,752 Plant and equipment under construction 93,201 52,826 Total plant and equipment 280,189 2 58,578 8B(ii). Infrastructure Electrical/site services facilities - 30 June fair value 28,248 29,728 Less accumulated depreciation - 10,289 28,248 19,439 Total infrastructure 28,248 19,439 ANSTO ANNUAL REPORT 2011-12 PAGE 66 22 2011-12 FinAnCiAl stAteMents AUSnTRAoLtIAeNs N tUoCL EaAnR dSC fIEoNrCEm AiNnD gTE pCHaNrOtL OoGfY OthRGeA NFISiAnTaIOnNcial statements NOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTS for thfeo yera rt ehndeed y30e Jaunre 2e01n2ded 30 June 2012 8 Non-financial assets (continued) Consolidated 2012 2 011 $'000 $'000 8B(iii). Major national and major research facilities Major national research facilities - 30 June fair value 7,128 7 ,795 Less accumulated depreciation - 1 ,070 7,128 6 ,725 Major research facilities- 30 June fair value 6,122 6 ,597 Less accumulated depreciation - 2 ,887 6,122 3 ,710 OPAL nuclear research reactor - 30 June fair value 418,802 4 57,937 Less accumulated depreciation 44 49,876 4 18,758 4 08,061 Total major national and major research facilities 432,008 4 18,496 Total infrastructure, plant and equipment and major facilities 740,445 6 96,513 Total land, buildings, infrastructure, plant and equipment and major facilities 1,021,849 9 05,677 Movement summary 2011-2012 for all consolidated assets irrespective of valuation basis (excluding intangibles) Land Buildings Total Land Infrastructure, Total and Buildings plant, equipment national and major facilities $'000 $'000 $'000 $'000 $'000 Gross value as at 1 July 2011 78,700 167,859 246,559 891,115 1,137,674 Additions - new assets - 34,443 34,443 64,206 98,649 Revaluation increment / (decrement) 18,500 22,716 41,216 50,299 91,515 Revaluation Adjustment (29,679) (29,679) (161,696) (191,375) Decommissioning Cost - 2,934 2,934 2,047 4,981 Transfers/reclassifications - (4,925) (4,925) 4,681 (244) Disposals - - - (2,343) (2,343) Gross value as at 30 June 2012 97,200 193,348 290,548 848,309 1,138,857 Accumulated depreciation/ amortisation 1 July 2011 - 37,395 37,395 194,602 231,997 Depreciation/amortisation - 1,428 1,428 75,899 77,327 Revaluation Adjustment - (29,679) (29,679) (161,696) (191,375) Adjustment for disposals - - - (941) (941) Accumulated depreciation/ amortisation 30 June 2012 - 9,144 9,144 107,864 117,008 Net book value as at 30 June 2012 97,200 184,204 281,404 740,445 1,021,849 Movement summary 2010-2011 for all consolidated assets irrespective of valuation basis (excluding intangibles) Land Buildings Total Land Infrastructure, Total and Buildings plant, equipment national and major facilities $'000 $'000 $'000 $'000 $'000 Gross value as at 1 July 2010 78,700 150,640 229,340 8 15,011 1,044,351 Additions - new assets - 16,757 16,757 54,558 71,315 Decommissioning Cost - 1,553 1,553 25,942 27,495 Transfers/reclassifications - (1,091) (1,091) 1,556 465 Disposals - - - (5,952) (5,952) Gross value as at 30 June 2011 78,700 167,859 246,559 891,115 1,137,674 Accumulated depreciation/ amortisation 1 July 2010 - 32,830 32,830 126,356 159,186 Depreciation/amortisation - 4,565 4,565 66,171 70,736 Impairment - - - 3,711 3,711 Adjustment for disposals - - - (1,636) (1,636) Accumulated depreciation/ amortisation 30 June 2011 - 37,395 37,395 194,602 231,997 Net book value as at 30 June 2011 78,700 130,464 209,164 696,513 905,677 Note: No impairment booked for property, plant and equipment for 2012 (2011: $3,711). No item of property, plant or equipment are expected to be sold or disposed of within the next 12 months. PAGE 67 FINANCIAL STATEMENTS 23 nAUoSTtReALIAN NUCLEANOTES TsO tAoND aFOnRdM Rf oSCrIEmNCiEn AND TECING PART OFg T HpEa FrINt H NoOLOGY ANCfIA tLh STe O A R TF GAN EiMnEa ISAT NTnSc IOiNal statements ffoor trhe tyheaer e nydeeda 30r J eunne 2d01e2d 30 June 2012 Consolidated 2012 2 011 $'000 $'000 8C. Inventories Raw materials and stores-not held for resale Stores - at cost 9,757 1 ,778 Cobalt-60 sources - at net realisable value 188 2 15 Reactor fuel and heavy water - at average purchase price 11,220 1 3,215 Nuclear materials - at net realisable value - - Provision for stock diminution (17) ( 95) 21,148 1 5,113 Work in progress - at cost 562 2 37 Finished goods - at cost 537 2 79 Total inventories 22,247 1 5,629 8D. Intangibles Licences at cost 1,224 1 ,224 Less accumulated amortisation 1,111 1 ,039 113 1 85 Design fees at cost 1,562 1 ,882 Less accumulated amortisation 357 3 98 1,205 1 ,484 Intellectual property at cost 1,125 - Less accumulated amortisation - - 1,125 - Software at cost 35,217 32,603 Less accumulated amortisation 26,052 1 9,659 9,165 1 2,944 Software under construction 9,192 4 ,335 Total intangibles 20,800 1 8,948 Movement summary 2011-2012 for all consolidated intangibles irrespective of valuation basis Intellectual Licenses Design Fees Property Software Total $'000 $'000 $'000 $'000 $'000 Gross value as at 1 July 2011 1,224 1,882 - 36,938 40,044 Additions - new assets - 1,655 1,125 7,227 10,007 Transfer/Reclassification - (1,975) - 244 (1,731) Gross value as at 30 June 2012 1,224 1,562 1,125 44,409 48,320 Accumulated depreciation/ amortisation 1 July 2011 1,039 398 - 19,659 21,096 Depreciation/amortisation 72 590 - 6,084 6,746 Transfer/Reclassification - (631) - - (631) Write back of accumulated depreciation 309 309 Accumulated depreciation/ amortisation 30 June 2011 1,111 357 - 26,052 27,520 Net book value as at 30 June 2012 113 1,205 1,125 18,357 20,800 Movement summary 2010-2011 for all consolidated intangibles irrespective of valuation basis Intellectual Licenses Design Fees Property Software Total $'000 $'000 $'000 $'000 $'000 Gross value as at 1 July 2010 1,009 467 - 29,310 30,786 Additions - new assets 215 1,415 - 8,566 10,196 Transfer/Reclassification - - - (465) (465) Disposals - - - (473) (473) Gross value as at 30 June 2011 1,224 1,882 - 36,938 40,044 Accumulated depreciation/ amortisation 1 July 2010 1,009 104 - 14,256 15,369 Depreciation/amortisation 30 294 - 5,403 5,727 Accumulated depreciation/ amortisation 30 June 2011 1,039 398 - 19,659 21,096 Net book value as at 30 June 2011 185 1,484 - 17,279 18,948 Note: No indicators of impairment were found for intangible assets. FINANCIAL YEAR No Intangibles are expected to be sold or disposed of within the next 12 months. Consolidated 2012 2011 $'000 $'000 8E. Other non-financial assets ANSTO ANNUAL REPORT 2011-12 PAGE 68 Deferred tax asset 1,200 - Prepayments 2,643 7 ,255 3,843 7 ,255 24 AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION NOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTS for the year ended 30 June 2012 Consolidated 2012 2011 $'000 $'000 8C. Inventories Raw materials and stores-not held for resale Stores - at cost 9,757 1 ,778 Cobalt-60 sources - at net realisable value 188 2 15 Reactor fuel and heavy water - at average purchase price 11,220 1 3,215 Nuclear materials - at net realisable value - - Provision for stock diminution (17) ( 95) 21,148 1 5,113 Work in progress - at cost 562 2 37 Finished goods - at cost 537 2 79 Total inventories 22,247 15,629 8D. Intangibles Licences at cost 1,224 1 ,224 Less accumulated amortisation 1,111 1 ,039 113 1 85 Design fees at cost 1,562 1 ,882 Less accumulated amortisation 357 3 98 1,205 1 ,484 Intellectual property at cost 1,125 - Less accumulated amortisation - - 1,125 - 2Sof0twar1e a1t cos-t 12 FinAnCiAl stAteMents 35,217 3 2,603 Less accumulated amortisation 26,052 1 9,659 9,165 1 2,944 Software under construction 9,192 4 ,335 notes to and forming part of the Financial statements fToorta lt inhtaeng yibelesar ended 30 June 2012 20,800 1 8,948 Movement summary 2011-2012 for all consolidated intangibles irrespective of valuation basis Intellectual Licenses Design Fees Property Software Total $'000 $'000 $'000 $'000 $'000 Gross value as at 1 July 2011 1,224 1,882 - 36,938 40,044 Additions - new assets - 1,655 1,125 7,227 10,007 Transfer/Reclassification - (1,975) - 244 (1,731) Gross value as at 30 June 2012 1,224 1,562 1,125 44,409 48,320 Accumulated depreciation/ amortisation 1 July 2011 1,039 398 - 19,659 21,096 Depreciation/amortisation 72 590 - 6,084 6,746 Transfer/Reclassification - (631) - - (631) Write back of accumulated depreciation 309 309 Accumulated depreciation/ amortisation 30 June 2011 1,111 357 - 26,052 27,520 Net book value as at 30 June 2012 113 1,205 1,125 18,357 20,800 Movement summary 2010-2011 for all consolidated intangibles irrespective of valuation basis Intellectual Licenses Design Fees Property Software Total $'000 $'000 $'000 $'000 $'000 Gross value as at 1 July 2010 1,009 467 - 29,310 30,786 Additions - new assets 215 1,415 - 8,566 10,196 Transfer/Reclassification - - - (465) (465) Disposals - - - (473) (473) Gross value as at 30 June 2011 1,224 1,882 - 36,938 40,044 Accumulated depreciation/ amortisation 1 July 2010 1,009 104 - 14,256 15,369 Depreciation/amortisation 30 294 - 5,403 5,727 Accumulated depreciation/ amortisation 30 June 2011 1,039 398 - 19,659 21,096 Net book value as at 30 June 2011 185 1,484 - 17,279 18,948 Note: No indicators of impairment were found for intangible assets. FINANCIAL YEAR No Intangibles are expected to be sold or disposed of within the next 12 months. Consolidated 2012 2011 $'000 $'000 8E. Other non-financial assets Deferred tax asset 1,200 - Prepayments 2,643 7 ,255 3,843 7 ,255 24 PAGE 69 FINANCIAL STATEMENTS AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION nNOoTtEeSs T tOo A NaDn FdO RfMoIrNmG PiAnRgT pOFa TrHtE o FfIN tAhNCeI AFLi nSTaAnTEcMiaENl TsSt a tements ffoorr t hteh yeea ry eendaerd 3e0n Judnee d20 1320 June 2012 Consolidated 9 Liabilities 2012 2011 $'000 $'000 9A. Interest bearing liabilities Other (a) 52 2,484 Total interest bearing liabilities 52 2,484 Provision 9B. Employee provisions Annual leave 11,202 10,267 Long service leave 20,171 18,261 31,373 28,528 Employee provisions are expected to be settled in: No more than 12 months 5,544 3,836 More than 12 months 25,829 24,692 Total employee provisions 31,373 28,528 9C Decommissioning provisions Decommissioning cost (c) 263,011 291,465 263,011 291,465 9D Other Other claims (b) 45 286 45 286 Total provision 294,429 320,279 Payables 9E Suppliers Trade creditors 14,786 11,383 Total suppliers 14,786 11,383 Supplier payables expected to be settled within 12 months Related entities 8 - External parties 14,778 11,383 Total suppliers 14,786 11,383 9F Employees Accrued salaries and wages 2,980 2,819 Redundancy payment 25 - Incentives 2,539 1,017 5,544 3,836 9G Grants Non-profit entities 481 687 481 687 9H Other Revenue received in advance 1,480 1,433 1,480 1,433 Total payables 22,291 17,339 Notes: (a) Relates to prepaid revenue under a lease of property. (b) This provision includes redundancy. (c) This provision includes decommissioning cost relating to property, plant & equipment and infrastructure and local and overseas legacy waste and current OPAL waste disposition. 9I Provision movement reconciliation Provision for Provision for Total Decommissioning Other Claims Provisions Costs $'000 $'000 $'000 Carrying amount 1 July 2010 269,517 270 269,787 Provisions not required (3,909) - (3,909) Additional provisions made 27,498 16 27,514 Amounts used (8,964) - (8,964) Change in accounting estimate (7,764) - ANSTO A(7N,7N64U) AL REPORT 2011-12 PAGE 70 Unwinding discount 15,087 - 15,087 Closing balance 30 June 2011 291,465 286 291,751 Carrying amount 1 July 2011 291,465 286 291,751 Provisions not required (2,893) (241) (3,134) Additional provisions made 4,981 - 4,981 Amounts used (5,273) - (5,273) Change in accounting estimate (37,567) - (37,567) Unwinding discount 12,298 - 12,298 Closing balance 30 June 2012 263,011 45 263,056 25 AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION NOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTS for the year ended 30 June 2012 Consolidated 9 Liabilities 2012 2011 $'000 $'000 9A. Interest bearing liabilities Other (a) 52 2,484 Total interest bearing liabilities 52 2,484 Provision 9B. Employee provisions Annual leave 11,202 10,267 Long service leave 20,171 18,261 31,373 28,528 Employee provisions are expected to be settled in: No more than 12 months 5,544 3,836 More than 12 months 25,829 24,692 Total employee provisions 31,373 28,528 9C Decommissioning provisions Decommissioning cost (c) 263,011 291,465 263,011 291,465 9D Other Other claims (b) 45 286 45 286 Total provision 294,429 320,279 Payables 9E Suppliers Trade creditors 14,786 11,383 Total suppliers 14,786 11,383 Supplier payables expected to be settled within 12 months Related entities 8 - External parties 14,778 11,383 Total suppliers 14,786 11,383 9F Employees Accrued salaries and wages 2,980 2,819 Redundancy payment 25 - Incentives 2,539 1,017 5,544 3,836 9G Grants Non-profit entities 481 687 481 687 9H Other Revenue received in advance 1,480 1,433 1,480 1,433 Total payables 22,291 17,339 Notes: (a) Relates to prepaid revenue under a lease of property. (b) This provision includes redundancy. 20(c1) T1his- p1rov2isio nF incilundes dAeconmmisCsioininAg clost reslating Ato prtopeertyM, planet & nequiptmesnt and infrastructure andlocal and overseas legacy waste and current OPAL waste disposition. notes to and forming part of the Financial statements for the year ended 30 June 2012 9I Provision movement reconciliation Provision for Provision for Total Decommissioning Other Claims Provisions Costs $'000 $'000 $'000 Carrying amount 1 July 2010 269,517 270 269,787 Provisions not required (3,909) - (3,909) Additional provisions made 27,498 16 27,514 Amounts used (8,964) - (8,964) Change in accounting estimate (7,764) - (7,764) Unwinding discount 15,087 - 15,087 Closing balance 30 June 2011 291,465 286 291,751 Carrying amount 1 July 2011 291,465 286 291,751 Provisions not required (2,893) (241) (3,134) Additional provisions made 4,981 - 4,981 Amounts used (5,273) - (5,273) Change in accounting estimate (37,567) - (37,567) Unwinding discount 12,298 - 12,298 Closing balance 30 June 2012 263,011 45 263,056 25 PAGE 71 FINANCIAL STATEMENTS AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION NOnToEtSe TsO t AoN aD nFOdR fMoIrNmG PinAgR Tp OaFr tT HoEf FtIhNAeN FCiInALa SnTcAiTaEl MsEtNaTtSe m ents fofr othre tyehaer eynedeadr 3 e0 nJudnee d20 1320 June 2012 Consolidated 2012 2011 $'000 $'000 10 Equity Contributed equity Replacement research reactor equity injections Balance 1 July 385,836 385,836 Balance 30 June 385,836 385,836 Other equity injections Balance 1 July 96,120 82,020 Equity injections from Government 7,400 14,100 Balance 30 June 103,520 96,120 Total contributed equity 489,356 481,956 Reserves, including movements Asset revaluation reserve Balance 1 July 339,108 328,456 Revaluation adjustment 129,148 10,652 Balance 30 June 468,256 339,108 OPAL depreciation reserve Balance 1 July 9,061 9,061 Balance 30 June (a) 9,061 9,061 Regional security of radioactive reserve Balance 1 July 567 939 Transferred to retained deficit (b) (339) (372) Balance 30 June 228 567 Nuclear & radiological security reserve Balance 1 July - 539 Transferred to retained deficit (c) - (539) Balance 30 June - - Low Dose Nuclear Waste Repository Balance 1 July 1,074 4,211 Transferred to retained deficit (d) - (3,137) Balance 30 June 1,074 1,074 Intermediate low level waste (ILLW) return Balance 1 July 785 - Transferred from retained deficit (e) 867 785 Balance 30 June 1,652 785 Foreign currency reserve Balance 1 July 214 13 Movement (f) (144) 201 Balance 30 June 70 214 Other reserve Balance 1 July - 139 Movement (g) - (139) Balance 30 June - - Total reserves 480,341 350,809 ANSTO ANNUAL REPORT 2011-12 PAGE 72 26 2011-12 FinAnCiAl stAteMents AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION NOnToEtSe TsO t AoN aD nFOdR fMoIrNmG PinARgT p OaFr TtH oEf F tINhAeN CFIiAnLa SnTcAiTaElM sEtNaTtSe m ents fofr othre tyehaer eynedeadr 3 0e nJudne 2d0 1320 June 2012 Consolidated 2012 2011 $'000 $'000 10 Equity (continued) Retained deficit Retained deficit 1 July (95,085) (58,404) Transfer from regional security of radioactive reserve (b) 339 372 Transfer from nuclear & radiological security reserve (c) - 539 Transfer from Low Dose Nuclear Waste Repository (d) - 3,137 Transfer to Intermediate low level waste (ILLW) return (e) (867) (785) Transfer to other reserve - 139 Transfer to foreign currency reserve - (9) (Deficit) (35,349) (40,074) Retained deficit 30 June (130,962) (95,085) Total equity 838,735 737,680 (a) OPAL depreciation reserve This reserve represents unused funding for OPAL depreciation. This was due to a delay in final commissioning of OPAL (b) Regional security of radioactive materials reserve This represents unused funding from prior years. This is due to delays in participation by some regional countries. (c) Nuclear and radiological security reserve This reserve relates to funding which started in 2009-10 and will run through up to 2010-11. (d) Low Dose Nuclear Waste Repository This reserve relates to funding for low level waste facility at ANSTO for its own use and used by other Commonwealth agencies (e) Intermediate low level waste (ILLW) return This reserve relates to unspent appropriation for ILLW return. (f) Foreign currency reserve This reserve relates to foreign currency translation at balance date. (g) Other reserves This reserve relates to ANSTO Inc. deferred tax assets.During 2010/11 the balance of this reserve was transferred to retained surplus. PAGE 73 FINANCIAL STATEMENTS 27 AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION NOnTEoSte TsO t AoN aDn FdO RfoMrINmGi nPAgR pTa OrFt ToHf Et hFIeN AFNinCaIAnLc SiaTlA sTEtaMtEeNmTSents forf toher ytehaer eynedeadr 3e0n Jduneed 2 03102 June 2012 11 Cash flow reconciliation Consolidated 2012 2011 Notes $'000 $'000 Reconciliation of Operating Surplus (Deficit) to Net Cash from Operating Activities: Operating (deficit) (35,349) ( 40,074) Non-cash items Depreciation/amortisation 84,073 8 0,174 Net write-down of Investment - 5 ,000 Net loss on disposal of non-financial assets 1,262 3 ,264 Write off obsolete stock Nuclear materials devaluation - - Unrealised foreign exchange (gain) loss 89 349 Net loss from sale of assets - - Unwinding of Discount - decommissioning costs 50,098 1 5,087 Loss on sale of subsidiary - - Changes in assets and liabilities (Increase) in trade goods and services receivables (4,710) ( 3,128) (Increase)/Decrease in other receivables (80) ( 297) (Increase)/Decrease in GST receivables 210 ( 277) (Increase)/Decrease in accrued interest 336 1 ,020 Foreign exchange (gain) (Increase) in prepayments 4,612 ( 1,029) (Increase) in inventories (6,618) ( 1,845) (Decrease) in provision for waste treatment and disposal - - Increase/(Decrease) in payables 3,314 ( 1,545) Increase in employee entitlements 4,553 4 ,062 Increase in revenue received in advance (159) 1 Increase/(Decrease) in deferred income tax (1,200) 4 33 Increase/(Decrease) in reserves - 1 6,560 Increase/(Decrease) in other provision (241) 16 Increase/(Decrease) in decommissioning cost provision (45,731) ( 26,350) Increase/(Decrease) in interest bearing liabilities (2,432) ( 1,013) Net cash from operating activities 52,027 5 0,408 12 Government funding Revenue from Government 157,676 165,592 Government equity injection 1,400 4,100 Education Investment Fund equity injection 6,000 10,000 165,076 179,692 Appropriations are made to the Department of Industry, Innovation, Science, Research and Tertiary Education (DIISRTE) which are then paid to ANSTO. ANSTO do not receive any Departmental Capital Budget (DCB). ANSTO ANNUAL REPORT 2011-12 PAGE 74 28 2011-12 FinAnCiAl stAteMents AUnSToRtAeLsIA tNo N UaCnLEAR SCIENCE AND TECHNOLOGY ORGANISATIONNOTES TO AND FORdM fINoGr mPAiRnTg O Fp TaHrEt FoINfA tNhCeIA LF SinTAaTnEcMiEaNlT sStatements forf toher y tehar een ydeda 3r0 Jeuned 2e01d2 30 June 2012 13 Board membership The members of the Board during the financial year and to the date of the report on the statements were: Term Term Member Appointed Concluded Concludes P Greenfield 25 July 2010 24 July 2014 C McLoughlin 13 March 2009 12 March 2013 A Scott 29 September 2011 28 September 2016 D Copolov 28 June 2012 27 June 2016 J Hearn 1 May 2008 30 April 2012 E Smyth 12 December 2008 11 December 2012 S Pond 1 July 2010 30 June 2014 J Ryan 24 February 2011 23 February 2016 J Raper 28 June 2012 27 June 2016 A Paterson 1 March 2009 28 February 2014 For the 2011-2012 financial year the aggregate remuneration paid to members of the Board is disclosed in Note 14. 14 Remuneration of members of the Board Consolidated 2012 2011 The number of non-executive directors of ANSTO included in Number Number these figures are shown below in the relevant remuneration bands: Remuneration between $0 to $29,999 1 1 $30,000 to $59,999 7 8 $60,000 to $89,999 1 - $120,000 to $149,999 - - Total 9 9 Total remuneration received or due and receivable by directors of the entity 320,231 309,912 Remuneration of the Chief Executive Officer is included in Note 15: Remuneration of senior executives. PAGE 75 FINANCIAL STATEMENTS 29 AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION NOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTS forn thoet yeesa rt eon daend d30 f Journme 2in01g2 part of the Financial statements for the year ended 30 June 2012 15 Remuneration of senior executives Note 15A: Senior Executive Remuneration Expense for the Reporting Period Consolidated 2012 2011 $ $ Short-term employee benefits: Salary 4,056,901 3,643,618 Annual leave accrued 276,682 254,544 Performance bonuses 454,188 534,100 Motor vehicle and other allowance 53,492 66,107 Total short-term employee benefits 4,841,263 4,498,369 Post-employment benefits: Superannuation 578,378 593,088 Total post-employment benefits 578,378 593,088 Other long-term benefits: Long-service leave 115,089 89,839 Total other long-term benefits 115,089 89,839 Termination benefits - - Total 5,534,730 5,181,296 Notes: 1. Note 15A was prepared on an accrual basis (so the performance bonus expenses disclosed above differ from the cash 'Bonus paid' in Note 15B). 2. Note 15A excludes acting arrangements and part-year service where remuneration expensed for a senior executive was less than $150,000. Note 15B: Average Annual Remuneration Packages and Bonus Paid for Substantive Senior Executives as at the end of the Reporting Period Consolidated as at 30 June 2012 Average annual reportable remuneration1 Total remuneration (including part-time arrangements): less than $150,000 $150,000 to $179,999 $180,000 to $209,999 $210,000 to $239,999 $240,000 to $269,999 $270,000 to $299,999 $300,000 to $329,999 $330,000 to $359,999 $360,000 to $389,999 $450,000 to $479,999 $480,000 to $509,999 Total Consolidated Average annual reportable remuneration1 Total remuneration (including part-time arrangements): less than $150,000 $150,000 to $179,999 $180,000 to $209,999 $210,000 to $239,999 $240,000 to $269,999 $270,000 to $299,999 $300,000 to $329,999 $330,000 to $359,999 $360,000 to $389,999 $450,000 to $479,999 $480,000 to $509,999 Total ANSTO ANNUAL REPORT 2011-12 PAGE 76 30 30 AUS2TR0ALIA1N 1NUC-L1EA2R S CFIENiCnE ANAD TEnCHNCOLOiGAY ORlGA NsISAtTIOAN teMents NOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTS for the year ended 30 June 2012 notes to and forming part of the Financial statements for the year ended 30 June 2012 Notes 1. This table reports substantive senior executives who received remuneration during the reporting period. Each row is an averaged figure based on 2. 'Reportable salary' includes the following: a) gross payments (less any bonuses paid, which are separated out and disclosed in the 'bonus paid' column); b) reportable fringe benefits (at the net amount prior to 'grossing up' to account for tax benefits); and 3. The 'contributed superannuation' amount is the average actual superannuation contributions paid to senior executives in that reportable remuneration band during the reporting period, including any salary sacrificed amounts, as per the individuals' payslips. 4. 'Reportable allowances' are the average actual allowances paid as per the 'total allowances' line on individuals' payment summaries. 5. 'Bonus paid' represents average actual bonuses paid during the reporting period in that reportable remuneration band. The 'bonus paid' within a particular band may vary between financial years due to various factors such as individuals commencing with or leaving the entity during the financial 6. Various salary sacrifice arrangements were available to senior executives including superannuation, motor vehicle and expense payment fringe benefits. Salary sacrifice benefits are reported in the 'reportable salary' column, excluding salary sacrificed superannuation, which is reported in the 'reportable salary' column, excluding salary sacrificed superannuation, which is reported in the 'contributed superannuation' column. Note 15C: Other Highly Paid Staff Consolidated as at 30 June 2012 Reportable Reportable Contributed allowances Bonus Average annual reportable remuneration1 Staff salary2&6 Superannaution3 4 paid5 Total No. $ $ $ $ $ Total remuneration (including part-time arrangements): $150,000 to $179,999 54 136,346 24,005 28 2,630 163,009 $180,000 to $209,999 16 150,308 31,447 - 13,228 194,983 $210,000 to $239,999 1 181,718 29,028 - 27,100 237,846 $240,000 to $269,999 1 251,053 15,775 - - 266,828 $270,000 to $299,999 1 217,952 41,556 - 23,300 282,808 Total 73 Consolidated as at 30 June 2011 Reportable Contributed Reportable Bonus Average annual reportable remuneration1 Staff salary2 Superannaution3 allowances4 paid5 Total No. $ $ $ $ $ Total remuneration (including part-time arrangements): $150,000 to $179,999 36 136,405 23,570 1 2,029 162,005 $180,000 to $209,999 7 159,792 21,403 - 7,786 188,981 $210,000 to $239,999 3 181,160 26,642 - 10,167 217,969 $240,000 to $269,999 2 226,919 26,603 - 2,500 256,022 $270,000 to $299,999 - - - - - - Total 48 Notes 1. This table reports staff: a) who were employed by the entity during the reporting period; b) whose reportable remuneration was $150,000 or more for the financial period; and c) were not required to be disclosed in Tables A, B or director disclosures. Each row is an averaged figure based on headcount for individuals in the band. 2. 'Reportable salary' includes the following: a) gross payments (less any bonuses paid, which are separated out and disclosed in the 'bonus paid' column); b) reportable fringe benefits (at the net amount prior to 'grossing up' to account for tax benefits); and c) exempt foreign employment income. 3. The 'contributed superannuation' amount is the average actual superannuation contributions paid to senior executives in that reportable remuneration band during the reporting period, including any salary sacrificed amounts, as per the individuals' payslips. 4. 'Reportable allowances' are the average actual allowances paid as per the 'total allowances' line on individuals' payment summaries. 5. 'Bonus paid' represents average actual bonuses paid during the reporting period in that reportable remuneration band. The 'bonus paid' within a particular band may vary between financial years due to various factors such as individuals commencing with or leaving the entity during the financial year. 6. Various salary sacrifice arrangements were available to other highly paid staff including superannuation, motor vehicle and expense payment fringe benefits. Salary sacrifice benefits are reported in the 'reportable salary' column, excluding salary sacrificed superannuation, which is reported in the 'contributed superannuation' column. PAGE 77 FINANCIAL STATEMENTS AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION NOnTEoSt TeOs A tNoD FaOnRdM INfoG rPmARiTn OgF TpHaE rFtIN oANf CtIAhLe S TFAiTnEaMnENcTSfor the year ended 30 June 2012 ial statements for the year ended 30 June 2012 16 OPAL Nuclear Research Reactor In the 2011-2012 financial year, the OPAL research reactor operated for 294 days at high power, which translates to a total availability of 80 per cent and a planned availability against the schedule of 96%. There has been a steady improvement in reactor availability over the early years of operation, with the latest result being amongst the highest in the world for research reactors. Successful production of reactor based radio-pharmaceuticals, neutron activation analysis for scientific research, and irradiation of neutron transmutation doped silicon was achieved during the year. The efficiency of the delivery of these products and services was enhanced through the ANSTO wide operational excellence initiative. The Cold Neutron Source, which supplies important low energy neutrons for research, was unavailable for about 20 per cent of the year. Further major rectification work is planned for this system in 2012-2013. The commissioning of the Heavy Water Upgrade System was completed, and the heavy water purity was increased to near optimum levels, which will assist with improved production efficiency. ANSTO plans to operate the reactor for about 270 days in 2012-2013. A six-week major shutdown is planned to commence in November 2012, to install a major new beam line for neutron scattering science purposes. 17 Insurances Insurance risks, including professional indemnity, general liability, industrial special risk for property used substantially for commercial purposes, directors and officers, and travel, are placed through Comcover, the Government's insurable risk managed fund. Workers compensation is insured through Comcare Australia and by virtue of statute under the Safety Rehabilitation and Compensation Act 1988. A Deed of Indemnity between the Commonwealth Government and ANSTO, under which the government has formally agreed to indemnify ANSTO and ANSTO Officers from any loss or liability arising from claims caused by ionising radiation, remains in place until August 2018. This indemnity does not specify that subsidiaries are included. Consolidated 2012 2011 $ $ 18 Remuneration of auditors Audit fees in relation to the financial statements for the reporting period 168,500 167,500 Grant audits 5,000 10,000 173,500 177,500 No other services were provided by the Auditor-General during the reporting period. 19 Related party disclosures Several ANSTO Board Members were associated with entities with which ANSTO had commercial transactions during the year as part of their role in hospitals or universities. All such transactions were in accordance with ANSTO's normal commercial terms and conditions. None of those transactions led to any conflict of interest. 20 Trust money Consolidated 2 0 1 2 2011 ANSTO receives monies from trade creditors as security deposits for $'000 $'000 contracts to be performed. These monies are held in a Trust Account and refunded to the respective trade creditors on satisfactory completion of the contract. Balance 1 July 7 20 Add: receipts 1 - Deduct: payments - ( 13) Balance 30 June 8 7 ANSTO ANNUAL REPORT 2011-12 PAGE 78 32 2011-12 FinAnCiAl stAteMents nAUoStTeRsA LtIAoN aNnUCdL EfAoRr mSCIiEnNgC Ep AaNrDt T oECfH tNhOeLO FGiYn OaRnGcANiaISlA sTItOaNtements fNoOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTSfor rth et hyeear yenedaedr 3 e0 Jnudnee 2d01 230 June 2012 21 Financial instruments (a) Categories of financial instruments Financial Notes Instruments Consolidated Carrying Carrying Amount Fair Value Amount Fair Value 2012 2012 2011 2011 $’000 $’000 $’000 $’000 Financial assets Loans and receivables Cash at bank 7A 3,411 3,411 3,278 3,278 Investment held to maturity 7C 67,389 67,389 115,268 115,268 Investment 7C - - - - Receivables for goods and services 7B 14,251 14,251 9,125 9,125 Loans 7B - - - - Interest accrued 7B 292 292 628 628 Other 7B 848 848 768 768 Total financial assets (recognised) 86,191 86,191 129,067 129,067 Total financial liabilities At amortised cost Trade creditors 9E 14,786 14,786 11,383 11,383 Employees 9F 5,544 5,544 3,836 3,836 Grant received in advance 9G 481 481 687 687 Interest bearing liabilities 9A 52 52 2,484 2,484 Other 9H 1,480 1,480 1,433 1,433 Total financial liabilities (recognised) 22,343 22,343 19,823 19,823 (b) Net income from financial assets Financial Notes Instruments Consolidated 2012 2011 $’000 $’000 Financial assets Loans and receivables Cash at bank 7A 124 124 Investment held to maturity 7C 4,916 7,233 Loans 7B - - Net Income from financial assets 5,040 7,357 (c) Net expenses from financial liabilities Financial liabilities At amortised cost Interest bearing liabilities 9A 192 105 Net expenses from financial liabilities 192 105 Financial assets The net fair values of cash, deposits on call and non-interest-bearing monetary financial assets are in accord with their carrying amounts. Loans receivable are carried at cost, which is above their net fair value, because it is intended to hold them to maturity. Financial liabilities The net fair values for trade creditors and revenue received in advance, all of which are short-term in nature, are in accord with their carrying amounts. (d) Credit risk exposures PAGE T7h9e FmIaNximAuNmC eIxApoLs uSrTe AtoT cEreMditE riNskT isS the risk that arises from potential default of a debtor. This is equal to the total amountof trade and other receivables as per note 7B. ANSTO has assessed the risk of the default on payment and has provided for doubtful debts account as per note 7B(b). ANSTO manages its credit risk by undertaking background and credit checks prior to allowing a debtor relationship. In addition, the Organisation has policies and procedures that guide employees to apply debt recovery techniques. The Organisation holds no collateral to mitigate against credit risk. 33 AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION NOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTS for the year ended 30 June 2012 21 Financial instruments (a) Categories of financial instruments Financial Notes Instruments Consolidated Carrying Carrying Amount Fair Value Amount Fair Value 2012 2012 2011 2011 $’000 $’000 $’000 $’000 Financial assets Loans and receivables Cash at bank 7A 3,411 3,411 3,278 3,278 Investment held to maturity 7C 67,389 67,389 115,268 115,268 Investment 7C - - - - Receivables for goods and services 7B 14,251 14,251 9,125 9,125 Loans 7B - - - - Interest accrued 7B 292 292 628 628 Other 7B 848 848 768 768 Total financial assets (recognised) 86,191 86,191 129,067 129,067 Total financial liabilities At amortised cost Trade creditors 9E 14,786 14,786 11,383 11,383 Employees 9F 5,544 5,544 3,836 3,836 Grant received in advance 9G 481 481 687 687 Interest bearing liabilities 9A 52 52 2,484 2,484 Other 9H 1,480 1,480 1,433 1,433 nTootatl efinsa ntcoia la linabdili tfieosrming part of the Financial statements f(roecro tghnisee dy)ear ended 30 June 2012 22,343 22,343 19,823 19,823 (b) Net income from financial assets Financial Notes Instruments Consolidated 2012 2011 $’000 $’000 Financial assets Loans and receivables Cash at bank 7A 124 124 Investment held to maturity 7C 4,916 7,233 Loans 7B - - Net Income from financial assets 5,040 7,357 (c) Net expenses from financial liabilities Financial liabilities At amortised cost Interest bearing liabilities 9A 192 105 Net expenses from financial liabilities 192 105 Financial assets The net fair values of cash, deposits on call and non-interest-bearing monetary financial assets are in accord with their carrying amounts. Loans receivable are carried at cost, which is above their net fair value, because it is intended to hold them to maturity. Financial liabilities The net fair values for trade creditors and revenue received in advance, all of which are short-term in nature, are in accord with their carrying amounts. (d) Credit risk exposures The maximum exposure to credit risk is the risk that arises from potential default of a debtor. This is equal to the total amount of trade and other receivables as per note 7B. ANSTO has assessed the risk of the default on payment and has provided for doubtful debts account as per note 7B(b). ANSTO manages its credit risk by undertaking background and credit checks prior to allowing a debtor relationship. In addition, the Organisation has policies and procedures that guide employees to apply debt recovery techniques. The Organisation holds no collateral to mitigate against credit risk. 33 ANSTO ANNUAL REPORT 2011-12 PAGE 80 2011-12 FinAnCiAl stAteMents nAUoStTeRAsL ItAoN NaUnCdLE fAoR rSmCIEiNnCgE ApNaDr TtE CoHfN tOhLOeG YF iOnRaGAnNcISiAaTlI OsNt atements fNoOrT EtSh TeO AND FORMING PART OF THE FINANCIAL STATEMENTSfor the year eynedead r30 e Junnde 2e0d12 30 June 2012 21 Financial instruments (cont.) (e) Liquidity risk ANSTO financial liabilities are payables and other interest bearing liabilities. The exposure to liquidity risk is based on the notion that the Organisation will encounter difficulty in meeting its obligations associated with financial liabilities. This is highly unlikely due to Australian Government Appropriation funding and mechanism available to the Organisation and internal policies and procedures put in place to ensure there are appropriate resources to meet its financial obligations. Consolidated Financial Notes Instruments 2012 Financial liabilities Trade creditors 9E Employees 9F Grant received in advance 9G Interest bearing liabilities 9A Other 9H Total financial liabilities (recognised) 2011 Financial liabilities Trade creditors 9E Employees 9F Grant received in advance 9G Interest bearing liabilities 9A Other 9H Total financial liabilities (recognised) 34 PAGE 81 FINANCIAL STATEMENTS AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION nAUoStTeRAsL tIAoN NaUnCdLE fAoR rSmCIEiNnCgE ApNaDr TtE CoHfN tOhLOeG YF iOnRaGAnNcISiAaTlI OsNt atements fNoOrT EtSh TeO AyNeDa FrO ReMnINdGe PART OF THE FINNOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTS for the year ended 30 June 20d12 30 June 2 A0N1C2IAL STATEMENTS for the year ended 30 June 2012 21 Financial instruments (cont.) 21 Financial instruments (cont.) (e) Liquidity risk (e) Liquidity risk ANSTO financial liabilities are payables and other interest bearing liabilities. The exposure to liquidity risk is based on the notion ANSTO financial liabilities are payables and other interest bearing liabilities. The exposure to liquidity risk is based on the notion that the Organisation will encounter difficulty in meeting its obligations associated with financial liabilities. This is highly unlikely that the Organisation will encounter difficulty in meeting its obligations associated with financial liabilities. This is highly unlikely due to Australian Government Appropriation funding and mechanism available to the Organisation and internal policies and due to Australian Government Appropriation funding and mechanism available to the Organisation and internal policies and procedures put in place to ensure there are appropriate resources to meet its financial obligations. procedures put in place to ensure there are appropriate resources to meet its financial obligations. Consolidated Consolidated Financial Notes Financial Notes Instruments Instruments 2012 2012 Financial liabilities Financial liabilities Trade creditors 9E Trade creditors 9E Employees 9F Employees 9F Grant received in advance 9G Grant received in advance 9G Interest bearing liabilities 9A Interest bearing liabilities 9A Other 9H Other 9H Total financial liabilities Total financial liabilities (recognised) (recognised) 2011 2011 Financial liabilities Financial liabilities Trade creditors 9E Trade creditors 9E Employees 9F Employees 9F Grant received in advance 9G Grant received in advance 9G Interest bearing liabilities 9A Interest bearing liabilities 9A Other 9H Other 9H Total financial liabilities Total financial liabilities (recognised) (recognised) 34 34 ANSTO ANNUAL REPORT 2011-12 PAGE 82 2011-12 FinAnCiAl stAteMents nAUoStTeRAsL ItAoN NaUnCdLE AfoR rSmCIEiNnCgE ApNaDr TtE CoHfN OthLOeG YF OinRGaAnNcISiAaTlI OsNt atements fNoOrT EtSh TeO AND FORMING PART OF THE FINANCIAL STATEMENTSfor the year eynedead r30 e Junnde 2e0d12 30 June 2012 21 Financial instruments (cont.) (f) Market risk - consolidated (i) Interest rate risk This refers to the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. ANSTO is exposed to interest rate risk primarily from Investment held to maturity. The impact as shown below. Consolidated Risk variable Change in variable Effect on Effect on 2012 2011 1.40% -1.40% 1.40% -1.40% Profit or Equity Profit or Equity loss loss 2012 2012 2011 2011 $’000 $’000 $’000 $’000 $’000 Investment held to maturity 67,389 71,888 Interest 1.40% 1.75% 943 943 2,017 2,017 Interest -1.40% -1.75% (943) (943) (2,017) (2,017) Interest rate sensitivity analysis has been calculated on a ‘reasonably possible’ change basis. A ‘reasonably possible’ change h as been estimated using both statistical and non-statistical analyses. The statistical analysis has been based on the cash rate for the past five years issued by the Reserve Bank of Australia (RBA) as the underlying dataset. This information is then revised and adjusted for reasonableness under the current economic circumstances. As a result of the analyses above, a standard rate of 140 basis points (2011: 175 basis points) shock level was selected as a ‘reasonably possible’ change in market interest rate. 140 basis points is managements best estimate of future volatility. (ii) Foreign currency rate This refers to the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign currency rates. ANSTO is exposed to foreign currency rate risk primarily from trade creditors. The impact only relates to assets and not profit and loss or equity. Consolidated Risk variable Change in variable Effect on Effect on 2012 2011 15.00% -15.00% 15.00% -15.00% Profit or Equity Profit or Equity loss loss 2012 2012 2011 2011 $’000 $’000 $’000 $’000 $’000 USD Currency 139 139 Foreign currency 15.00% 15.00% 21 21 21 21 Foreign currency -15.00% -15.00% (21) (21) (21) (21) The method used to arrive at the possible risk of 15% (2011, 15%) was based on both statistical and non-statistical analyses. Th e statistical analysis has been based on main currencies movement for the last five years. The two main currencies ANSTO has exposure to are USD. and EURO currencies This information is then revised and adjusted for reasonableness under the current economic circumstances. 15% (2011, 15%) is managements best estimate of future USD foreign exchange volatility. (g) Reconciliation of level 3 fair value hierarchy Investments 2012 2011 $’000 $’000 Opening balance - 5 ,000 Total gains or losses for the period recognised in profit and loss - (5,000) Closing Balance - - The investment in Australian Synchrotron Holding Company (ASHCo) of $5 million was assessed as requiring impairment testing. On the basis, ANSTO secured confirmation from the CEO of ASHCo that it only had secured funding to 30 June 2012 with a letter of comfort from the Victorian Government to 30 September 2012. On that basis ANSTO has determined that the investment of $5,000 thousand is fully impaired. PAGE 83 FINANCIAL STATEMENTS 35 notes to and forming part of the Financial statements AU NOf SoTTEr R S AL TtOh IAN NUC AeN Dy eFOa LEAR SCIENCE RrM IeNnG dPAeRdT 3 A0N DJ TECHNOLOGOF THEu FnINeA N2C0IA1L2 Y ORGANISATION STATEMENTS for the year ended 30 June 2012 Consolidated 2012 2011 $’000 $’000 22 Operating lease arrangements Payment recognised as expense Minimum lease payments 193 203 193 203 Operating lease commitments One year or less 137 137 From one to five years 685 685 Over five years 903 1,040 1,725 1,862 ANSTO has a twenty five year lease contract with Central Sydney Area Health Services that will expire on 29 Jan 2025 with an annual rental payable of $137,000 (2011: $137,000).The annual rental is subject to review every three years. 23 Income tax expense (benefit) Income tax benefit (1,200) - Reversal of Deferred Tax Asset - 345 Total income tax expense (benefit) (1,200) 345 ANSTO's subsidiaries are subject to normal taxation but are in tax loss positions. Unbooked deferred tax assets in relation to unrecouped tax losses including timing difference in the subsidiaries is $52 thousand (2011: $1,047 thousand). The total deferred tax assets recognised in relation to PETNET Australia Pty Ltd for 30 June 2012 is $1,200 thousand 24 Other comprehensive income Changes in asset revaluation reserves 129,148 10,652 Total revaluation adjustments in other comprehensive income 129,148 10,652 25 Information relating to ANSTO ('the parent entity') ANSTO only presents the financial statements on a Consolidated basis. A summary of ANSTO (parent company only) financial information is as follows: FINANCIAL YEAR 2012 2011 $ $ Current assets 99,199 141,891 Total assets 1,155,946 1,078,019 Current liabilities 25,700 21,318 Total liabilities 316,531 339,854 Contributed equity 489,356 481,956 Retained surplus (129,937) (94,387) Asset revaluation reserve 467,981 339,109 Other reserve 12,015 11,487 Total equity 839,415 738,165 Profit or loss of the parent entity (35,043) (42,156) Total comprehensive income of the parent entity 93,829 (31,504) The parent has issued the following guarantees in relation to the debts of its subsidiaries: The ANSTO's Board has passed resolutions that in the event that its subsidiaries, PETNET Australia Pty Ltd and ANSTO Inc., do not meet their obligations under the terms of the overdrafts, loans, leases or other liabilities, ANSTO will guarantee its payments. The parent has no contingent liability for 2012 (2011: nil). ANSTO ANNUAL REPORT 2011-12 PAGE 84 36 GOveRnAnCe AnD PeRFORMAnCe Compliance The functions of the Board ANSTO is subject to the provisions A Board established under Section 8 of the of various Commonwealth Acts and Australian Nuclear Science and Technology Regulations made under these various Acts Organisation Act 1987 (ANSTO Act) governs and Commonwealth Awards. ANSTO. The general functions of the Board, as set out in Section 10 of the ANSTO Act, The principal Act is the Australian Nuclear are to ensure the proper and efficient Science and Technology Organisation Act 1987. performance of the functions of the The principal Award is the Australian organisation and to determine the policy of Nuclear Science and Technology the organisation with respect to any matter, Organisation (General) Award 1990. having regard to the current policies of the Commonwealth Government. In particular, it has responsibility for: Amendments to governance parts of the AnstO Act • approval of organisational strategy and the annual business plan and budget There were no changes to the governance part of the ANSTO Act during the 2011-12 • monitoring financial performance reporting period. • monitoring managerial performance • ensuring that the significant risks facing the organisation have been identified, nuclear liability and that appropriate control, monitoring The minister executed a new Deed of and reporting mechanisms are in place. Indemnity on 27 August 2008 for a period The Commonwealth Authorities and Companies of ten-years. The indemnity commits the Act 1997 (CAC Act) requires the Board to Government to meeting any damages comply with certain accountability and awarded against ANSTO, its employees corporate governance principles, including: and its contractors for damage caused by ionising radiation whilst providing comfort • the maintenance of an Audit Committee to the local community and to ANSTO’s • specific financial and reporting suppliers, who cannot be covered by provisions ANSTO’s normal insurance arrangements and are not accustomed to being exposed • disclosure of all Board members’ to risks of this nature. Any claim would first personal interests attach to the general $50 million cover that ANSTO has with Comcover to the extent • provision of indemnities and indemnity that it was insured under that policy, with insurance in certain circumstances. the remainder covered by this indemnity All CAC Act requirements are currently agreement. being met. PAGE 85 GOVERNANCE AND PERFORMANCE Processes are in place for performance Board membership assessment of both the Board as a whole and of the individual members of the Board. During the 2011-12 financial year, the Board comprised eight non-executive members, The Board has established a Risk & Audit drawn from the broader community, who Committee and a Remuneration Committee. are not involved in the day-to-day running All matters considered by those Committees of the organisation, and the Chief Executive are submitted to the Board for information Officer. and, where appropriate, for ratification. The ANSTO Act provides that the Chief Executive Officer shall manage the affairs of the organisation, subject to the directions of, Board Charter and in accordance with, policies determined ANSTO has an established Board Charter, by the Board. Senior management attend setting out the respective rights and Board meetings as required to report on responsibilities, functions and powers of matters relevant to their individual areas of Board members and ANSTO executives. responsibility. It is made available internally on ANSTO’s Each Board member brings complementary intranet and on ANSTO’s website in line with skills and experience to the Board. Its current best practice. members during the 2011-12 financial year had experience in areas that included industry, information and communication technology, mining, scientific research, medicine and the commercialisation of research. meetings – Board member eligible to attend Attended Dr Paul Greenfield AO (Chair) 6 6 Professor David Copolov, OAM 5 5 Professor John Hearn 5 3 Ms Christine McLoughlin 6 5 Dr Susan Pond, AM 6 5 Professor Judy A Raper 0 0 Mr John Ryan, PSM 6 6 Ms Erica Smyth 6 6 Professor Andrew M Scott 6 6 Dr Adrian Paterson (Chief Executive Officer) 6 6 ANSTO ANNUAL REPORT 2011-12 PAGE 86 GOveRnAnCe AnD PeRFORMAnCe The Board meets regularly in accordance Report of operations with a formally approved timetable and agenda. Section 9 and Schedule 1 of the CAC Act requires that the Organisation’s Annual Six Board meetings were held during Report include a report of operations, the 2011-12 financial year. Details of the financial statements and the Auditor number of Board meetings attended by General’s report on those financial each member during the period in which statements. The Commonwealth Authorities each member held office during the (Annual Reporting) Orders 2011 set out the financial year are shown above. requirements for such a report. The Board reports that: Board remuneration and allowances • ANSTO’s mission and strategic directions are being actioned The remuneration and allowances of members of the Board, including the Chief • Actual performance is reported against Executive Officer, are determined by the approved performance indicators Remuneration Tribunal. Remuneration of • There have been no significant changes members of the Board is disclosed in the in ANSTO’s state of affairs or principal Financial Statements. activities during the year • ANSTO has continued to manage both Disclosure of interests of Board the risks and opportunities it faces. members The Board also reports that, in the opinion Sections 27F-27K of the CAC Act provide for of senior management and the Board, at the disclosure of material personal interests the time of making this report, adequate in a matter that is being considered by cash resources are, and will continue to be, the Board, and prohibits participation, available to cover ANSTO’s requirement for deliberation and decision making by working capital, to pay existing debts, and any member on such matters. All these meet obligations during the next financial requirements were met during the year. year. The Board states that a risk oversight and management policy and supporting Board member access to independent processes are in place to guide risk professional advice management activities in the organisation. The Board has established procedures by which members, in the interests of their duties, may seek independent professional advice at ANSTO’s expense. In brief, members must first seek permission from the ANSTO Board Chairman. PAGE 87 GOVERNANCE AND PERFORMANCE health, safety and environmental With the support of the CEO and Executive protection leadership team, ANSTO has developed a safety strategy that complements the The Board places primary importance strategic aims in the 2010-2015 Corporate on the safe performance of all ANSTO Plan. The safety strategy was developed activities. The monitoring of health, with input from across the organisation, safety and environmental protection in including Health and Safety Representatives general and compliance with relevant and trade union delegates. The strategy legislation in particular, is designated will identify key actions and programs to as a responsibility of the whole Board. deliver the strategic aims over the coming During 2011-12, ANSTO continued to focus financial years. on improving the organisational safety culture and on initiatives relating to key elements underpinning a good safety Risk & Audit Committee culture. Improvements were made to the event reporting system which has seen The Risk & Audit Committee, a formal a significant improvement in the data, sub-committee of the Board, comprised particularly from the ‘near-hit’ events. during the year of Ms C McLoughlin (Chair), This, coupled with a CEO-directed focus Professor AM Scott, Professor D Copolov on appropriate and timely investigation of OAM, Professor J Hearn, Ms E Smyth, Dr S all reported events, has driven continuous Pond AM, Mr J Ryan PSM and a member improvement in safety performance external to ANSTO, Mr W Wilton. Mr Wilton as evidenced in a significant reduction is a Chartered Accountant. The Chair of the in worker injuries. Contractor safety ANSTO Board, the Chief Executive Officer, management has also remained a key area the Chief Financial Officer, representatives of focus for the organisation, with the aim of the Australian National Audit Office, of integrating ANSTO’s contract partners Deloitte representatives (who are under into its safety culture and encouraging contract by the Australian National contractors to support ANSTO as a learning Audit Office) and the Senior Manager, organisation by sharing elements of best Governance, Risk & Audit attended all safety practice. This approach has been meetings or relevant parts of all meetings translated into a legal obligation under by invitation. Others attend meetings, the Work Health and Safety Act, which as appropriate, at the invitation of the was enacted on 1 January and represents committee. a significant change by harmonising WHS legislation across the majority of federal, state and territory jurisdictions. ANSTO prepared for the new legislation and focussed on engaging across the organisation to disseminate information relating to the changes and ensuring that its processes are compliant with the changes in legislation. ANSTO ANNUAL REPORT 2011-12 PAGE 88 GOveRnAnCe AnD PeRFORMAnCe meetings – Risk & Audit Committee member eligible to attend Attended Ms Christine McLoughlin 5 4 Professor David Copolov OAM 4 4 Professor John Hearn 4 3 Dr Susan Pond AM 5 4 Mr John Ryan PSM 5 5 Professor Judy A Raper 0 0 Professor Andrew M Scott 5 5 Ms Erica Smyth 5 5 Mr Warren Wilton (External Representative) 4 3 In accordance with good practice, all Board The committee scrutinises the annual members receive copies of the Risk & Audit financial statements of ANSTO and Committee papers and meeting minutes, considers the appropriateness of accounting and can attend committee meetings as a practices reflected therein. It receives a right. The committee has been established signed recommendation from the Chief by the Board under a formal written Executive Officer, and the Chief Financial charter to oversee the organisation’s Officer, as to the veracity of the financial risk management policies, practices statements signed by the Board. and controls in relation to financial and commercial activities, including the financial Five Risk & Audit Committee meetings were reporting process, legislative and regulatory held during the financial year. Details of the conformance, corporate governance and number of committee meetings held and asset protection. Its charter extends to attended during the period in which each the review of safety and environmental member held office during the financial year systems and performance. Additionally, are provided in the table above. in accordance with the provisions of the The committee generally meets quarterly. CAC Act, the committee is responsible for assisting Board members to fulfil their The remuneration and allowances of Board specific responsibilities under that Act. The members who are members of the Risk & committee has unlimited access to both the Audit Committee are determined by the internal and external auditors and to senior Remuneration Tribunal. The remuneration management. of the External Representative is determined by the Board on appointment. PAGE 89 GOVERNANCE AND PERFORMANCE meetings – Remuneration Committee member eligible to attend Attended Dr Paul Greenfield AO (Chair) 2 2 Mr John Ryan PSM (Member) 2 2 Remuneration Committee In July 2011 the ANSTO Board undertook an evaluation and review of its performance The Remuneration Committee, a formal which indicated that the Board is operating subcommittee of the Board, comprised efficiently and effectively. during the year Dr Paul Greenfield AO (Chair) and Mr John Ryan. The Chief Risk management Executive Officer attends all meetings or The Board is responsible for the governance relevant parts of all meetings by invitation. of risk through formal processes, Others attend meetings, as appropriate, at which include the development and the invitation of the committee. implementation of a policy and plan for This committee was established by the a systematic and disciplined approach to Board under a formal written charter to evaluate and improve the effectiveness of oversee: risk management, as well as the related internal control, compliance and governance • The overall remuneration policy and processes. Management is accountable strategy for the organisation to the Board for designing, implementing • The performance and remuneration and monitoring the system and process of policies for the Chief Executive Officer risk management and integrating it into the day-to-day activities of the organisation. • The compliance of remuneration The Board recognises that developing and policies and practices with statutory and implementing ANSTO’s strategies require regulatory requirements. careful consideration and balancing of both risk and opportunity. In this regard, the Board ensures that it understands the induction and continuing professional implications of risks taken by management, development of AnstO Directors and as well as the potential impact of risk-taking executives on ANSTO’s stakeholders. Processes are in place for induction and The Board regularly receives and reviews a ongoing education to inform directors and register of ANSTO’s key risks and ensures executives of their responsibilities and that particular attention is focussed on rights. New directors and executives have those risks that may negatively impact access to appropriate induction documents the sustainability and reputation of the and processes (including those relating to organisation. The Board also receives safety and security) and to ANSTO officers. regular assurance regarding the Under the Statement of Intent, the ANSTO implementation of the risk management Board committed to the principles of good plan and the risk management maturity of corporate governance and the efficient and ANSTO. effective execution of its duties, including an During the financial year the Board initiated evaluation and review of its performance. and participated in a full day strategic risk workshop. ANSTO ANNUAL REPORT 2011-12 PAGE 90 GOveRnAnCe AnD PeRFORMAnCe ethical standards internal audit ANSTO’s ethics policy is set out in a The ANSTO Internal Audit function has document entitled Code of Ethics. The a dual reporting line to the Risk & Audit Code provides a reference point for ethical Committee and the Chief Executive behaviour and applies to members of the Officer. Its responsibility is to provide an Board, management and all staff. The code independent, risk-based advisory and sets out the standards for ethical behaviour assurance function, as set out in a formal and conduct and provides guidance by charter periodically reviewed by the Risk defining the expected values and standards & Audit Committee and endorsed by of workplace behaviour and performance. the Board. The Risk & Audit Committee approves the annual Internal Audit plan and receives regular reports on progress against Fraud control that plan. ANSTO has an established fraud control policy, plan and related strategies, in internal control line with the Commonwealth Fraud Control guidelines and as required by the The Board is responsible for ensuring that Commonwealth Protective Security Policy appropriate policies and internal controls Framework. are in place and operating. Compliance and review are monitored through the Risk & Audit Committee and the external audit Internal Audit function. Under Section 8 of the CAC Act the Commonwealth Auditor-General, through the Australian National Audit Office (ANAO), service Charter is the external auditor for ANSTO. ANSTO’s Service Charter sets out a The ANAO, as a matter of policy, provides statement of what ANSTO does and the only audit services to ANSTO. standards of product and service that customers, stakeholders and the community The Risk & Audit Committee reviews the can expect from the organisation. ANAO audit plan and reports and meets with ANAO representatives prior to recommending to the Board that the annual financial statements be accepted and the Statement by Directors signed. PAGE 91 GOVERNANCE AND PERFORMANCE Judicial decisions and reviews by indemnities and insurance premiums outside bodies for officers There were no judicial decisions or decisions ANSTO’s insurance coverage includes of administrative tribunals that had a professional indemnity and directors’ and significant impact on the operations of officers’ liability. Certain sections of the CAC ANSTO during the reporting year. Act contain prohibitions against ANSTO giving indemnities and paying insurance There were no specific reports issued by premiums relating to liabilities arising from the Commonwealth Auditor-General, other conduct involving a lack of good faith by than that issued in relation to the 2011-12 officers. There have been no exceptions to financial statements. these provisions and no claims were made There were no reports on the operations against ANSTO in respect of such liability of ANSTO by a Parliamentary Committee or that required a claim on ANSTO’s insurer, the Commonwealth Ombudsman during the Comcover. reporting year. It should be noted that all fully owned ANSTO subsidiaries are fully covered under ANSTO’s overarching Comcover policies. ministerial directions Workers Compensation coverage is however There were no ministerial directions to dependent on whether employees of a ANSTO made under either the ANSTO Act or subsidiary are Commonwealth Government the CAC Act during the reporting year. employees or employed under state labour legislation. statement of expectations The Board approved and signed the Statement of Intent for ANSTO which acknowledges and responds to the Statement of Expectations from the responsible minister for Innovation, Industry, Science and Research. This statement recognises and ensures that ANSTO will play an active role in implementing Australia’s innovation agenda outlined in Powering Ideas: An Innovation Agenda for the 21st Century. Further, it recognises ANSTO’s commitment to undertake research and deliver outcomes relevant to the National Research Priorities, including supporting an environmentally sustainable Australia; promoting and maintaining good health; developing frontier technologies for building and transforming Australian industries; and safeguarding Australia. ANSTO ANNUAL REPORT 2011-12 PAGE 92 GOveRnAnCe AnD PeRFORMAnCe Business continuity planning Continuity of ANSTO business is a critical issue that has been considered and planned for by the Board, the Chief Executive Officer and senior management. Many services delivered by ANSTO are critical to the economic and social well-being of our society. A failure to deliver these could have significant consequences for those concerned. As a consequence, ANSTO regularly reviews all aspects of its business continuity management plans to ensure a constant state of readiness, including ANSTO’s response to any incident that may eventuate at the OPAL research reactor. A test schedule is in place and is being monitored, additionally plans are scheduled to be reviewed and updated annually. Regulatory Relationships ANSTO operates under the regulatory control of several organisations in particular, ARPANSA, Comcare and TGA. The Board is responsible for ensuring that appropriate policies and internal controls are in place to comply with the regulations. The Board recognised ANSTO’s regulatory compliance in relation to various matters throughout the year. PAGE 93 GOVERNANCE AND PERFORMANCE APPenDix 1 Equality of Employment Opportunity ANSTO’s March 2012 certified Enterprise Agreement reaffirmed the organisation’s commitment to: 1. supporting staff achieve a balance in their work and personal life including reviewed working from home and phased retirement provisions; 2. providing a positive working environment through preventing and eliminating workplace bullying and harassment; and 3. recognising the value of diversity in the workplace and making all reasonable endeavours to improve the diversity of ANSTO’s workforce, including Aboriginal Torres Strait Islander employees, employees with a disability and employees from culturally and linguistically diverse backgrounds. The Enterprise Agreement also contains extended maternity leave entitlement. Family services and Childcare Centre ANSTO continued its Corporate Family Program which is a partnership between ANSTO and Expect A Star Education Services that provide a range of family services, including parenting seminars; a range of qualified, background checked, and First Aid-trained nannies, babysitters and emergency care workers; and the purchase of educational resources. ANSTO also continued it partnership with Sutherland Shire Council for vacation care for ANSTO employees and contractors at their Lucas Heights venue during school holidays. The building of ANSTO’s Child Care facility has commenced with an expected completion date of July 2013. equality of employment opportunity for 2010-11 Number % of total Average employed staff salary Female 329 28% $ 73,204 Male 830 72% $ 90,388 People with disabilities 8 1% $ 65,782 Aboriginal & Torres Straight Islander 9 1% $ 75,203 Non-english speaking background 266 23% $ 92,403 ANSTO ANNUAL REPORT 2011-12 PAGE 94 APPenDix 2 Functions and powers of the organisation under the ANSTO Act This appendix describes the functions and powers of the organisation under the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act), which is ANSTO’s enabling legislation. In the text below, ‘Organisation’ means the Australian Nuclear Science and Technology Organisation. Section 5: Functions of the Organisation (1) The functions of the Organisation are: (a) to undertake research and development in relation to: (i) nuclear science and nuclear technology; and (ia) the application and use of nuclear science and nuclear technology; and (ii) the production and use of radioisotopes, and the use of isotopic techniques and nuclear radiation, for medicine, science, industry, commerce and agriculture; and (iii) such other matters as the Minister directs; and (b) to encourage and facilitate the application and use of the results of such research and development; and (ba) to condition, manage and store radioactive materials and radioactive waste, arising from: (i) the Organisation’s activities (including the production of radioactive materials for other persons); or (ii) the activities of companies in which the Organisation holds a controlling interest (including the production of radioactive materials for other persons); or (iii) the use by other persons of radioactive materials produced by the Organisation or such companies; or (iv) the activities of other persons who are specified in the regulations; and (bb) to condition, manage and store radioactive materials and radioactive waste generated, possessed or controlled by the Commonwealth or a Commonwealth entity; and (bc) to condition, manage and store radioactive materials and radioactive waste at the request of: (i) a law enforcement agency; or (ii) a Commonwealth, State or Territory agency responsible for the management of emergencies or disasters; including, but not limited to, radioactive materials or radioactive waste involved in, or arising out of, a radiological incident or a radiological emergency; and (bd) to condition, manage and store radioactive waste that has been, or is to be, sent to Australia under contractual arrangements relating to the conditioning or reprocessing of ANSTO spent nuclear fuel; and PAGE 95 APPENDICES APPenDix 2 Functions and powers of the organisation under the ANSTO Act (c) to produce, acquire, provide and sell goods, and to provide services, that are: (i) in connection with the production and use of radioisotopes, and the use of isotopic techniques and nuclear radiation, for medicine, science, industry, commerce and agriculture; or (ia) in connection with the conditioning, management and storage of radioactive materials or radioactive waste; or (ib) in connection with nuclear science and nuclear technology; or (ic) in connection with the application and use of nuclear science and nuclear technology; or (ii) otherwise in connection with matters related to its activities; and (d) to act as a means of liaison between Australia and other countries in matters related to its activities; and (e) to provide advice on aspects of: (i) nuclear science and nuclear technology; and (ii) the application and use of nuclear science and nuclear technology; and (iii) other matters related to its activities; and (ea) to make available to other persons, on a commercial basis, the knowledge, expertise, equipment, facilities, resources and property of the Organisation by: (i) providing training and management expertise; or (ii) selling or leasing equipment; or (iii) leasing land, buildings and facilities; or (iv) taking any other action that the Organisation thinks appropriate; and (f) to cooperate with appropriate authorities of the Commonwealth, the States and the Territories, and with other organisations and institutions in Australia or elsewhere, in matters related to its activities; and (g) to publish scientific and technical reports, periodicals and papers on matters related to its activities; and (h) to collect and sell or distribute, as appropriate, information and advice on matters related to its activities; and (j) to arrange for training, and the establishment and award of scientific research studentships and fellowships, in matters related to its activities; and (k) to make grants in aid of research into matters related to its activities; and (m) to make arrangements with universities and other educational research institutions, professional bodies and other persons for the conduct of research or of other activities in matters related to its activities. ANSTO ANNUAL REPORT 2011-12 PAGE 96 APPenDix 2 Functions and powers of the organisation under the ANSTO Act (1A) A regulation made for the purposes of subparagraph (1)(ba)(iv) must not have the effect of authorising the premises on which the Lucas Heights Research Laboratories are situated to become a national nuclear waste repository. (1B) In subsection (1A): national nuclear waste repository means a site chosen by the Commonwealth, after the commencement of this subsection, for the storage of nuclear waste with a view to it never being moved to another site. (1C) Without limiting paragraph 5(1)(bb): (a) radioactive materials and radioactive waste generated by a Commonwealth contractor under a contract between the Commonwealth contractor and the Commonwealth or a Commonwealth entity are taken to be generated by the Commonwealth or the Commonwealth entity, as the case requires; and (b) radioactive materials and radioactive waste possessed or controlled by a Commonwealth contractor under a contract between the Commonwealth contractor and the Commonwealth or a Commonwealth entity are taken to be possessed or controlled by the Commonwealth or the Commonwealth entity, as the case requires. (2) The Organisation shall not undertake research or development into the design or production of nuclear weapons or other nuclear explosive devices. (3) In undertaking its functions, the Organisation is to have regard to: (a) the Commonwealth Government’s national science, technology and energy policy objectives; and (b) the Commonwealth Government’s commercialisation objectives for public research institutions. (4) The Minister shall not give a direction under subparagraph (1)(a)(iii) to the Organisation to undertake research or development in relation to a matter unless the Minister is satisfied that research or development by the Organisation in relation to that matter would be an effective use of the staff of the Organisation, and would not duplicate unnecessarily any activity being carried on, or proposed to be carried on, by any other agency or authority of the Commonwealth. (5) The Organisation may perform its functions to the extent only that they are not in excess of the functions that may be conferred on it by virtue of any of the legislative powers of the Parliament, and, in particular, may perform its functions: (a) in so far as it is appropriate for those functions to be performed by the Organisation on behalf of the Government of the Commonwealth as the national Government of Australia; and (b) for purposes for which it is appropriate for the Parliament as the national Parliament of Australia to authorise the Organisation to perform functions; and (c) by way of expenditure of money that is available for the purposes of the Organisation in accordance with an appropriation made by the Parliament; and PAGE 97 APPENDICES APPenDix 2 Functions and powers of the organisation under the ANSTO Act (d) in the course of, or in relation to, trade and commerce with other countries, among the States, between Territories or between a Territory and a State; and (e) for purposes related to external affairs; and (f) for purposes in or in relation to a Territory; and (g) for purposes related to the defence of the Commonwealth. section 6: General powers of Organisation (1) Subject to this Act, the Organisation has power to do all things necessary or convenient to be done for or in connection with the performance of its functions and, in particular, has power: (a) to enter into contracts; (b) to acquire, hold and dispose of real or personal property; (c) to occupy, use and control any land or building owned or held under lease by the Commonwealth and made available for the purposes of the Organisation; (d) to erect buildings and structures and carry out works; (e) to form, or participate in the formation of, a company or partnership; (f) to appoint agents and attorneys, and to act as an agent for other persons; (g) to engage persons to perform services for the Organisation; (h) to design, produce, construct and operate equipment and facilities; and (j) to do anything incidental to any of its powers. (2) The powers of the Organisation may be exercised within or outside Australia. (3) To avoid doubt, the Organisation has the power to construct buildings and facilities for the sole purpose of performing the function referred to in paragraph 5(1)(ea). ANSTO ANNUAL REPORT 2011-12 PAGE 98 APPenDix 3 Environmental Protection and Biodiversity Conservation Act 1999 (EPBC Act), section 516A environmental Protection ANSTO is committed to operating in a manner that protects the environment and is consistent with Australian and international standards. ANSTO’s commitment to environmental protection and sustainability principles is defined in its OHSE Policy and Corporate and Strategic Plans which inform its social, economic and environmental core values. These priorities are integral to ANSTO’s Business Management System – the framework that defines how business is conducted to deliver outcomes to our customers and stakeholders in a safe, consistent and environmentally responsible manner. Targets and objectives for protecting human health, safeguarding our operations and minimising our environmental footprint derive from these overarching documents and are managed through documented operational and business plans. Environmental protection is formally considered when funding, planning and undertaking major capital works and any proposed radiation facilities are assessed for referral under the EPBC Act. No such referrals were made during the period. Proposals for new (or modifications to existing) facilities or processes undergo a rigorous safety, regulatory and environmental assurance process. Environmental awareness is promoted throughout the organisation through site inductions, training and communication programs. environmental management system To provide assurance that ANSTO is maintaining sound environmental protection practices, we maintain an environmental management system (EMS) that is certified to the International Standard ISO 14001. This standard requires that environmental risks and legal requirements are understood, managed and mitigated; an effective measurement and review system is in operation; and that there is an organisational commitment to continual improvement. In addition, all parts of our environmental monitoring program operate within a quality system certified to the ISO 9001:2000 standard for Quality Management Systems. environmental performance indicators ANSTO is focussing on reducing its environmental footprint by minimising waste and the consumption of resources such as paper, electricity and water, and by recycling consumables. Whilst power and water consumption increased very slightly compared to the previous year, less waste was sent to landfill and recycling increased by 45% overall. PAGE 99 APPENDICES APPenDix 3 Environmental Protection and Biodiversity Conservation Act 1999 (EPBC Act), section 516A Resource usage units 2010-11 2011-12 % Difference Electricity GWh 37.12 37.95 2.2% Water m3 280,086 283,090 1.1% Waste Disposal Waste sent to landfill tonnes 307.5 268.6 -14.5% Liquid effluent discharged to sewer m3 111,055 118,421 6.2% Recycled Waste Cardboard tonnes 20.2 21.2 4.7% Co-mingled containers tonnes 4.17 7.0 40.7 Paper tonnes No data 12.54 environmental monitoring program ANSTO conducts an extensive environmental monitoring program that measures radioactivity in authorised emissions to air and liquid effluent discharges to the sewer; and in samples of air, surface water, ground water, sediment and biota from the local environment. Environmental radiation and local weather conditions are reported online via the ANSTO webpage. Many of the monitoring results are independently verified. Results of environmental monitoring in 2011-12 demonstrate that ANSTO’s authorised releases of radioactive material to the air and sewer were effectively controlled, complied with regulatory limits and had minimal impact on humans or the environment. ANSTO’s environmental monitoring program was peer-reviewed by an international team of experts during the periodic safety review of the OPAL research reactor in 2011. The program was found to be fit-for-purpose and confirmed that the modern OPAL reactor has significantly reduced the contribution made by ANSTO’s research reactor to the already tiny potential public dose from liquid and airborne emissions. ANSTO ANNUAL REPORT 2011-12 PAGE 100 APPenDix 3 Environmental Protection and Biodiversity Conservation Act 1999 (EPBC Act), section 516A liquid effluent discharges within limits Effluent discharged from ANSTO into the sewer complied with all limits for radioactive discharges in accordance with the Trade Waste Agreement with Sydney Water Corporation. A total of 118,421 m3 of waste water (trade waste and sewage) was treated, tested and discharged. Compliance with these limits ensures that water at the Cronulla sewage treatment plant meets World Health Organisation drinking water standards for radioactivity. Concentration limits for nonradioactive materials such as ammonia, zinc and total dissolved solids were also met. Sydney Water conducts independent testing of liquid effluent discharges to sewer and the Trade Waste Agreement is periodically reviewed to provide assurance that ANSTO’s discharges remain within authorised limits and pose no threat to the environment. Effluent from the Sutherland Shire undergoes tertiary treatment at the Cronulla sewage treatment plant and is ultimately discharged to the ocean at Potter Point. Compliance with airborne discharge authorisation Air ventilated from laboratories and facilities working with radioactive materials is treated and/or filtered prior to discharge and continuously monitored at 18 locations. Stack releases from all facilities were well within the annual operating compliance limits in 2011-12. modelled dose to the public Computer modelling is used to estimate the potential radiation dose to people from operations at the Lucas Heights site. The model inputs include actual stack discharges, local weather data and conservative assumptions about environmental pathways and food consumption. The maximum public dose estimated for ANSTO’s airborne emissions in 2011-12 was 0.0018 mSv. This is 0.2 per cent of the annual public dose limit of 1.0 mSv established by ARPANSA, and slightly lower than the previous year. Doses from ANSTO’s airborne emissions in 2011-12 remain below the 0.02 mSv ALARA objective despite increased production of beneficial medical isotopes (see Figure 1). For its closest neighbours, ANSTO’s activities added less than 0.2 per cent to the 1.5 mSv dose that every Australian receives from natural background radiation each year, as shown in Figure 2. Studies carried out for marine biota in the environment at Potter Point have confirmed that the radiological risk to humans and marine life from ANSTO’s liquid effluent discharges is negligible. PAGE 101 APPENDICES Annual ALARA objective: 0.020 mSv APPenDix 3 Environmental Protection and Biodiversity Conservation Act 1999 (EPBC Act), section 516A 0G.00o22od w0.00a18ter quality Stormwater runoff from the Lucas Heights site does not contribute to any public drinking 2003-2004 2004-2005 2005-2006 2006-2007 2007-2008 2008-2009 2009-2010 20w10a-20t1e1r 2s0u11p-2p01l2y, however ANSTO regularly monitors stormwater leaving the site, as well as sampling the nearby Woronora River. Results show that concentrations of tritium in water in the local environment have decreased since the HIFAR reactor closed in January 2007, and are well below the level considered safe for Australian drinking water. Gross alpha and beta measurements were also below the levels required for surface waters under the NSW Protection of the Environment Operations Act 1997. In fact, most measurements were below the stricter levels of the Australian Drinking Water Guidelines. There is an extensive network of shallow and deep monitoring wells designed to monitor potential sources of contamination to groundwater, water quality and groundwater movement. Groundwater from the Lucas Heights site contained low levels of tritium and naturally-occurring radionuclides. 2007-2008 2008-2009 2009-2010 2010-2011 20F1ig1u-2r0e1 12: Maximum annual effective dose from LHSTC airborne discharges at the 1.6 km boundary of ANSTO’s buffer zone. Annual ALARA objective: 0.020 mSv 0.0022 0.0018 2003-2004 2004-2005 2005-2006 2006-2007 2007-2008 2008-2009 2009-2010 2010-2011 2011-2012 Figure 2: Annual dose to the general public from various sources compared to the maximum potential dose from ANSTO airborne emissions at 1.6 km in 2011-12. ~0.8 mSv from medical diagnostics ANSTO 0.0022 mSv ~1.5 mSv from natural background 2007-2008 2008-2009 2009-2010 2010-2011 2011-2012 ANSTO ANNUAL REPORT 2011-12 PAGE 102 ~0.8 mSv from medical diagnostics ANSTO 0.0022 mSv ~1.5 mSv from natural background HIFAR shutdown HIFAR shutdown APPenDix 3 Environmental Protection and Biodiversity Conservation Act 1999 (EPBC Act), section 516A Detailed reporting Reports on airborne and liquid effluent discharges are submitted to the relevant regulatory authorities on a quarterly basis. Results and findings from our environmental monitoring program are available to the public on the ANSTO website. In addition, ANSTO reports environmental radiation dose-rates recorded in the nearby suburb of Engadine via the ANSTO webpage. The local Lucas Heights weather data is also available on ANSTO’s website. ANSTO also reports annually to the Department of Sustainability, Environment, Water, Population and Communities about any of its activities that fall under the National Environmental Protection Measures. Overall, ANSTO commits significant resources to effectively monitor, manage and report on its environmental impacts and responsibilities. ecologically sustainable development (esD) ANSTO is integrating ESD principles into its management processes by including environmental risk assessments at the project planning phase. Major capital projects include environmental impact statements and environmental protection plans. We have implemented an improved building code with minimum 4.5 star NABERS rating for new and renovated office accommodation, to improve the energy and water efficiency of buildings and have installed numerous water tanks for collection of rainwater. The ANSTO building code will guide the sustainable development of the campus into the future. ANSTO activities that contribute to ESD include our research into significant environmental issues such as air quality, natural water systems and water resource management, wetland health, climate variability, and global warming impacts such as rising sea levels and temperatures. This research provides practical, science-based advice to inform decision makers, creating opportunities to conserve resources and sustain our fragile environment. We are monitoring our carbon footprint and participating in the Sustainability Advantage Program run by the NSW Office of Environment and Heritage. By utilising our assets and infrastructure more effectively, we have increased scientific productivity thereby enhancing the environmental sustainability of our operations. ANSTO’s support of nuclear non-proliferation ideals and the development of nuclear safeguards through its collaborative research with bodies such as the International Atomic Energy Agency and the comprehensive Test Ban Treaty Organisation, also accords with ESD principles. Finally, ANSTO’s commitment to sound environmental management and ecologically sustainable development means that special emphasis is placed on reducing our environmental footprint by minimising waste and the consumption of resources and by recycling consumables. It also ensures that we manage our past and current waste in a manner that protects human health and the environment, now and in the future. PAGE 103 APPENDICES APPenDix 4 Occupational Health and Safety Act 1991, section 74 / Work Health and Safety Act 2011 (Cth) (from 1 January 2012) safety commitment ANSTO is committed to ensuring a safe and healthy environment for employees, visitors, contractors and the community. ANSTO strives, through a process of continuous improvement, to fully integrate safety, health, and environment into all aspects of its activities. Safety and environmental principles, values and commitments are set out in the ANSTO Health, Safety and Environment Policy which is supported by a framework of documents that constitutes our safety management system. Key elements of the safety system are: • documented requirements and guidance • formal review and approval of potentially hazardous work • auditing and evaluation of safety performance • communication of safety issues and performance to employees, contractors and the community • encouraging reporting and an open empowered approach to talking about safety and safety behaviours. 2012 saw the introduction of harmonised Work, Health and Safety (WHS) legislation across the majority of federal and state and territory jurisdictions, hailed as the most significant change in the WHS legislative landscape in Australian history. As a result ANSTO has implemented a fundamental review and update of its safety management system to meet the requirements of the new legislation. Accidents and incidents An important part of ANSTO’s safety management system is the capturing of information on all safety-related events including accidents and ‘near hits’. This ensures the proper investigation of all such events and the implementation of safety improvements. It also provides data to drive improvements in ANSTO’s safety performance. One key indicator of ANSTO’s safety performance is its lost time injury frequency rate (LTIFR). In 2011-12 there was a slight increase from 2.6 compared to 1.6 in 2010-11. Despite this increase, ANSTO’s LTIFR remains well below the industry average. Another key indicator of safety performance is the number of Opportunities For Improvement (OFIs) reported which are regarded as an essential component of a robust safety culture and key driver for continuous safety improvement. 2011-12 saw a continued focus on increased event reporting, focussed investigation and completion of arising actions, with a 29% increase in OFIs and a consequential 14% reduction in injuries resulting in the ANSTO ANNUAL REPORT 2011-12 PAGE 104 APPenDix 4 Occupational Health and Safety Act 1991, section 74 / Work Health and Safety Act 2011 (Cth) (from 1 January 2012) loss of one or more shifts; with a total of six Lost-Shift Injuries being recorded for the full years operation. Although the trend in such injuries remains downward, ANSTO continues to focus on meeting our stated objective of Zero Harm to our workers. ANSTO also works with its regulators to improve Work Health & Safety (WHS) across the site. In 2011-12 ANSTO informed Comcare of 23 notifiable incidents. ANSTO was issued one ‘non- disturbance notice’ in 2011-12 by Comcare for a dangerous incident when an active electrical service was inadvertently damaged during excavation works for a construction project. This notice was lifted by Comcare on the same day upon site inspection confirming the incident was being appropriately managed by ANSTO. No one was injured as a result of this incident. safety initiatives The following initiatives contributed to ANSTO’s commitment to the health and safety of employees, contractors (who are now both regarded as workers under the WHS legislation), and visitors: • Improved induction processes • Worked with contract partners to ensure construction is carried out safely • Introduction of the Managing @ ANSTO program, with an emphasis on the key role of health and safety responsibilities of managers in WHS • A continued emphasis on ANSTO having a ‘reporting culture’ whereby incidents, near hits, hazards and safety observations are encouraged • Initiation of a detailed asbestos survey of individual buildings and areas and the extension of the asbestos register to include additional legacy hazards. • Roll out of a personally issued STAR card (Stop, Think, Act, Review) to all staff reminding them of ANSTO’s shared safety values and behaviours • Bimonthly safety focus that encouraged ANSTO workers to be vigilant regarding particular safety topics Through the first half of 2012, ANSTO developed a safety strategy focussing on its people, places (of work) and processes. The strategy is designed to be complementary to the 2010-2015 Corporate Plan and was developed with senior management leadership and input from across the organisation, including trades union delegates and health and safety representatives. Initiatives targeted at the health and welfare of employees included the Men’s and Women’s Health Programs, Bowel Screening and Flu Vaccination Program. PAGE 105 APPENDICES APPenDix 4 Occupational Health and Safety Act 1991, section 74 / Work Health and Safety Act 2011 (Cth) (from 1 January 2012) Australian Radiation Protection and nuclear safety Regulations 1999, statutory Rules 1999 no. 37 as amended. Everyone in the world is exposed to ionising radiation from natural sources. People may also be exposed to radiation from non-natural sources, including nuclear medical procedures for diagnosis and treatment of certain illnesses. Personal radiation exposure (‘dose’) is measured in sieverts (Sv), however, typical annual exposures are so small that they are usually expressed in units of one thousandth of a sievert, known as a millisievert (mSv). According to the most recent data from ARPANSA, the average dose an Australian receives from natural background radiation (excluding medical sources) is 1.5 mSv per year. Federal and state regulations require that a member of the public should receive no more than 1 mSv per year from radiation sources other than background radiation and medical procedures. The regulatory limit for radiation workers is 20 mSv per year, averaged over five years, with no more than 50 mSv in any one year. This is derived from recommendations made by the International Commission on Radiation Protection (ICRP), that have specified three basic principles for radiation protection, which are applied at ANSTO: 1. All exposures to ionising radiation shall have a positive net benefit 2. All exposures shall be maintained as low as reasonably achievable (ALARA), accounting for social and economic factors 3. All exposures shall be less than the relevant statutory limit. The application of these principles requires us to ensure that our occupational exposures are not just less than the statutory dose limit(s), but are as far below them as we can reasonably achieve. To this end ANSTO has imposed its own annual dose constraint of 15 mSv to any member of staff. The radiation exposure of ANSTO’s workers, who are routinely engaged in working with ionising radiation, is monitored by our specialist dosimetry service, with records of all exposures maintained. Monitoring results for 2011-12 show that the radiation doses received by ANSTO workers remain significantly below regulatory limits. In 2011-12 the average effective dose across all ANSTO workers was 0.5mSv. Table 1: Effective dose 2007-08 2008-09 2009-10 2010-11 2011-12 Maximum Effective Dose (mSv) 8.9 8.6 7.0 6.2 6.4 Average Effective Dose (mSv) 0.6 0.6 0.4 0.4 0.5 Collective Effective Dose (mSv) 531 542 399 425 431 Table 1 shows the maximum, average and collective effective doses for the past five years. Collective effective dose is the total cumulative dose to an exposed group, in this case all ANSTO personnel registered with our radiation dosimetry service. ANSTO ANNUAL REPORT 2011-12 PAGE 106 APPenDix 4 Occupational Health and Safety Act 1991, section 74 / Work Health and Safety Act 2011 (Cth) (from 1 JanuarAyn n2u0al 1A2LA)RA objective: 0.020 mSv Table 2: Distribution of individual effective dose mSv 2007-08 2008-09 2009-10 2010-11 2011-12 0 to <2 914 907 890 989 934 2 to <5 36 37 28 23 20 5 to <10 13 12 8 7 3 10 to <15 0 0 0 0.0022 0 0.0018 0 >15 0 0 0 0 0 2003-2004 2004-2005 2005-2006 2006-2007 2007-2008 2008-2009 2009-2010 2010-2011 2011-2012 Table 2 shows the distribution of individual effective doses over the same period. The graph in Figure 1 compares maximum effective dose to a single worker and the average effective dose across all relevant ANSTO workers. Figure 1: Comparison of Maximum and Average Effective Doses. 2007-2008 2008-2009 2009-2010 2010-2011 2011-2012 Regulations give annual dose limits for radiation workers for the whole body (effective dose), for the skin (shallow dose) and for extremities such as hands or feet. The respective dose limits are: • whole body 20 mSv, averaged over five years • shallow (skin) 500 mSv • extremities 500 mSv. Exposures to ANSTO workers for the last year have all been well below all statutory dose limits.   PAGE 107 APPENDICES ~0.8 mSv from medical diagnostics ANSTO 0.0022 mSv ~1.5 mSv from natural background HIFAR shutdown APPenDix 5 Freedom of Information Act 1982, subsection 8 The Freedom of Information Act 1982 (FOI Act) provides the public with a general right of access to documents held by Australian Government agencies, by requiring agencies, such as ANSTO, to publish the information and provide a right of access to the documents. This general right is limited by exceptions to protect essential public interests, including the privacy of individuals and the business affairs of those who give information to the agency. From May 2011, ANSTO has been implementing initiatives in compliance with the Information Publication Scheme (IPS) requirements of the FOI Act. The IPS is part of recent reforms to the FOI Act designed to promote open and transparent communication of government information. Set out below is the information required to be published by ANSTO under Section 8 of the FOI Act. 1. AnstO’s Agency Plan ANSTO’s Information Publication Scheme plan is currently available on the ANSTO website at http://www.ansto.gov.au/ips. ANSTO is reviewing and updating this plan. 2. Details of the structure of the Agency’s organisation An organisational chart detailing the structure of ANSTO can be found on ANSTO’s website. 3. Details of AnstO’s functions, including its decision making powers and other powers affecting members of the public Information in relation to ANSTO’s powers and functions can be found at pages 95 - 98 of this report and a link to this information including information about ANSTO’s purpose, Board composition, Corporate Plan and Research and Service Charters can be found on ANSTO’s website at http://www.ansto.gov.au/ips. 4. Details of officer appointments at AnstO Details of officer appointments can be found at page 3 - 4 of this report and a link to this information can be found on ANSTO’s website at http://www.ansto.gov.au/ips. 5. AnstO’s Annual Report A link to this annual report and annual reports of previous years can be found on ANSTO’s website at http://www.ansto.gov.au/ips. 6. Details of arrangements for members of the public to comment on specific policy proposal for which AnstO is responsible ANSTO regularly communicates with its stakeholders, which includes the local community and councils, relevant federal ministers and other government-related personnel, both state and federal, to ensure that they are kept up to date about what is happening at ANSTO. The community is kept informed of ANSTO’s operations via the website which publishes news updates such as media releases. A link to this information can be found on ANSTO’s website at http://www.ansto.gov.au/ips. ANSTO ANNUAL REPORT 2011-12 PAGE 108 APPenDix 5 Freedom of Information Act 1982, subsection 8 7. information which AnstO routinely gives access to in response to requests for access under the FOi Act (excluding documentations exempt from production under the FOi Act) During 2011-12 there was no requested documentation falling within this category. 8. AnstO’s FOi Disclosure log The FOI Disclosure Log lists information which has been released in response to a FOI access request. The disclosure log requirement does not apply to: • personal information about any person if publication of that information would be unreasonable • information about the business, commercial, financial or professional affairs of any person if publication of that information would be ‘unreasonable’ • other information covered by a determination made by the Australian Information Commissioner if publication of that information would be ‘unreasonable’ • any information if it is not reasonably practicable to publish the information because of the extent of modification that would need to be made to delete the information listed in the above dot points. A link to ANSTO’s disclosure log can be found on ANSTO’s website at http://www.ansto.gov.au/ips. 9. information held by AnstO which is provided to Parliament A link to the information which ANSTO provides to parliament can be found on ANSTO’s website at http://www.ansto.gov.au/ips. 10. Contact details of AnstO officers who can be contacted about access to information or documents under the FOi Act Direct enquiries in relation to FOI process to the Mail: FOI Coordinator ANSTO Locked Bag 2001 Kirrawee DC NSW 2232 Email to: foi@ansto.gov.au Telephone: +61 2 9717 3199 (FOI Coordinator) These contact details can be found on ANSTO’s website. 11. Operational information required under section 8 of the FOi Act, that is, information held by AnstO to assist in the performance or exercise of AnstO’s functions or powers in making decisions or recommendations affecting members of the public ANSTO has a range of publications, reports, information available for the public, including our annual reports, information on safety, research reports, educational books and leaflets, and DVDs. ANSTO also provides access to a searchable database of all of ANSTO’s science publications, as well as an online archive for older publications. PAGE 109 APPENDICES APPenDix 6 Index of Annual Report requirements Index of compliance with reporting guidelines under various Acts, Regulations and Orders applicable to ANSTO as a Commonwealth authority ANSTO Act 1987 Functions and Powers 95-98 Commonwealth Authorities and Companies Orders (Financial statements for reporting periods ending on or after 30 June 2005) under the Commonwealth Authorities and Companies Act 1997 Financial statements and reports 43-84 Commonwealth Authorities (Annual Reporting) Orders 2011 under the Commonwealth Authorities and Companies Act 1997 Board members/information about directors (clause 13) 3-4, 85-93 Certification of report of operations (clause 6) i Disclosures requirements for Government Business Enterprises (clause 20) N/A Effects of ministerial directions (clause 12) 92 Enabling legislation (clause 10) 85 Summary of objectives and functions of legislation 1-2, 95-98 Indemnities and insurance premiums for officers (clause 19) 92 Judicial decisions and reviews by outside bodies (clause 17) 92 Key activities and changes affecting the authority (clause 16) N/A Organisational structure and location of major activities and facilities (clause 14) 7-8, 121 Subsidiaries 65 Requirements under other guidelines and legislation (clause 12) Ecologically sustainable development and environmental performance 99-103 Equality of employment opportunity 94 Fraud control 91 Freedom of information 108-109 Occupational health and safety 104-107 Service charter 91 Responsible minister (clause 11) 2 Statement on governance (clause 14) 85-93 ANSTO ANNUAL REPORT 2011-12 PAGE 110 ACROnYMs ime Institute of Materials Engineering imss Institute of Materials Structure Science J-PARC Japan Proton Accelerator Research Complex KAeRi Korean Atomic Energy Research Institute KeK High Energy Accelerator Research Organisation leu Low enriched uranium llWP Local Liaison Working Party lhC Large Hadron Collider lhsTC Lucas Heights Science and Technology Centre MOu Memorandum of understanding MOx Mixed oxide neA Nuclear Energy Agency nmC National Medical Cyclotron nYsF National Youth Science Forum OAM Order of Australia Medal OeCD Organisation for Economic Co-operation and Development OPAl Open Pool Australian Lightwater reactor PeT Positron emission tomography sAns Small-angle neutron scattering sAxs Small-angle X-ray scattering seRA Safety, Environmental and Radiological Assurance sinAP Shanghai Institute of Applied Physics sTAR Small Tandem for Applied Research usA United States of America WTiA Welding Technology Institute of Australia PAGE 111 ACRONyMS The open pool design of ANSTO’s OPAL research reactor makes it easy to see and manipulate items inside the reactor pool (p.29). ANSTO ANNUAL REPORT 2011-12 PAGE 112 The OPAL research reactor building (p.29). PAGE 113 ANSTO ANNUAL REPORT 2011-12 inDex A Organisation (ANSTO) activities, 1, 17–42 accelerators, 12, 32 annual report requirements, 87 Australian National Tandem Accelerator awards, 34. 85 for Applied Research (ANTARES) Board see also Board accelerator, 1, 23, 24, 32, 41 business continuity planning, 93 Centre for Accelerator Science, 32, 41 Business Management System, 99 Large Hadron Collider (LHC), 32 businesses, 35, 36 Small Tandem for Applied Research capital investment, 41 (STAR) accelerator, 1, 21, 32, 41 chairperson’s report, 9, 10 accidents and incidents, 104 chief executive officer’s report, 11, 12 acronyms, 111 Code of Ethics, 91 Alzheimer’s disease, 19, 31 community and education, 33 ANSTO see Australian Nuclear Science and compliance, 85, 88, 90, 91, 93, 101, 108, Technology Organisation (ANSTO) 110 ANSTO Childcare Centre, 94 contact details, 121 ANSTO Eureka Prize for Innovative Use of Corporate Plan 2010-2015, 2, 9 Technology, 34 Distinguished Lecture Series, 34 ANSTO Health, 35 environmental protection, 99, 103 revenue, 16, 35 Equality of Employment Opportunity, ANSTO Minerals, 36 94 revenue, 16, 36 ethics policy, 91 ANSTO silicon, 36 Executive Team, 5 earnings, 16, 36 executives, 90 irradiation service, 36 external audit, 91 Antarctic miniature forests, 21 external revenue, 16 Arambatzis, Peter, 5 financial statements, 43–84 Arkwright, Dr John, 34 fraud control, 91 audit freedom of information, 108, 109 external, 91 functions under ANSTO Act, 95–98 independent auditor’s report, 43–4 governance and performance, 85–93 internal, 91 health, safety and environmental Austin Health protection, 88 Centre for Positron Emission highlights 2011-12, 13–15 Tomography (PET), 40 indemnities and insurance premiums, Solid Targetry Laboratory, 40 92 Australian Academy of Science, 34 innovation, 11, 27, 92 Australian Academy of Technological internal audit, 91 Sciences and Engineering (ATSE) internal control, 90, 91, 93 Clunies Ross awards, 34 international conferences and Australian Collaboration for Accelerator workshops, 34 Science (ACAS), 39 judicial decisions and reviews by Australian Drinking Water Guidelines, 101, outside bodies, 92 102 key performance indicators, 42 Australian Institute of Marine Science (AIMS), lectures, 34 17 ministerial directions, 92 Australian Museum’s 2011 Eureka Prize mission 7 People’s Choice Award, 15 neutron beam facilities, 30 Australian National Audit Office (ANAO), 91 nuclear science and technology, 1 Australian National Tandem Accelerator for organisational chart, 7–8 Applied Research (ANTARES) accelerator, 1, overview 1–2 23, 24, 32, 41 partnerships and associations, 37 Australian National University, 17 performance against strategic Australian Nuclear Science and Technology objectives, 42 ANSTO ANNUAL REPORT 2011-12 PAGE 114 inDex PETNET Solutions, 35 members, 3, 86 powers, general, under ANSTO Act, membership, 86 95–98 remuneration and allowances, 87 regulatory relationships, 93 Remuneration Committee, 90 Remuneration Committee, 86, 90 report of operations, 87 reporting guidelines, index of Risk & Audit Committee, 88, 89 compliance, 110 risk management, 90 research, 14, 15, 18–21, 23–26, 28–32, Boardman, David, 28 36–41, 86, 92, 95–97, 103, 109 Bragg Institute, 8, 38 responsible Minister, 2 brain, inflammation and diseases, 19 Risk & Audit Committee, 86. 88–89 Brain and Mind Research Institute (BMRI), 14 risk management, 87, 89–90 Bredell, Riaan, 7 role, 35, 41, 92, 105 bushfires and soil erosion, 23 science workshops, 33 business continuity planning, 93 Service Charter, 91, 108 sponsorship and events, 34 C Statement of Compliance, 2 Statement of Expectations, 92 capital investment, 41 strategic directions 2010-2015, 2 Carilli, Jessica, 22 tours, 33 CEA see French Atomic Energy Commission vision, 2 (CEA) visitors, 104–5 cell membrane studies, 19 website, 108 Centre for Accelerator Science (CAS), 1, 32, workshops, 33, 34, 39 41 Australian Nuclear Science and Technology CERN see European Organisation for Nuclear Organisation Act 1987 (ANSTO Act), 85 Research (CERN) functions and powers of ANSTO under, Chairman’s Report, 9, 10 85, 95 Chief Executive Officer’s Report, 11, 12 Australian Radiation Protection and Nuclear climate change, 21 Safety Agency (ARPANSA), 17–18, 29 carbon dating, 21 Australian Radiation Protection and Nuclear reefs affected by, 22 Safety Regulations 1999, 93, 106–107 climatic instability, 24 Australian Synchrotron, 38 flooding, 24 tropical cyclones, 24 B Cold Neutron Source System, 29 cold triple-axis spectrometer (SIKA) Banati, Professor Richard, 5 Cole, Stephanie, 5, 7 Banos, Connie, 20 Comcare, 93, 105 Bashir, Professor Marie, AC CVO, 14 Comcover, 85, 92 Beckett, Michael, 5, 7 Commonwealth Auditor-General, 91, 92 Bilby - time-of-flight SANS instrument, 29 Commonwealth Authorities and Companies Act BioGill Environmental Pty Ltd, 11, 15, 36 (CAC Act), 85, 87, 89, 91, 92 Blissett, Robert (Rob), 5, 8 Commonwealth Ombudsman, 92 Board, 7 community and education, 33 ANSTO Corporate Plan 2010-2015, 2, 9, visitors, 104–5 88, 105 compliance with reporting guidelines, 110 Charter, 86 Comprehensive Test Ban Treaty Chief Executive Officer, 86–91, 93 Organisation, 103 disclosure of interests, 87 contact details, 117 functions, 85 Copolov, Professor David, OAM, 3, 86, 89 health, safety and environmental coral, and heat stress, 22 protection, 88 Corporate Plan 2010-2015, 2, 9, 88, 105 independent professional advice, 87 Cory, Professor Suzanne, 34 meetings, 86 Cosmogenic-Exposure Dating Group, 24 PAGE 115 INDEX CSIRO, 17, 34 Environmental Radioactivity Measurement Cubbin, Douglas (Doug), 6, 8 Centre (ERMC), 13, 41 Curtin University, 26 Equality of Employment Opportunity, 94 cyclone frequency, study, 24 ethics, 91 Eureka Prizes 2011, 15, 34 D European Organisation for Nuclear Research (CERN), 2, 32, 37 Darwish, Tamim, 25 Large Hadron Collider (LHC), 32 decommissioning Evans, Senator Chris, 2, 7, 13 HIFAR reactor, 18, 33 Evans, Tegan, 28 Moata research reactor, 18 Executive Team, 5, 6 National Medical Cyclotron (NMC), 14 exposure see radiation exposure Deed of Indemnity, 85 external audit, 91 deuteration facility, 31 external revenue, 16 Dinning, Dr Philip, 34 Health business, 16, 35 Distinguished Lecture Series, 34 Minerals, 16, 36 Dodson, Professor John, 6, 8 silicon irradiation, 16, 36 e F ecologically sustainable development (ESD), family services, 94 103 financial statements, 45–84 education see community and education Flinders University, 34 Education Investment Fund, 30 Flynn, Alison, 28 Edwards, Professor Lyndon, 6, 8 forensic trace evidence, radioactive employment contamination of, 28 Equality of Employment Opportunity, French Atomic Energy Commission, 2 94 fraud control, 91 engineering/technology freedom of information, 108 accelerators, 32 associated organisations, 108 irradiation facility, 31, 36 categories of documents, 108 nuclear safety, 17, 85 facilities for access, 108 operation of OPAL and other facilities, Liaison groups, 108 29, 37, 38, 39 requests, 108 environment and climate change see also state government arrangements, 108 climate change Freedom of Information Act 1982, 108–109 Environmental and Effluent Monitoring, 100, Fujioka, Toshiyuki, 24 101, 103 Fukushima Daiichi Nuclear Power Station, environmental management system, 99, 103 17, 30 environmental performance, 101–103 marine environment study, 17 environmental protection, 99 Fulbright Professional or Senior Scholarship airborne discharge, 101 in Nuclear Science and Technology, 34 ecologically sustainable development (ESD), 103 G environmental management system, 99 environmental monitoring program, Gage, Kristian, 43, 44 100 gallium-67 (Ga-67), 30 environmental performance, 99 gamma irradiation, 20 liquid effluent discharges, 101 Gamma Technology Research Irradiator, modelled dose to the public, 101 (GATRI), 31 reporting, 103 Global Initiative to Combat Nuclear water quality, 102 Terrorism, (GICNT) Iron Koala, 18 Environmental Protection and Biodiversity global sea levels, 24 Conservation Act 1999 (EPBC Act), 99–102 global warming, 24 ANSTO ANNUAL REPORT 2011-12 PAGE 116 inDex Gnangara Mound, groundwater age International Atomic Energy Agency (IAEA), assessment, 21 17 governance and performance, 85–93 International Commission on Radiation audits, 91 Protection (ICRP), 106 Board see also Board International Science Olympiads, 34 ethical standards, 91 International Science Organisations, 9 fraud control, 91 iodine 131 (I-131), 30 internal control, 91 iodine-123 mlBG (I-123), 30 judicial decisions and reviews by ion beam analysis (IBA) research, 32, 41 outside bodies, 92 Iron Koala, Global Initiative to Combat legislation covering, 85–87 Nuclear Terrorism, 18 nuclear liability, 85 irradiation services and facility, 2, 31, 36 professional development of Gamma Technology Research executives, 90 Irradiator, (GATRI), 31 risk management, 87, 89, 90 Italian and Australian Archaeology and Service Charter, 91 Cultural Heritage Workshop Greenfield, Professor Paul, AO, 3, 11, 86 ITRAX Corescanner, 13 chairperson’s report, 9–10 Gregoire, Dr Marie-Claude, 6, 8 J Griffiths, Hefin, 5, 7 Jacobson, Dr Geraldine, 15 h Japan High Energy Accelerator Research Hamelin, Cory, 26 Organization, 2 Hatty, Claire, 19 JRR-3M research reactor, 30 Health business revenue, 16 Memorandum of Understanding (MoU), health, safety and environmental protection 39 see also environmental protection; Proton Accelerator Research Complex occupational health and safety (J-PARC) neutron spallation source, 30 Hearn, Professor John, 3, 86, 89 SPring-8 Centre, 39 Heavy Water Upgrade System, 29 Jenkinson, Shaun, 5, 8 HIFAR reactor, decommissioning, 18, 33 Jones, Paul, 5, 8 Higgins, Emeritus Professor Dame Julia, 34 judicial decisions and reviews by outside High Energy Accelerator Research bodies, 92 Organization (Japan), 2 Hodgkin’s disease, 30 K Hotchkis, Michael, 23 Hua, Quan, 21 key performance indicators, 42 hydrogen storage, 25 Koala - single-crystal Laue diffractometer, 18 i l IAEA International Working Group, 17 Large Hadron Collider (LHC), 32 project, 18 Law, Dr Michael, 15 IAEA’s Research Reactor Decommissioning Le Brun, Anton, 19 Demonstration Project (R2D2), 18 LEU (low enriched uranium), 35 indemnities and insurance premiums, 92 Levchenko, Vladimir, 23 Indemnity, Deed of, 85 Levin, Nadia, 5, 7 Institute for Environmental Research, 8, 21 LHSTC airborne discharges, 102 Institute of Materials Engineering, 8 Life Sciences, 8, 19, 37 insulated rail joints (IRJs), 27 liquid effluent discharges, 100, 101, 103 residual stresses, in, 27 Lucas Heights Storage Facility for medical Integrated Waste Management Facility, 41 and research waste, 18, 41 internal audit, 91 Ludwig Institute for Cancer Research, 12, 40 PAGE 117 INDEX Lumpkin, Greg, 26 instruments under construction, 30 Luzin, Vladimir, 27 Nuclear Forensics Research Facility, 28 Lyras, Con, 6, 8 nuclear liability, 85 nuclear materials, identification, 28 m Nuclear Materials Security Index Report, 17 nuclear medicines, 2, 30 McLoughlin, Christine, 3, 86, 89 see also radiopharmaceuticals Macquarie University, 39–40 nuclear plant breakdown in Japan, 17, 30 Department of Earth and Planetary nuclear safety, 17, 106 Sciences, 40 Nuclear Materials Security Index mango industry and gamma irradiation Report, 17 study, 20 nuclear waste, 2, 41, 97 materials biotech, 31 O nano, 31 nuclear waste, 41, 97 occupational health and safety radioactive, 36 accidents and incidents, 104 radiological and nuclear, identification emergency preparedness and of, 28 responses, 95 Membrane bioreactor and sewage safety commitment, 104 treatment technology, 15, 36 safety initiatives, 105 Meredith, Karina, 21 Occupational Health and Safety Act 1991, 104, microelectronics, 1 105 minerals OPAL see Open Pool Australian Light-water ANSTO revenue, 16, 36 Reactor (OPAL) Minerals Precinct Facilities, 41 Open Pool Australian Light-water Reactor minerals industry, 2 (OPAL), 15, 29 radioactive materials, 2 building project, 41 Minister for Tertiary Education, Skills, Science facilities, 30, 37–39 and Research, i,2,13 neutron beam instruments, 30 Moata research reactor decommissioning, operation, 29 18 safety, 29 molybdenum-99 (Mo-99), 16, 30, 35 use, 1, 29–31, 38, 39, 42, 93, 100 export of, 35 Organic light-emitting diodes (OLEDs), 25 Monash University, 38–39 Multiple sclerosis disease, 19 P n Parkinson’s Disease, 31 partnerships and associated organisations, National Deuteration Facility, 31 37 National Environmental Protection Paterson, Dr Adrian (Adi), 4, 5, 7, 34, 86 Measures, 103 chief executive officer’s report, 11–12 National Imaging Facility Research Cyclotron, Pelican - time-of-flight spectrometer, 30 14 performance against strategic objectives, 42 National Research Priorities, 92 Peterson, Vanessa, 15 National Science Week, 33–4 PETNET Solutions, 35 National Youth Science Forum (NYSF), 34 Platypus - neutron reflectometer, 19 Naude, Kobus, 5, 7 Pond, Dr Susan, AM, 3, 86, 89 neuroinflammation studies, 19 neutron beam instruments, 30 Q neutron diffraction, 27 neutron relfectometry, 12, 25 Quality Management Systems, 99 synthesised deuterated molecules, 25 Queensland Department of Employment, neutron scattering, 30 Economic Development and Innovation, 20 ANSTO ANNUAL REPORT 2011-12 PAGE 118 inDex Queensland University of Technology, 27 Assurance (SERA) Team, 13 Quokka - small-angle neutron scattering Science Workshops for Kids, 33 instrument (SANS), 38 Scott, Professor Andrew M, 4, 86, 89 Service Charter, 91, 108 R sewage treatment technology, 15 Shoko, Elvis, 25 radiation exposure, 28, 106 silicon irradiation revenue, 16, 36 ANSTO workers, 106 small-angle neutron scattering instrument contamination, 28 (SANS), 29, 38 detection systems, 28 time-of-flight SANS instrument (Bilby), dose limits, 107 29 International Commission on Radiation small-angle X-ray scattering (SAXS) beamline, Protection (ICRP), 106 38 protection services and advice, 36 Small Tandem for Applied Research (STAR) radiation services, 36 accelerator, 1, 21, 32, 41 radiation-tolerant materials, developing, 26 Smyth, Erica, 4, 89 radioactive waste soil erosion management facility, 18 bushfire-effected, 23 radioisotopes labelling, 12 SPring-8 Centre, 39 radiopharmaceuticals staff achievements, 15 exports, 30, 40 Storr, Dr Greg, 6, 7 gallium-67, 30 Sutherland Shire Australia Day events, 34 iodine-123, 30 Sydney Water, 101 iodine-131, 30 synchrotron 38 Mo-99, 16, 30, 35 Synchrotron and Neutron New Users PETNET Solutions, 35 Symposium, 38 production facilities, 30 US radiopharmaceuticals (USR), 40 T Raper, Professor Judy A, 4, 86, 89 Reinhard, Mark, 28 Tasmanian megafauna study, 23 Remuneration Committee Protemnodon anak (a giant wallaby), 23 meetings, 90 technetium-99m (Tc-99m), 30 members, 86, 90 time-of-flight SANS instrument (Bilby), 29 Remuneration Tribunal, 87, 89 time-of-flight spectrometer (Pelican), 30 reporting guidelines, 110 Trade Waste Agreement, 101 revenue, 16 Health business, 16, 35 u Minerals, 16, 36 silicon irradiation, 16, 36 Ultimate Science Guide, 33 Risk & Audit Committee, 86, 88, 89, 91 University of Canberra, 28 establishment, 86 University of Melbourne, 23 function, 89 University of Plymouth, UK, 23 meetings, 88–9 University of Queensland, 25 members, 88–9 University of Sydney, 19–20 risk management, 87, 89, 90 Brain and Mind Research Institute Robinson, Dr Robert (Rob), 6, 8 (BMRI), 14 Ryan, John, PSM, 4, 86, 89 Memorandum of Understanding (MoU), 39 s University of Technology, Sydney, 28 University of Wollongong, 21, 24, 27 safety see also occupational health and uranium safety low enriched (LEU), 35 initiatives, 105 US Radiopharmaceuticals, Inc, 40 Safety, Environmental and Radiological PAGE 119 INDEX v visitors, 104-5 W water cleansing technology, 11, 15, 36 welds, study of effects, 26 Whittle, Karl, 26 Wilton, Warren, 89 workshops, 33, 34, 39, 41 ANSTO ANNUAL REPORT 2011-12 PAGE 120 COntACt DetAils AnstO Canberra New Illawarra Road, Lucas Heights ANSTO representative New South Wales 2234 Australia Level 7, 15 London Circuit GPO Box 1620 Postal Address Canberra ACT 2601 Locked Bag 2001 T + 61 2 62758300 Kirrawee DC NSW 2232 Telephone vienna +61 2 9717 3111 Counsellor (Nuclear) Facsimile Australian Embassy +61 2 9717 9210 Mattiellistrasse 2-4 A-1040 Vienna email Austria enquiries@ansto.gov.au T + 43 1 5067 4119 Website www.ansto.gov.au Annual Report on the web www.ansto.gov.au Public information ANSTO produces regular updates on its science and technology, has available a range of publications and conducts free tours of its site. For bookings, information or to get on our database, call +61 2 9717 3111 or email enquiries@ansto.gov.au © Commonwealth of Australia 2012 This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced by any process without prior written permission from the Commonwealth. Requests and inquiries concerning reproduction and rights should be addressed to the Commonwealth Copyright Administration, Attorney General’s Department, Robert Garran Offices, National Circuit, Barton ACT 2600 or posted at www.ag.gov.au/cca PAGE 121 CONTACT DETAILS street Address: New Illawarra Road, Lucas Heights NSW 2234 Postal Address: Locked Bag 2001, Kirrawee DC NSW 2232 Telephone email +61 2 9717 3111 enquiries@ansto.gov.au Fax Website +61 2 9543 5097 www.ansto.gov.au